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ABSTRACT
Jack F. Bukowski, Ph. D. Immnology, August 1984, University of
Massachusetts Medical School.
Definitive evidence that natural killer (NK) cells mediate an
antiviral effect in vivo was obtained using nurine cytomegalovirus
(MCMV) as a- model system. Adopti ve transfer studies usi n9 a variety
of p sical and immnochemical techni es to enrich and deplete NK
cell activity showed that the cell population capable of mediating
resistance (as assayed by enhanced survival and reduction in spleen
vi rus ti ters) had the phenotype of an NK cell: a nylon wool
+ -
nonadherent, aSlalo GMl , NK 1. 2 , Ly 5 , Thy-1 , Ia ,
1 ow-density lymphoc te. Adopti ve transfer of IL- dependent cloned
NK cells (but not T cells) also provided resistance. NK cells did
not provide resistance to lymphocytic choriomeningitis virus (LCMV).
Selective depletion of NK cell activity by injection of mice
with antibody to anti-asialo GMllowered resistance to MCMV, mouse
hepatitis virus, and vaccinia virus but not to LCMV. NK cell
depletion resul ted in up to lOOO- fol d increases in spl een and 1 i ver
vi rus ti ters, correlating wi th more severe pa thol ogy in these
orgns. NK cells were found to have antiviral effects early (0-
days) but not late (6- 9 days) postinfection. NK cell depl etion
reSul ted in lI rkedly increased MCMV- induced suppressi on of T cell
function, which is probably responsible for the delayed clearance of
virus seen in these mice. NK cell depletion resulted in increased
virus synthesis during persistent MCMV infection, but had no effect
, '
on the course of persistent LCMV infection, despite elevated NK cell
and interferon (IFN) levels found in these LCMV- infected mice. The
reason why NK cells playa role against MCMV but not LCMV infection
was not due to differences in NK cells induced by these 2 viruses,
but IIre likely due to target cell susceptibility. IFN pretre tmnt
of MCMV- infected cells failed to protect them against NK
cell-mediated lysis, whereas uninfected and LCMV- infected cells were
almost totally protected. These IFN- pretre ted, LCMV- infected cell s
were not resistant to cell-mediated lysis in general , as this
tre tmnt incresed thei r sensi ti vi ty to vi rus-speci fic T
cell-mediated lysis by 2- fold. This enhanced sensitivity to lysis
correlated with increased surface expression of H- 2 antigens, but
not vi rc 1 a nti gens. In summry, these studies provide compelling
evidence that NK cells can mediate antiviral effects in vivo, and
provide some insights into their mode of action and conse~ences of
their disfunction.
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CHAPTER 1
Introducti on
Characteristics of NatUral Killer (NK) Cells
Natural killer (NK) cells (1) are medium to large granular
lymphocytes (2) possessing the capabil ity to lyse certin types of
target cells both in vitro (1) and in vivo (3). They have been
found in every DBDllian species examined so far, including DBn (4),
mouse (5), hamster (6), and rat (7). NK cells do not re~ire prior
exposure to target cells in order for lysis to occur and do not
exhibit immnologic memory (1). The basis of NK cell recognition of
target cells is unknown, but is the subject of intense investigation
in IBny laboratories. NK cells do not adhere to plastic or to nylon
wool (5), which distinguishes them from macrophages. They do not
ber surface inmnoglobulin (8), as do B cells, nor do they possess
the T cell antigens Ly 1 or Ly 2 (9). They possess low ~antities
of surface thy- 1 antigen (10), but are present in T cell-deficient
In the mouse, NK cells are present at high levels in the
athymic nude mice (11), indicating that they are distinct from
classically defined T cell s. They bea r Fc receptors for IgG (12),
and have the ability to recognize and destroy antibody-coated
ta rgets by hi ndi ng the Fc porti on of I gG (13). NK cell s bea r hi 
~antities of the neutral glycosphingolipid asialo GM1 on their
surfaces (14), as well as NK alloantigens (15).
, "' : ,
peripheral blood and spleen, and at lower levels in the bone marrow,
lymph nodes, lungs, and peritoneum; NK cell activity is absent in
the thymus (1,5). Newborn mice have low NK cell activity until 4
weeks of age. Peak NK cell activity occurs at 4- 10 weeks of age,
and declines thereafter in "the spleen 0, 5), but less markedly in
the peri phera 1 blood (16).
Because of their apparent nonspecificity and their ability to
efficiently lyse tumor cells on contact without prior sensitization,
NK cells may represent a first line of defense against tumor cells.
The evidence for a role of NK cells in mediating tumor surveillance
now overwhelmingly supports the concept. Ea r1y evi dence
demonstrated a correlation between high HK cell activity and tumor
resistance. Mice whose NK cell activity is low due to genetic
predisposition, age, nonspecific immnosuppression, or the beige
mutation have deficiencies in resisting tumor implants and
control 1 i ng metastases (17- 19). In syngeneic systems, there is a
good correlation between in vitro sensitivity of tumor cells to
lysis by NK cells and their ability to be rejected in vivo (17, 19).
More recent evidence showing that selective depletion of NK cell
activity by injection of antibody to asialo GM1 (20) or to NK 1 (21)
resul ts in increased tumor growth and decreased cl ea rance of tumor
cell s consi derably strengthened the hypothesi s that NK cell s had an
antitumor role. Definitive evidence for this hypothesis was
obta ined in adopti ve transfer studi es when NK cell-depl eted mice
reconsti tu ted wi th NK cell-conta i ni ng spl een cell s resi sted tumor
growth while those given NK cell-depleted spleen cells did not
-- - . .- - ::. . -. . . '- .- - - . _ ::: - -, ---- - -- - .- -
(3, 22).
Despi te progress made in assessing the rol e of NK cell s in
tumor su rveillance, the rol e of NK cell s in vi rus i nfecti ons has not
been definitively determined until now, and is the subject of this
thesi s.
Characteristics of Interferon (IFN)
The interferons are a group of glycoproteins first described by
Isaacs and Undenmann as having the ability to protect cells against
virus infections (23). There are 3 mjor types of interferon (IFN),
but each of these is presently being divided into subtypes based on
DNA setJence and biological function using homogeneous preparations
of cloned IFN's. The 3 major subtypes have so far been shown to
behave similarly in biological assays and are classified as follows
(reviewed in 24): type alpha is produced by leukocytes in response
to stioulation with viruses or polynucleotides, wheres type beta is
produced by fibroblasts and epithelial cells in response to these
same stinula tors. Type gamm is prockced by lymphocytes undergoing
immne stimulation by antigen or stimulation by plant lectins.
Biological effects mediated by IFN have been described
extensively (reviewed in 24), but will be dealt with more thoroghly
in a subse~ent secti on.
NK Cell s as Mediators of Host Resistance to Vi rus Infections--
an Hi stori ca 1 Perspecti ve
In 1977 a number of investigators (25-28) reported that virus
infections in mice rapidly augmented the lytic activity of
non-specific lymphocyte effector cells tenned IInatural killer cells
by Kiesslinget ale (1). These activated NK cells have 
incresed
target cell range (25, 29), enhanced kinetics of lysis (30), and an
abil i ty to kill over and over aga in (31). It was noted that NK cell
activation closely paralleled the appearance of virus-
induced IFN
(32), and subsequent experiments demonstrated that IFN by itself was
capabl e of activa ting NK cell s (32, 33) and causi ng thei r
blastogenesis (34). These observations led to speculation that NK
cells may be playing a role in natural resistance to VlruS
i nfecti ons, consti tu ti ng a fi rst 1 i ne of defense, several days
before antigen-specific T cells and B cells are mobilized. A large
body of circumstantial evidence for this 
~pothesis exists in
several virus systems, but until now, no one has been able to
convincingly demonstrate an antiviral role for NK 
cells.
Several lines of evidence support a role for NK cells in
resistance to virus infections. Strains of mice with genetically
high NK cell activity have increased resistance to infection with
cert in vi ruses such as herpes simplex type 1 (HSV- 1) (35), and
IIrine cytomegalovirus (MCMV) (36) as compared to mice with
genetically low NK cell activity. Nonspecific immnosuppression by
cyclophosphamide and cortisone results in 
incresed severity of
HSV- l (35) and MCMV (37) infections before virus-specific T and B
cells are detectable in control, vinas- infected mice. Newborn mice,
whose NK cell activity is low, are susceptible to MCMV (38, and
mose hepatitis virus (ttV) (39, 40) until 3- 4 weeks of age, at which
time NK cell activity matures 0,5). In som virus systems, NK
cells can lyse virus- infected cells more efficiently than uninfected
. ..
cells (35,41). Each of these lines of evidence will now be
discussed in detail.
Kumar and Bennett (42) noted a correlation between resistance
to Friend leukemia virus (FLV) and resistance to bone marrow
allografts. The latter type of resistance was first described by
Cudkowicz et ale (43, 44), who demonstated that the cell responsible
for the rejection of bone ma rrow allogra fts was itsel f dependent on
an intact bone ma rrow envi ronment, and was genetically detennined by
two dominant loci outside the H-2 complex. This system of
resistance, tenned the hematopoietic histocompatability (Hh) syste,
s mediated by a type of lymphocyte tennd a narrow-dependent (M)
cell, which bore no similarity to classically defined T cells.
Meanwhile, Kiessling et al examined the inheritance pattern of NK
cell activity in mice, and found that this pattern was similar to
that described for the Hh system (45), indicating that the M cell
and the NK cell nay be the same, and since stniins with genetically
high NK cell activity are more resistant to FLV infections than
those with low NK cell activity (42), the evidence, though only
correlative, suggests that NK cells may be mediating resistance to
FLY. Similar evidence inki ngthe abil i ty to reject bone ma rrow
allognifts with resistance to infection was obtained by Lopez (35)
using HSV-
Another line of evidence which correlates the genetics of
resistance to virus infections with the genetics of NK cell activity
is the work of Shellam and his colleagues in the (MCMV) system
(36). Mice with genetically hi h NK cell activity were more
resistant to the lethal effects of MCMV than mice with genetically
low NK cell activity. Further work indicated that mice homozygous
for the beige nutation (bg/bg), a condition resulting in low NK cell
activity, were more susceptible to MCMV than heterozygous (bg/+),
phenotypi ca lly norml mice wi th hi gh NK cell acti vi ty (46).
Transfer of bone ma rrow cell s from bg/+ donors to bg/bg recipients
conferred resistance upon the recipients challenged 8 weeks later
wi th MCMV , indica ti ng that resi stance wa s mediated by a bone
marrow-derived cell from bg/+ mice. These data indicated a good
correlation between the presence of high NK cell activity and
resistance to MCMV. However, the beige nutation, though more
selective in its imnnosuppressive effects than cortisone and
cyclophosphamide treatmnts, is not completely selective for NK cell
function , as other imnne functions such as neutrophil and platelet
functions are abnonJ 1 (47). Because several il1ne functions are
affected by the beige nutation, it was not certin which one was
responsible for the resistance against MCMV.
Another piece of cin:umstantial evidence implicating NK cells
as mediators of resistance to virus infections is the time fralE
wring whi ch ani ma 1 s become sic k. Aci 1 t mi ce gi ven 1 a rge doses of
MCMV (46) or HSV- 1 (35) exhi bit ma rked genetic di fferences in
suscepti bil i ty wi thin 2 days of inocula tion, and suscepti ble .ice
, "
111 '
die between 3 and 7 days postinfectio
. Two days postinfection
falls before that time during which specific 
;mnne responses such
as vi rus-speci fic cytotoxic T cell s (CTL) (48) and anti bodies (49)
a re detectable. Even more suggesti ve is the 
fact that newborn mice
suddenly acqui re resi stance to MCMV (39) and (MHV) (40) between 3
and 4 weeks of age, correlating with the 
developmnt of NK cell
activity (1,5).
There is also a body of evidence which suggests that NK cells
do not playa role against virus infections such as Sindbis and LCMV
(50,51), despite the ability of these viruses to activate NK cells
in vivo (32,51). NK cell-deficient beige mice did not exhibit
greater sensitivity to LCMV (50), or Sindbis (51) infection than
control mice. Radiation or cyclophosphamide treatments did not
increse virus titers in mice persistenly infected with LCMV (52).
There is no indication that genetically high NK 
cell activity
confers upon mice resistance to LCMV (53).
One potential mechanism whereby NK cells could mediate antiviral
effects is by preferential lysis of virus-
infected cells. There are
several ways this can happen. Santoli et ale (54
55) showed that
increased in vitro NK cell-mediated lysis of influenza-and
HSV- i nfected cell scan occu r as a resul t of IFN inooction and
subse~ent activation of endogenous NK cells during 16 hour
cytotoxicity assays, but not during shorter assays. This has also
been shown to occur in the mouse system (56). However, enhanced
lysis of virus-infected cells by endogenous NK cells in culture is
not always due to IFN, as Lee and Keller 
(41) demonstrated tht
MCMY- infected fi broblasts a re killed by endogenous spl een cells more
efficiently than uninfected fibroblasts in the absence of detectable
IFN. MCMV- infected fi broblasts a re innately less sensitive than
uninfected fibroblasts to lysis by prectivated NK cells (36), so
perhaps the endogenous NK cell s in cul tu re a re being activa ted by an
IFN-independent mechanism. Viral glycoproteins from mumps (57) and
measles (58) viruses have been shown to activate human NK cells
independent of IFN. This activation could lead to enhanced lysis of
virus- infected cells. Enhanced binding of NK cells to
virus-infected targets has been reported in the human system with
Epstein-Barr virus (59), and in the mouse system with Sendai virus
(56), but this enhanced binding does not always lead to enhanced
lysis, as Sendai- infected L-929 cells are actually more resistant to
NK cell-mediated lysis despite the fact that they bind NK cells
better (56).
Virus infection may somehow increase the innate sensitivity of
a target cell to NK cell-mediated lysis, but this has not been
convincingly demonstrated (60). More often it is observed that
virus infection actually decreses the susceptibiltiy of target
cells to lysis by previously activated NK cells. This has been seen
with MCMV (36), Sendai, Sindbis, and vesicular stol1titis virus
(VSV) infections (56). HSV- infected Vero cells do not bind NK
cell s and therefore resi st lysi s (56), but the mechani sm of
decresed resistance to lysis in the other viral systems is not
known, but could involve protection of these cells by IFN (discussed
below), ora recUcedability of these cells to trigger the NK cell
lyti c mechani sm.
Trinchieri et a1. (61) showed that IFN treatment of target
cells can influence their sensitivity to NK cell-mediated lysis,
depending on the condition of the target cell. Whereas a variety of
nonnl target cells are protected by IFN against NK cell-mediated
lysi 5, ta rget cell s whose meta bolic functions have been al tered by
tretmnt with actinomycin 0 or cyclohexamide are no longer
IFN-protected. Cells infected with influenza or vaccinia vinAS (VV)
are not protected (61). ThJs, IFN can protect nOnIl cells from 
cell-media ted lysis, whil e 1 ea ving vi nAs- i nfected cell s suscepti bl e
to lysis. Welsh and coworkers (62) have shown that IFN-mediated
protection of target cells occurs in vivo, bJt it is still not clear
what role, if any, this mechanism plays in resistance to vinAS
infections.
Definitive evidence that NK cells are or are not playing a role
aga inst vi nAS infections has been lacking. Fu rther, the evi dence
for or against an antiviral role for NK cells has often been
conflicting. For example, LCMV (32), Sindbis (51), MCMV (36) and
HSV-l (35) are all capable of activating NK cells in vivo, but
genetic or dnAg-induced deficiencies in NK cell activity correlate
with lowered. resistance to MCMV (46) and HSV- l (35), but not LCMV
(50), or Sindbis (51) vinAS infections. Activated NK cells lyse
HSV-l (56) and MCMV-infected (36) targets less efficiently than
uninfected, Sindbis vinAs- infected, or LCMV- infected cells (56),
making it difficult to attribJte in vivo resistance to MCMV and
HSV- 1 to NK cell-mediated lysis as assayed in vitro. One of the
aims of this thesis is to clarify these data by accurately
detennining which virus infections are subject to NK cell-mediated
resistance, and by using these data to detennine how NK cell 
mediate resistance, and why they may be effective in controlling
some virus infections, but not others.
The Role of IFN in Virus Infections:
Mechanisms of Antiviral Action In Vivo
The protective role of IFN inclced dJring virus infections has
been clearly demonstrated. Fauconnier (63) injected mice with
antibody to IFN and observed that Semliki Forest virus infections in
these mice prodJced produced greater mortlity in these mice as
compared to control virus- infected mice. Gresser et al. (64,65)
showed that antibody to IFN enhanced virus replication
pathgenesis, and mortlity in mice infected with HSV- , VSV
encephalomyocarditis, Moloney sarcoma, and Newcastle disease
viruses. However, these investigators showed that anti- IFN had no
effect on intranasal influenza virus infection, although it did
exacerbate intranasal VSV infection (65).
Wheres the above studi es show that endogenous IFN provides
resistance to viral infections, definitive evidence regarding its
mode of action in vivo is lacking. There are a oomber of ways in
which IFN could be mediating antiviral effects, but most of this
evidence has been gathered in in vitro systems. IFN cool d protect
by simply bathing an are of susceptible cells and inhibiting virus
replication (23). Alternatively, it could serve to potentiate
cell-mediated defense mechanisms, such as NK cells. IFN induces
activation (32, 33) and blastogenesis (34) of NK cells, and could
thus potentiate NK cell-mediated destruction of virus- infected
cells. IFN enhances the phagocytic (66) and cytotoxic (67)
functions of nacrophages, cells which might have antiviral effects
(68, 69,70). IFN may enhance antibody production (71) and my 
re~ired for the generation of CTL (72), which my be responsible
for clearance of virus in vivo (73).
There have also been studies demonstniting the in vivo efficacy
of tretment with exogneous IFN or inducers. In general, these
tretmnts are most efficacious when administered early in the
infection or before infection (24). The fi rst demonstration that
IFN could mediate antiviral effects in vivo was by Undenmann et a1.
(74), who showed that prophylactic tretment with IFN protected
rabbIt skin against vaccinia virus. Prop~lactic IFN is also
effective against a generalized infection, as Denys (75) showed tht
IFN could protect rats against generalized Sindbis virus infection.
The IFN inducer poly I:C was effective in protecting against HSY-
keratitis infection in the eyes of rabbits (76). Again, the mode of
protection by IFN in these studies was not determined, but in vitro
evidence (see above) suggest possible mechanisms. The data in this
thesis provide new in vivo evidence pertinent to the in vivo mode of
antiviral action of IFN, and provides new in vitro evidence
suggesting mechanisms whereby IFN nay mediate antiviral effects in
vi vo.
Aim of the Thesis
The aim of this thesis is to present data addressing the
following
~esti ons:
1. Do NK cells provide resistance against acute and persistent virus
i nfecti ons?
2. What are the pathological conse(Jences of NK cell depletion
4!ring acute virus infections?
3. By what mechanisms do NK cells mediate antiviral effects?
In what ways does IFN enhance the ability of host defenses to
mediate antiviral effects?
III.
I V.
CHAPTER 2
Manuscripts
Throughout the discussion section (Chapter 3), manuscripts 
will
be referred to by their Roman numerals (I-VI). Tables and Figures
within these manuscripts will be referred to by placing a notation
after the relevant manuscript. For instance
, Table 3 in manuscript
number I I wi 11 be wri tten as: II -Tab 1 e 
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Abstract
To assess the effects of chronic virus infection on natural
killer (NK) cells, the related phenomena of interferon (IFN) production
NK cell activation, and resistance to tumor implants were studied in
mice persistently infected with lymphocytic choriomeningitis virus
(LCMV) . NK cell s from these LCMV-carri er mi ce di spl ayed augmented
killing of the NK-sensitive YAC-l target cell. They di d not lyse the
more resistant targets L-929 and P815 , while NK cells from acutely
infected mice efficiently lysed all three cell types. The pl asma from
LCMV-carrier mice contained an antiviral substance identified as IFN
type I, based on species specificity, virus non-specificity, resistance
to pH 2 , and sensitivity to antibody to type I IFN. IFN titers in
plasma from LCMV-carrier mice were 32 to 64 Ujml, about 20 - fold less
than those in acutely- i nfected mi ce Both the IFN and NK cell evel s
continuously remained elevated in the LCMV carrier mice up to at least
6 months of age. IFN is known to activate NK cells and to induce
their blastogenesis in vivo. As determined by centrifugal elutriation
large NK blast-size cells were isolated from the spleens of acutely
infected mice, but not from either normal or LCMV-carrier mice, sug-
gesting augmented NK cell-mediated lysis in the absence of enhanced
proliferation. Poly inosinic-cytidylic acid induced high levels of NK
cell-mediated cytotoxicity and blastogenesis in both control and
LCMV-carrier mice, but IFN was induced to lower levels in carriers as
compared to controls. Coincidental with augmented NK cell activity,
the LCMV-carrier mice rejected intravenously injected 125 IUDR- labeled
tumor cells more efficiently than did normal mice. Thus, LCMV carrier
mice have low levels of type I IFN , moderately augmented NK cell
activity lasting for at least 6 months , and increased resistance to
tumor cell impl ants. s i ndi cates that augmented NK cell-medi ated
cytotoxicity can be maintained vivo over prolonged periods of time
in the presence of chronic low-level IFN stimulation.
Introducti on
It has been known for several years that interferon (IFN) induced
during acute viral infection activates natural killer (NK) cells
(1, 2). A substanti al bod of evi dence now i ndi cates that NK cell 
play a role in tumor surveillance (reviewed in 3). Talmadge et. ale
(4) have shown that mice whose NK cells have been activated by acute
viral infection are more resistant to tumor growth and metastasis than
are uninfected mice. However , very little is known about the effect
of persistent viral infection on NK cells and tumor resistance.
A well characte ized persistent infection is that of lymphocytic
choriomeningitis virus (LCMV) in mice. Mice infected utero or at
bi rth carry thi s arenavi rus for ife and often do not show overt
disease symptoms (5), though they do suffer from chronic immune complex
di sease (6). These LCMV-carrier mice have LCMV-specific antibody
existing in the form of immune complexes (7), but they have no detectable
cytotoxic T cells specific for LCMV and they respond abnormally to
certain non-viral antigens (8). Us in g th is model we exami ne the th ree
interrelated phenomena of IFN production , NK cell activation , and
tumor resistance during chronic virus infection.
We report here that 1) LCMV-carrier mice have levels of NK cell-
mediated cytotoxicity intermediate between normal and acutely infected
mice, 2) these carriers have low but detectable levels of plasma IFN
and 3) these carriers reject tumor cells more efficiently than do
normal mi ceo
Materi al s and Methods
Animal s. BALB/c byJ mice were purchased from Jackson Laboratories
Bar Harbor, ME. SWR/J mice were kindly provided by Dr. Aldo Rossini
UMass Medi cal School.
. -18. (BALB/c byJ X SWR/J) F1 mi ce were bred in our
own facil i ti es.
Ce 11 s . YAC-l cells were derived from a Moloney leukemia virus- induced
lymphoma in A/Sn mice. 'P8l5 cells were from a methylcholanthrene-
induced mastocytoma in DBA/2 mi ce. These cells were maintained in
RPMI-1640 medium (GIBCO, Grand Island, NY) supplemented with anti-
biotics, glutamine and 10% heat-inactivated fetal bovine serum (FBS)
(M.A. Bioproducts , Walkerville , MD). Vero cells are a continuous
monkey kidney line , and L-929 cells are a continuous liver cell line
fran C3H mi ce. These cells were maintained in minimal essential
medium (MEM) with the same additives as listed above.
Vi ru s. The lymphocytic choriomeningitis virus (LCMV) used in these
studi es was the Armstrong strai n (9). The Indiana strain of vesicular
stanatitis virus (VSV) was obtained from Dr. John Holland , UCSD, San
Di ego, CA. Seml i ki Forest vi rus (SFV), neurotropi c strai n , and herpes
simplex virus type I (HSV- I), a mouse-adapted strain , were obtained
fran Dr. Michael Oldstone, Scripps Clinic , San Diego , CA.
Ant i sera. Rabbit anti-asialo GM1' a gift from Drs. S. Habu and K.
Okumura (10), was used in vitro at a final dilution of 1:150 and in
by injecting mice intravenously with 200 ul of a 1:40 dilution.
The antiserum to NK 1. 2 was a gift from Dr. Robert Burton (11) and was
used at a final dilution of 1:40. Monoclonal anti-thy 1. 2 was provided
by Dr. Edward Clark, Genetic Systems Corp., Seattle , WA and used at a
final dilution of 1:50. For in vitro treatment of cells , 1 X 10
spl een eukocytes suspended in 100 ul serum-free medi um were treated
wi th 50 ul anti serum for 30 mi n at RT. Twenty-fi ve ul compl ement (C'
we re then added, and the mi xture was further incubated at 37 C for 45
mi n. Gui nea pig serum absorbed with spleen leukocytes was the source
of C' Rabbit serum was used as the source of C' with anti-NK 1.
The cells were then pelleted and resuspended in assay medium. Ant i -
serum to IFN- 0( /.1 (type I) was obtai ned from the NIH and used at a
final dilution of 1:100.
Interferon Assay Blood was co 11 ected in hepari ni zed Nate 1 son tubes
fram the retro-orbital sinus of mice anaesthetized with ether. Pl asma
was obtained by centrifugation and was titrated by 2-fold serial
dilutions in a 96 well flat bottom microtiter plate. L-929 or Vero
cells were then added at 3 x 104 cells/well. Eighteen to twenty-four
hours later, the wells were challenged with 100 TCID
50 units of VSV.
SFV and HSV-l were also used to assay for virus specificity. IFN
titers were expressed as the 1092 of the highest reciprocal dilution
resulting in a 50% reduction in CPE.
Interfe ron. IFN type I uq) was purchased from Lee Bi omol ecul ar (San
IF N type I I ( ) was from the 48 hour supernatant of 10Di ego , CA).
mouse spleen cells incubated in 10 ml of RPMI with 2 ug/ml concanavalin
A (Sigma, St. Louis , MO).
Establishment of LCMV-Carrier Mice. BALB/c mice were injected intraperi-
toneally wi th . 03 ml LCMV at 8 X 104 pfu/ml wi thi n 24 hours of bi rth
(5) . In some animals, 3 X plaque-purified LCMV was used as an inoculum.
Congeni tal carriers, i nfected utero by the mother I S persi stent
infection , were maintained in our facilities. Experiments were done
with congenitally infected mice , unless otherwise stated.
totoxicit Assa Assay medium was RPMI supplemented with . 01 M N-
hydroxylethyl piperazine- 2-ethane sulfonic acid (HEPES) (Sigma),
10% fetal bovine serum , glutamine , and antibiotics. The assay was
perfonned as described (1). Briefly, target cells labeled with 100
uCi sodium chromate ( Cr; Amersham Corp., Arlington , Hts., IL) for 1
hour at 37 C were washed and mi xed with effector cell s in round-bottom
microtiter wells at 104 target cells/well. For spontaneous rel ease
detennination , medium was added to the wells and 1% Nonidet P-40 was
added for maximum release determination. Pl ates were incubated for 6
to 16 hours at 37 C in a humidified atmosphere of 5% C02' 95% air. 
the end of incubation, plates were centrifuged at 200 g for 5 min.,
and 0. 1 ml of the supernatant was pi petted off and counted in a Beckman
gamma 5500 counter (Beckman , Palo Alto, CA). Data a re expressed as %
specific release:
Centrifu al Elutriation. Size separation of cells was accomplished
usi ng a Beckman JE-6B centri fuge. About 3 X 108 spl een 1 eukocytes
were treated with deoxyribonuclease (Sigma) to prevent clumping.
These cells were loaded into the rotor which was spinning at 3200 rpm
at 5 The rate of flow of the el uti on medi um (Hank I s bal anced sal t
solution , 1. 5% calf serum) was 15 , 22 , 28, 32, 38 and 46 ml/min and
corresponded to fract ions 1- , respecti vely Cell recovery was about
65%.
Poly I:C Induction Some mice were injected intraperitoneally with
100 ug poly inosinic:cytidylic acid (poly I:C) (Sigma) dissolved in
phosphate-buffered saline. IFN titers and NK activities were deter-
mi ned 18-24 hr post- i njecti on (12).
In Vi vo Reject i on Assay In thi s procedure descri bed by Ri ccardi et.
ale (13), 50 ml of YAC-1 cells in the log phase of growth at 2 X
/ml were labeled with 20 uCi 125IUDR in an upright 75 cm2 flask for
18 hours at 37 C. When L-929 cells were used , 1. 5 X 106 cells in 25
ml MEM were seeded into a 75 cm2 fl ask, incubated for 2 days , and
labeled with 20 uCi 125IUDR for 18 hr prior to harvest. After ex-
tensive washing, the cells were adjusted to 2 X 106 cells/ml for YAC-
and 1 x 106 cells/ml for L-929 and 0. 5 ml of the suspension was in-
jected i. v. into each recipient mouse. Two to four hours later , the
mice were sacrificed , their spleens were assayed for NK activity, and
their lungs were placed into test tubes and counted for radioactivity
in a gamma counter.
Resul ts
NK Cell Levels of LCMV-Carrier Mice. When compared to age-matched
controls, LCMV-carri er mi ce had si gni fi cantly hi gher cytotoxi c acti vi ty
against YAC-1 targets (Table 1). This was seen both in short (6 hr)
assays where little activity at all was mediated by normal cells
(Table 1A), and in long (16 hr) assays , which demonstrated that the
low endogenous NK strain , BALB/c, had splenocytes capable of killing
YAC-l cells to a significant degree (Table 1B). Endogenous NK cell
act ivi ty in mi ce dec 1 i nes rapi dly after 12 weeks of age , even in
strains with genetically high activity (1). However, even at 26 weeks
of age, spleen cells from LCMV carrier mice continue to lyse YAC-
targets very effi ci entl y, (Table 1A).
Table 2 shows that LCMV-carrier cytotoxic cells are intermediate
in act ivi ty between endogenous NK cell s and those acti vated by acute
LCMV infection. Carrier cell s lyse YAC-1 targets more effi ciently
than do normal cells, but unlike NK cells from acutely infected mice,
they do not efficiently lyse NK-insensitive L-929 cells (Table 2) or
P8lS cells (data not shown).
Characteristics of S lenic C totoxic Cells in Carrier Mice. To further
test the hypothesis that the cytotoxic cells were in fact NK cells,
they were subjected to treatment with various antisera and complement
i n vi t r 0 . Tab 1 e 3 shows the resul ts of these experiments. When
treated with antisera to the NK cell antigens NK 1. 2 or asialo GM 1 and
, leukocyte cytotoxicity against YAC-l cells was drastically reduced.
Treatment of carrier mice with anti-asialo GM vivo also depleted
the cytotoxic activity. In contrast , very little cytotoxic activity
was deleted When monoclonal anti-thy 1. 2 antibody and C' was used.
Similar results were obtained when these reagents were used to deplete
NK cell activity in control or three day-acutely infected BALB/c
mice. Untreated or C' treated control spl een 1 eukocytes mediated 16
to 18% lysis (at 100:1 effector to target ratios in a 14 H assay),
While 0. , 2. 9 and 19% lysis was observed after treatment with anti-
asialo GM
l' anti-NK, and anti-thy 1. 2 antibodies , respectively.
Untreated or C' -treated acutely infected spleen leukocytes lysed 68 to
74% of targets (at 33:1) whereas 6. , 39 and70% lysis was mediated by
cells treated wi th anti -asi al 0 GM
l' anti -
NK and anti -thy 1. 2 anti bodies
respect ively. These studies thus provi de strong evi dence that the
effector cell s in the carrier mi ce are cl assi cally defi ned NK cell 
Interferon Levels in Carrier Mice Since NK cells are known to be
act ivated by IFN (1 2), we performed IFN assays on spl een extracts and
plasma from carrier and normal mice. Spleen extracts had no detectable
act i vi ty (data not shown) but pl asma from carri er mi ce had a low but
significant level of IFN-like activity (32-64 units/ml; Table 4).
Every carrier mouse examined (40 BALB/c, 12 SWR, and 9 (BALB/c x SWR)
F1) had plasma IFN-like activity ()16 units/ml). In contrast , of the
normal mi ce exami ned, only 4 of 21 BALB/c, 4 of 10 SWR, and 2 of 10
(BALBlt x SWR) F1 had )4 units/ml IFN. Acutely infected mi ce had
substantially higher levels of IFN-like activity (Table 4), confirming
previ ou s repo rts (1).
In order to minimize the possibility that the IFN-like activity
in the plasma of these carri ers was brought about by an unknown con-
taminant of our LCMV stock, carriers were established by injecting
newborn BALBlc mice with 3 x plaque-purified LCMV. Three of these
mice were tested for pl asma IFN at 5 weeks of age , and all three had
32 units/ml. Thus , LCMV was most likely responsible for the putative
IFN production in the carriers.
Characteristics of Anti-Viral Substance in Carrier Mice. Si nce many
investigators (14-17) have failed to find IFN in LCMV carrier mice , it
was important to characterize the anti-viral substance we had tenta-
tively called IFN. Carrier plasma did not induce anti-viral activity
in Vero cells (data not shown) but did protect mouse L-929 cells from
HSV- I, SF V (data not shown) and our standard assay virus, VSV. These
experiments showed that the anti-viral activity was species specific
and virus non-specific. Further , the antiviral activity in the
carrier plasma was acid stable , but sensitive to treatment with antibody
to type I IFN , consistent with the acti vity bei ng type I and not type
II IFN (Table 5). Since this antibody neutralizes both and L? IFN
the di stinction between them was not made. The acid stability of the
antiviral activity also indicates that LCMV, an acid-labile virus , is
not i nduci ng IFN in vitro.
mentation of C totoxicit and IFN Level s Wi th Pol I :C. To explore
the effects of IFN on carrier splenic effector cells, these mice and
age-matched controls were treated with poly I:C. Cytotoxicity mediated
by cells from both normal and carrier mice was significantly elevated
Tumor Cell ection Vivo. Because we had found that LCMV carriers
had IFN and elevated NK activity, we questioned whether these carriers
would reject tumor cells more efficiently than normal mice in a short
term in vivo assay. In vivo rejection of 125 IUDR-labeled tumor cells
correlates with in vitro NK cell activity and with resistance to
outgrowth of tumor cell implants (4 19). Table 8 shows that carrier
mice are more efficient in clearing 125 IUDR-labeled YAC-l and L-929
cells from their lungs than normal mice. This increased rejection
correlated with increased vitro cytotoxicity against YAC-1 cells in
a 51CR release assay (Table 8). Since L-929 cells are cleared dif-
ferently by carriers and normal mice vivo , carrier mice may be more
active than normal mice in eliminating relatively NK-insensitive as
well as sensitive targets.
by this treatment (Table 6), furthering our notion that the carrier
effector cells were NK cells. Plasma IFN levels were elevated by poly
I:C treatment in both carriers and normal mice (Table 7), but carriers
had lower levels than normals, an observation consistent with previous
work (14).
Size of Carrier NK Cells. Recent worK in our aboratory (18) has
shown that acute LCMV infection causes spleen NK cell blastogenesis
i n vi vo . These blast NK cells are larger than those in uninfected
mice and can be separated on the basis of size by centrifugal e1utri-
at ion. To examine the size of carrier NK cells compared to acutely
infected and uninfected mouse NK cells, these three types of spleen
cells were sUbjected to e1utriation , and each fraction was assayed for
cytotoxi c act i vi ty agai nst YAC-1 targets. As shown before (18), acute
LCMV infection caused a shift in peak NK activity from the smaller
fractions to the larger ones (Fig. 1). In contrast , carrier NK cells,
though exhibiting higher activity in each fraction , did not show a
shift of peaK activity to large, blast-size fractions. Thus, in
contrast to the acute infection , there was no evidence for large-scale
blastogenesis of NK cells in LCMV-carrier mice. Carrier NK cells were
capable of undergoing blastogenesis if stimulated with poly I:C.
Figure 2 shows that poly I:C treatment of LCMV-carrier or control mice
results in very similar elutriation profiles , suggesting that carrier
NK cells ' can undergo b astogenesi s to the same extent as control NK
cells .
Di scuss ion
The resul ts presented here demonstrate that mice persi stent ly
infected with LCMV have plasma IFN , elevated NK cell-mediated cyto-
toxicity, and are more efficient in rejecting tumor cells than normal
mice.
( '
observati on that LCMV-carri er mi ce have el evated NK cell-
mediated cytotoxicity led us to a search for IFN in these mice despite
the failure of others to detect it (14-17). To be sure that we were
detecting IFN and not another antiviral entity (20), we characterized
the substance and found that the activity was species specific, virus
non-specific, acid stable , and sensitive to treatment with an antibody
to IFN type It had previously been difficult to understand why
LCMV-carrier mice did not produce IFN whi le acutely infected mice made
high levels of IFN. We now know from our present results that carrier
mice do make IFN , though at low levels. It shoul d be noted that
'",
during the course of our present study, Saron et. al. (21) reported
low levels of IFN in the serum of LCMV-carrier mice and demonstrated
the IFN-induced enzyme 2 - 5 A synthetase in cells from these mice.
It has been suggested (22) that the pl aque reduction IFN assay used in
the negative studies by others is not as sensitive as the assay
employed by us and by Saron et. al. (21). Other possible reasons for
discrepancies in results include virus and mouse strain differences.
IFN induction was unlikely due to a contaminant in the virus prepar-
ation , as 3 X plaque-purified LCMV also induced IFN in carrier mice.
With the knowledge that LCMV-carrier mice have IFN, one might
have predi cted the outcome of the experiments ; n whi ch poly I:C induced
a lower level of IFN in carriers than in normal mice. It has been
known for some time that cells stimulated to produce IFN are refractory
(hy' poresponsive) to a second stimulus for several days , i.e., they
will produce less IFN than previously unstimulated cells (23). Ho 1 te rman
and Havell (14) observed that lCMV-carrier mice challenged with Newcastle
disease virus (NDV) had lower serum IFN titers than NDV-challenged
nonnals. However, this result could have been explained by the fact
that LCMV- i nfected cell s are resi stant to superi nfecti on with NDV
(23). It now seems likely that hyporesponsiveness to IFN stimulators
could account for this result. Saron et. a 1. (25) reported that
carrier mice produce more IFN after poly I:C inoculation , and con-
cluded that their mice might be interferon primed. Both primi n9 and
hyporesponsiveness can be induced by IFN , but it is not known why the
report by Saron et. ale (25) conflicts with ours and that of others
(14).
Another observation consistent with the presence of IFN in LCMV-
carriers is the presence of elevated cytotoxicity against YAC-1 targets.
This cytotoxicity was sensitive to treatment with anti-asialo GM
vivo , anti-NK 1. 2 or anti-asialo GM
1 and complement 
vitro , but not
to anti-thy 1. 2 and complement and thus was mediated by NK cells.
Previous studies failed to show NK cell activation in LCMV-carrier
mice (1, 26). However, one such study only looked at the lysis of L-
929 cells, and we have shown here that the NK cells in the carrier
mice are not sufficiently activated to lyse those cells, in agreement
with that previous result (1). In another imited study, no dif-
ferences were observed between control and LCMV-carrier SWR/J mice
but extensive investigations on our part have shown that 
control SWR/J
(but not BALB/c) mice sometimes have elevated NK 
cell mediated lysis
campa rab 1 e to the carri ers. The reason for thi s is not known but
could involve an undefined infection.
A series of experiments shown here using 6-month old mice revealed
that cells fram these LCMV-carriers had augmented NK 
cell medi ated
1 ys i s and that the substanti al di fferences between normals and carri ers
we re ap pa rent. Normal mice have peak NK cell evel s at 4- 10 weeks and
by 6 months have little if any endogenous NK cell activity, but retain
the ability to respond to IFN or IFN inducers (1). Wi th LCMV-carri ers
it is likely that the sustained presence of IFN in the plasma is
maintaining the high NK cell levels.
Recent work in our aboratory has demonstrated that IFN induces
blastogenesis of NK cells in viv0 Blast NK cells are also seen when
high levels of IFN are generated during acute infection with LCMV
( 18) . Although low levels of IFN were sustained in persistently
infected mice (Table 4), large-size, blast-NK cells were not induced
to a significant degree; NK cells isolated from LCMV-carrier mice were
contained predominantly in small-size classes (Fig. 1). NK cell s from
carrier mice were , nevertheless , capable of blastogenesis
, since poly
I:C treatment induced higher levels of IFN and blast-NK cells (Fig.
2) . The elevated lysis mediated by NK cell populations isolated from
carrier mice could result from either an increase in NK cell number or
an activation by IFN of individual NK cells to a higher lytic capacity.
Although we cannot distinguish between these mechanisms, it is clear
that b1ast-NK cells do not contribute substantially to the activity.
In our short term vi vo tumor cell rejection assays , both YAC-
cells and L-929 cell s were c1 eared more effi ci ent1y from the 1 ungs 
carrier mice as compared to normals. The rejection of YAC- 1 cells
from the lung is thought to be mediated by NK cells (19). Ta 1 madge
et. a1. (4) showed that increased melanoma tumor cell rejection from
the lung correlates with smaller mean tumor diameters and a smaller
number of metastases. Furthermore , these investigators showed that
acute LCMV infection rendered mice more resistant to growth and
metastas i s of tumors. Thi s resistance was markedly decreased when NK-
defic1 ent beige mice were used. Recent work in our aboratory (27)
has shown that mice acutely infected with LCMV reject tumor cells more
efficiently in a short term 125IUDR assay. It therefore seems likely
that carriers having elevated levels of NK cell-mediated lysis pre-
sumably due to chronic IFN activation could be more resistant to tumor
growth and metastasi s. To our know1 edge , thi s is the fi rst body of
evidence indicating that persistent infection may enhance resistance
to tumor imp1 ants. It should be noted that although the relatively
NK-insensitive L- 929 cells were lysed poorly vitro by normal or
LCMV carrier NK cells, carriers rejected them more efficiently than
normal s vi vo vi vo rejecti on of targets refractory to detect-
able in vitro lysis has been reported previously (4).
LCMV is a natural mouse pathogen and the carrier state is very
cammon among mice in the wild (28). Why has the virus persisted amng
mouse populations for many years? It is interesting to speculate that
increased resistance to tumors could give carrier mice a survival
ad vantage. Also, it is well Known that LCMV carriers are resistant to
many types of viruses including polio (29), leukemia (30), Western
equine encephalitis (31), Eastern equine encephalitis (32), MM virus
(33), polyoma (34), and VSV (35). This observation is consistent with
the presence of IFN which could provide carriers with an additional
survival advantage. Further , recent work in our aboratory indicates
that NK cells may medi ate natural resi stance to a vari ety of vi ruses,
and this resistance may increase if the NK cells are activated (BuKowski
& Welsh , unpubli shed).
In summary, the LCMV carrier mice give us some insight into the
effect of persistent infection on NK cells, IFN production , and tumor
resistance. The carrier could be used as an in vivo model to study
the effects of chronic IFN treatment on tumor resistance.
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Table 1. Cytotoxic Activity Against YAC-l Cell s Medi ated 
Leukoc es From Normal and LCMV-Carri er BALB/c Mi ce
Effector to % Specific Release
Age Tar et Ratio No rma 1 LCMV Carrier
5 wks. 100 6 + 1.5 31. + 5.
6 + 2. 19. + 3.
1.7 + 0. 0 + 5.
8 wks. 100 7 + 1. 22. + 8.
3+2. 13. + 2.
6 + 0. 5+2.
12 wks. 100 7 + 3. 20. + 5.
0 + 1.7 16. + 5.
1.3 + 1.2 0+4.
26 wks. 100 4 + 1.5 29. + 4.
8 + 1.3 14. + 3.
5 + 0. 3 + 3.
5 wks. 100 19. + 2. 52. + 4.
3 + 0. 36. + 3.
0 + 1.0 16. + 3.
22 wks. 100 12. + 3. 38. + 4.33 Q O + 6. 27. + 5.11 3. 0 + 2. 16. + 6.
Cytotoxic activity of BALB/c spleen cells against YAC-l targets in a
standard 51Cr release assay. Each number represents the mean activity
of a least 3 separate animals 1 S.D. A. The assay length was 6 hr
and the spontaneous release was between 8 and 14%. B. The assay length
was 16 hr , and the spontaneous release was between 16 and 24%.
Tab le 2. Effect of Acute and Persi stent Infecti on on Spleen
Cell Cytotoxicity Against NK-Resistant L-929 Cell s
% Speci fi c Cr Release
e of Infection YAC- 929
None
. . .
21.
Pe rs i stent (LCMV carrier) 63.
Acute LCMV 88. 22.
Splenic effector cells from an 8 wk. old BALB/c mouse , an age-matched
LCMV carrier , or a mouse acutely infected for 3 days were mixed with
targets at 100: 1 in a 16 hr 51Cr rel ease assay. Spontaneous re-
lease was between 20 and 27% for YAC-l cells and 24-34% for L-929.
Tab le 3. Characteristics of Cytotoxic Spleen Cells in
LCMV-Carri er Hi ce
riment Treatment ecific Cr Release
None 20. + 3.
15. + 1.0
3+2.Anti -AGM 1 + C'
None
Ant i -AGM 1 i. vi vo
65. + 6.
+3.
None
C I
36.
34.
13.
+ 3.
+ 1.2
+ 3.Ant i -NK 1. 2 + C I
None 64.
61.
53.
+ 2.
+ 1.2
+ 2.Anti-thy- 2 + C'
BALB/c carrier spleen leukocytes were mixed with YAC-1 cells
in a standard 51Cr release assay at effector to target ratios
of 100: 1 (experiment 3 was 50: 1). Assays were 16 hr long
except for experiment 1, which was 6 hr long. The numbers
represent the mean activities of 4 separate assay wells 
1 S. D. In experiment 2 , the mean activities of 3 mice are
presented. Spontaneous release was 9- 23%.
Table 4. Interferon Level s in LCMV-Carri er , Acutely Infected
And Normal Mi ce.
Mouse Strai n
Interferon Titer
uni tslml 
(2.
7 + 0.
Infection
BALBlc uni nfected
carri er
acute ly infected + 010.
uni nfected (2.SWR
carri er 3 + 0.
acutely infected + 012.
(BALB/c x
SWR) F 
uni nfected (2.
carri er
Each number represents the mean pl asma IFN titer of 3 separate control
or carrier mice or 2 acutely infected mice 1 S. The acutely infected
mice received an intraperitoneal inoculation of 8 x 10
4 PFU of LCMV 3
days pri or to sacri fi ce.
Table 5. Characteristics of Anti-Viral Substance
in Plasma of LCMV-Carrier Mice
Sarp 1 e
Interferon Titer
Treatment 1092 (uni ts/ml )
None
pH 2.
Ant i-type I IFN
None
pH 2.
Ant i-type I IFN
None
pH 2.
Ant i-type I IFN
Type I IFN Standard
Con A Supe rnatant
(Type II IFN)
LCM V-Carri er Pl asma
LCMV-carrier serum was pooled from five 5-month-old mice. The
pH 2 treatment was carried out by overnight dialysis in pH 2.
glycine HCl buffer, followed by an overnight dialysis in Hank'
balanced salt solution. Anti-type I IFN treatment was carried
out at room temperature for 30 min. Con A supernatant , a source
of immune IFN , was drawn from a 48 hr culture containing 10
splenic leukocytes/ml in RPMI assay medium supplemented with
2 ug/ml concanaval i n A.
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Table 8. Clearance of Tumor Cells In Vivo:
Normal and Carrier Mi ce
Compari son of
e r ment
1 a
Mouse Tumor Cell
Counts Remaining
in lun
Y AC -
Spec ifi c
Cr Release
BALB / c
norma 1 Y AC - 39. + 1.
carri er 5 + 30. + 6.
BALB / c
norma 1 929 71.
44. 15.carri er
Exp. 1. Five normal male 6-month-01d BALB/c mice and 5 age-matched
carr ers were injected i. v. with 106 125 IUDR-1abe1ed YAC-1 cells as
described in materials and methods. Two hours later the mice were
ki 11 ed and thei r 1 ungs were removed and counted ; n a gamma counter.
The results are expressed as the % of total injected counts recovered
from the 1 ungs. The spl eens from these ce were used as effectors in
a 6 hr 51Cr release assay against YAC-l cells. The results are ex-
pressed as % specific 51Cr release at a 100:1 effector to target
ratio. Spontaneous release was 13%. Each number represents the mean
activity of 5 separate mice + 1 S.
Si x femal e 4 month 01 d BALB/ mi ce and 6 age matched LCMV-carr ers
were injected with 5 X 105 125 lUDR- labe1ed L-929 cells. Lungs were
harvested and counted 4 hr after injection , and spleen leukocytes
were pooled from the individual mice for use in a cytotoxicity assay.
Legends to Fi gures
Figure 1. Size distribution of NK cells isolated from LCMV-carrier
mi ce. Three groups of five BALB/C mice (3 months old) were
sacri fi ced and thei r spl eni c 1 eukocytes were separated into
six fractions on the basis of size by elutriation. Each of
these fractions (1--6 = smallest largest) was used
as an effector population against 51Cr labeled YAC-1 cells
in a 14 hour assay at various effector to target ratios.
The data obtai ned at an effector to target ratio of 11: 1
are presented here. Spontaneous lys is was 16%. Acutely
infected mice were injected i. p. with 8 X 10
4 pfu LCMV 3
days prior to sacrifice. At 100: 1 effector to target
ratio, unseparated normal spleen cells mediated 251 specific
release, and acutely infected and carrier mice mediated 76%
and 54%, respecti vely. Control mice ( ), LCMV carri 
mi ce ( ), LCMV-acutely infected mi ce ( 
Figure 2. Size distribution of NK cells isolated from LCMV-carrier
mice after activation with poly I:C in vivo Th ree groups
of three BALB/c mi ce (3 months 01 d) were sacri fi ced and
separated by elutriation as described in Fig. 1. Effector
cell populations were tested in a 7 hr 51Cr release assay
aga nst YAC- l cells. Resul ts at an effector to target
ratio of 12:1 are reported here. Spontaneous re 1 ease was
8%. Spl een cell s were i sol ated from unt reated LCMV-carri er
mice ( ), LCMV-carrier mice injected i. p. with 100 
poly I:C 24 hr prior to harvest ), and control mice
injected with lOa ug poly I:C 24 hr pri or to harvest
(8-) .
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Abstract
The role of natural killer (NK) cells in the natural resistance
of mice to infections by several viruses was examined.
Mi ce were
specifically depleted of NK cells by intravenous injection of rabbit
antiserum to asialo GMl' a neutral glycosphingolipid present at high
concentrations on the surface of NK 
cells. Control mice were left
untreated or injected with normal rabbit serum. Four to 
si x hours
later, these mice were infected with lymphocytic choriomeningitis
virus (LCMV), mouse hepatitis virus 
(MHV), mouse cytomegalovirus
(MCMV), or vacci ni a vi rus. The mi ce were sacri fi ced th ree 
days post-
infection and assayed for virus in liver and spleen
, spleen NK cell
activity, and plasma interferon 
(IFN). All mice treated with anti-
asialo GM l antibody had drastically reduced NK cell-mediated lysis.
Correlating with NK cell depletion, these mice had significantly
higher (up to 500-fold) titers of MCMV, MHV, or vaccinia virus in
their livers and spleens as compared to 
control mice. NK cell-depleted
MCMV and MHV-infected mice had higher levels of plasma IFN than controls,
correlating with the higher virus 
titers. These NK ce ll-depl eted,
virus-infected mice had more extensive hepatitis as assayed by the
number of inflammatory foci in their livers as compared to control
virus-infected mice; these foci were also larger and contained more
degenerating liver cells than those in 
control mice.
In contrast to the results obtained with MHV, MCMV
, and vaccinia
virus, NK cell depletion had no effect on virus titers in the early
stages of acute LCMV i nfecti on or duri ng persi stent 
LCMV infection.
Mice depleted of NK cells had similar amounts of LCMV in their spleens
and similar plasma IFN levels. Since this antibody to asia10 GM l does
not impair other detectable immunological mechanisms, these data
support the hypothesi s that NK cell s act as a natural resi stance
mechanism to a number of vi rus i nfecti ons but suggest that thei r
relative importance may vary from virus to virus.
I nt roduct ion
Wh i 1 e much is known about spec i fi c T ce ll-med i ated and anti body-
dependent responses to virus infections , less information is available
concerning host factors contributing to natural immunity. Certai n
individuals are more susceptible to virus infections than others, and
this can often be traced to either the genetic or physiological status
of the individual. Of the vari ous components of the natural immune
system, i.e., natural antibody, complement, macro phages, polymorpho-
nuclear leukocytes , and natural killer (NK)
2 cells, the NK cells
appear to be most sensitive to genotype , age , physiological , and
honnonal variations (1). NK cell activity is augmented by interferon
(IFN) (1) and reduced by corticosteroids (2), agents known to increase
and decrease resistance to virus infections , respectively. The di s-
covery that NK cell s become acti vated duri ng the early stages of vi rus
infections in mice (3 6) led to the speculation that they may
provi de a fi rst 1 i ne of defense agai nst di ssemi nat i on of vi ruses (7).
This hypothesis was reinforced by work showing that cultures of virus-
infected cells are more sensitive than uninfected cultures to lysis by
NK cell s (8-13). This enhanced lysis of virus-infected cells may
involve any of several mechanisms, including 
situ activation of NK
cells (9 15), enhanced binding of NK cells to viral glycopro-
teins displayed on the infected cell (12 16), and possibly to synergism
between a cytopathic virus and a cytotoxic NK cell (17).
Direct evidence linking NK cells to resistance to virus infections
has been lacking, though a number of indirect approaches have supported
the concept. NK cell development is dependent on the bone marrow, and
resistance to Friend leukemia virus (18), herpes simplex I virus
(HS V), (14) and mouse he pat i tis vi rus (MHV) (20 21) has been shown to
depend on a bone marrow cell having features similar to NK cells,
including age of maturation , independence of the thymus, and sensi-
tivities to various drugs. With certai n vi ruses the suscept i bi 1 ity to
infect ion varies markedly with the strai n of mouse , and with mouse
cytomegalovirus (MCMV) infections the resistance correlates with hi gh
NK cell activity (22 23). Virus-infected tumor cells are rejected
from athymic nude mice more efficiently than are uninfected tumor
cells in a manner correlating with vitro sensitivity of those tumor
cells to NK cell-mediated lysis (16). Mice are more highly suscepti-
ble to virus infections when NK cell activity is low, such as at birth
or under various types of immunosuppression (24). While suggestive,
none of the above studies convincingly implicates NK cells as effectors
of natural resistance to virus infections , as other components of the
immune response were not ruled out. Because methods for spec i fi cally
depleting NK cell activity vivo have not been available , it has not
been possible to state with any degree of certainty that NK cells
were responsible for resistance.
A recently prepared reagent , antibody to asialo GM 1 (25), appears
to selectively deplete NK cell activity vivo (26 27). Asialo GM
is a neutral glycosphingolipid present at high quantities on the
surface of NK cells (25 28). Thi s antiserum in the presence of
complement reduces virtually all spleen NK cell activity and eliminates
virtually all the large granular lymphocytes, while lysing less than
5% of the total number of spleen leukocytes (25 28). The fl uorescei n-
ated ant i body does not sta in granulocytes , though it does react wi th a
subpopulation of monocytes (26). When administered vivo it markedly
, .
reduces NK cell activity while having no effect on cytotoxic macrophage
(27), cytotoxic T cell (27), or natural cytotoxic (NC) cell (unpublished
data) funct ions. Further, the concanavalin A response (26) and the
percentage of Thy- posi ti ve (26) and surface immunoglobulin-positive
(unpublished data) cells found in the spleen of vivo-treated mice
are unaffected (26). Habu et. al. have shown that mice treated with
thi s reagent become more sensi ti ve to the outgrowth of NK-sensit i ve
tumor implants (26).
We report here a survey of the effects of thi s reagent in mi ce on
virus synthesis and hepatic pathology induced by viruses representing
four di sti nct groups. These include lymphocytic choriomeningitis
virus (LCMV), arenavirus group, MCMV , herpesvirus group, MHV, corona-
virus group, and vaccinia virus , poxvirus group. The resul ts show
that this selective NK cell depletion markedly enhances the infection
of three of the four viruses tested and provide the most convincing
evidence thusfar indicating that NK cells may play a major role in the
natural immunity to certai n vi ruses.
; .
Materials and Methods
Animal s. C3H/St mi ce were purchased from West Seneca Laboratories,
Wes t Seneca, N. C57BL/6 (bg/+ and bg/bg) and BALB/c byJ mi ce were
ori gi nally purchased from Jackson Laboratori es, Bar Harbor , ME , and
then bred in our own facilities. Male mice 6-12 weeks old were used
in these experiments unl ess otherwi se indicated.
Cell s . YAC-l cells were derived from a Moloney leukemia virus- induced
lymphoma in A/Sn mice and maintained in RPMI- 1640 medium (Gibco, Grand
Island, NY) supplemented with antibiotics, glutamine and 10% heat-
inactivated fetal bovine serum (FBS) (M. Bioproducts, Walkerville
MD) . WEHI-164 cells, a target for NC cells (29), were obtained from
Dr. R. Burton and propagat d in RPMI medium supplemented as above.
Vero cells are a continuous monkey kidney cell line , and L-929 cells
are a continuous liver cell line from C3H mice. Mouse embryo fi bro-
blasts (MEF) were obtained as previously described (30) from C57BL/6
mou se emb ryos . These cells were maintained in minimal essential
medium (MEM) (Gibco) with the same additives as listed above. Mouse
BALB-3T3 and baby hamster kidney (BHK) 21/13S cells were maintained in
Dulbecco s modified essential medium (Gibco) supplemented with 10%
tryptose phosphate broth and the same additi ves as isted above.
Vi ruses. The lymphocytic choriomeningitis virus (LCMV) used in these
studies was the Armstrong strain, which was grown in BHK cells (31).
Vaccinia virus, WR strain, was obtained from Dr. Robert Singer, 
Mass. Medical School. Thi s vi rus was grown in mouse L-929 cell s ,
yielding titers of about 10
9 pfu/ml. MHV (strain A-59) was obtained
from Dr. K. V. Holmes , USUHS , Bethesda , MD (32). The vi rus was mai n-
tained by passage in 3T3 cells. Before use in experiments, tissue
culture - grown MHV was passed once vivo by intracerebral inocu-
lation of C3H/St or C57BL/6 mice with 10
5 pfu. Three days later , the
1 i vers were homogeni zed in a 10% suspensi on and cl eared by centri fuga-
tion. A stock containing about 5 x 10
5 pfu/ml was routinely obtained.
The Smi th st rai n of MCMV was obtained from Dr. John Nedrud, Uni versi ty
of North Carolina , Chapel Hill, N.C. (33). Thi s vi rus was mai ntai ned
by in vivo passage in weanling BALB/c mice. Salivary glands from mice
inoculated 2-3 weeks previously with 10
4 pfu MCMV were homogenized in
This procedure yieldeda 10% suspension and cleared by centrifugation.
stocks with titers of 5 x 10
6 - 2 x 107 pfu/ml.
Establishment of Mice Persistentl Infected with LCMV. BALB/c mice
were injected intraperitoneally with 2. 4 x 10
4 PFU of LCMV within 24
hours of bi rth (34). These mice became persistently infected for life
and gave bi rth to congeni tally persi stently infected offspri ng.
these experiments, those congenitally infected mice were used.
Hi sto a tho lo Liver sections were fixed in formalin , embedded in
glycol methacrylate, cut at 2. 6 u and stained with acid fuchsin -
toluidi ne blue - eosin. Inflammatory foci/10 low power fields were
determined by observing the sections with an American Optical one-ten
microscope equipped with a lOx objective and 10x wide field oculars
yielding a field diameter of 1. 7 mm.
Anti-asialo GM Antiserum. Rabbit antiserum to bovine asialo GM
was prepared as previously described (25). Briefly, purified asialo
1 was emulsified with complete Freund'
s adjuvant and injected into
each foot pad of a rabbi t. The rabbit was gi ven a booster shot four
weeks later and then bled two weeks later. This antiserum has pre-
viously been shown to selectively deplete NK cells 
in vivo (26 27) and
vitro (25 28). To deplete NK cells in vivo , anti-asia10 GM 1 was
diluted 1:10 in RPMI medium and given intravenously in a volume of 0.
ml.
Interfe ron Assa Blood was collected in heparinized Nate1son tubes
from the retro-orbita1 sinus of mice anaesthetized with ether. Plasma
was obtained by centrifugation and some samples were dialyzed over-
night in pH 2 glycine-HC1 buffer followed by an overnight dialysis in
Hank' s balanced salt solution (HBSS) (Gibco). Samples were titrated
by 2 - fold serial dilutions in a 96 well flat bottom microtiter plate
to which L-929 cells were added at 3 x 10
4 cells/well. Eighteen to
twenty-four hours later , the wells were challenged with 100 TCID
units of vesicular stomatitis virus (VSV). IFN ti ters were expressed
as the 1092 of the highest reciprocal dilution resulting in 50% re-
duction in cytopathic effect (CPE). Results are expressed as the
geometric mean titers of four separate animal s titrated for IFN in-
di vidual1y.
Cyt otoxicit Assa Assay medi urn was RPMI medi urn supp1 emented with
1 M N- hydroxylethy1 piperazine - N' - 2 - ethane sulfonic acid
(HEPES) (Sigma Chemical Co., St. Louis , MO), 10% FBS , glutamine , and
antibiotics. The assay was performed as described (35). Briefly,
target cells labeled with 100 uCi sodium chromate ( Cr; Amersham
Corp., Arlington Hts., IL) for 1 hr at 37 C were washed and mixed with
6 effector cells in round-bottom microtiter wells at 10
4 target
cells/well. For spontaneous release determi nat ion , medi urn was added
to the wells, and 1% Nonidet P-40 was added for maximum release deter-
mination. Pl ates were incubated for 6 to 16 hours at 37 C in a
humi di fi ed atmosphere of 5% C02' 95% ai 
r. At the end of the i ncubat ion
plates were centrifuged at 200 g for 5 min , and 0. 1 ml of the super-
natant was collected and counted for radioactivity in a Beckman Gamma
5500 counter (Beckman Instruments , Palo Alto , CA). Data are expressed
as % specific release:
100 x (c m ex erimental - c m s ontaneous)
(cpm maxi mum - cpm spontaneous)
Spontaneous rel ease was between 8 and 17%. Standard devi ati ons of
quadruplicate replica samples were ( 10% of the mean and were not
listed in the tables. Results of cytotoxicity assays using several
individual mice are tabulated as the mean % specific 51Cr release of
four separate animal s one standard deviation.
Virus Titration. Spleen and liver virus titers were determined by
using a 10% homogenate of tissue taken from individual mice. The
number of plaque forming units (pfu) per spleen or per gram liver
was determined by plaque assays using Vero cells for LCMV and vaccinia
virus , MEF for MCMV , and L-929 cells for MHV. Resul ts are reported as
the geometric mean titers , i.e. the arithmetic averages of the logs of
four separate animals titrated for virus individually. P val ues
represent the si gni fi cance of the di fferences of the means between the
designated sample and the normal non-anti body-treated control , and
were cal culated using Student. s.t - test.
erimental Procedure. The protocol for the experimental design is
shown in Fi gure 1. Mice in groups of 4 were injected i. v. with 0. 2 ml
anti-asialo GM I diluted 1:10. In some experiments , an additional
group of mice was injected in the same manner with normal rabbit serum
( NR S ) . Four to si x hours 1 ater , these mi ce and 4 age-and sex-matched
controls were injected i.p. with LCMV or MCMV , or i. v. with vaccinia
vi ru s . MHV was given either i.p. or i. Th ree days post infect ion
the mice were sacrificed and were assayed individually for spleen NK
cell-mediated cytotoxicity, PFU in the spleen and liver
, plasma IFN
and hepatic inflammation. For each vi rus used in thi s study, thi 
experimental procedure was performed on 3-6 separate occasions , and
the results of representative experiments are presented.
Resul ts
Activation of NK Cells Durin Acute Viral Infections. To exami ne NK
cell activation under conditions employed for NK cell depletion
studies , mice were injected with MHV , vaccinia virus, MCMV , or LCMV
and sacrificed three days later. Spleen cell suspensi ons were prepared
and cytotoxicity assays were performed using YAC-l cells as targets.
Spleen leukocytes from mice infected with any of the four viruses
lysed target cells more efficiently than control spleen cells (Table
I) . This confirms previous observations (3 , 4 , 36 , 37). Simil arly,
spleen cells from mice persistently infected with LCMV displayed a
higher degree of lysis than control spleen cells (Table I), confirming
our recent observation (34). At the begi nni ng of the present studies
we tested the efficacy of the antiserum to asialo GM I on the mice used
and found that it inhibited endogenous and virus-induced NK cell
activity (Tables II-VII), had no effect on the formation of LCMV-
specific cytotoxic T cells, and had no effect on the lysis of WEHI-164
cells, a target for the NC cell (29) (data not shown).
Effect of NK Cell De letion on LCMV Infection. Treatment with anti-
asialo GMl markedly depleted detectable LCMV-
induced NK cell activity
in C3H/St and C57BL/6 mice, but this treatment had no significant
effect on spleen LCMV titers or plasma IFN levels 3 days postinfection
(Tab le I I). Under these conditi ons of i nfecti on no LCMV was found in
the liver, and the negative liver data are not tabulated. BALB/c mice
persistently infected with LCMV also did not have significant differences
C).
in spleen virus titers when compared to NK cell-depleted mice (Table
III). When these persistently infected mice were bled from the retro-
orbital sinus on successive days , LCMV titers in the plasma increased
in both the normal and NK cell-depleted mice over this three day
period. This is a consistent finding in both treated and untreated
mice, and the reason for it is unknown. However , NK cell dep1 
et ion
had no effect on, this observation or on the viral titers. (Table IV).
Effect of NK Cell De letion on MCMV Infection. In contrast to the
results obtained with acute LCMV infection , NK cell depletion with
anti-asialo GM 1 resulted in enhanced MCMV synthesis in the spleen and
the liver as compared to untreated controls. Table V shows that
C57BL/6 mice treated with anti-asia1o GM 1 synthesized 30-
500 fold more
MCMV in their spleens, and 10- 30 fold more MCMV in their livers as
campa red to cont ro 1 mi ce. Spleen and liver MCMV titers in NK cell-
deficient bg/bg mice were also elevated (Table V), confirming the
work of Shellam et. ale (5). When C3H/St mice were challenged with
the same virus dose (5 x 10
3 PFU) given to C57BL/6 mice , NK cell
depletion had no si nificant effect on virus titers in the C3H/St
mice. However, when the MCMV challenge dose was increased 5-fold, NK
cell-depleted C3H/St mice had significantly higher virus titers in
their spleens and livers as compared to controls (Table V). Intra-
venous injection of normal rabbit serum did not affect either NK cell-
mediated lysis or virus titers in MCMV-infected C57BL/6 mice (data not
shown) .
High plasma IFN titers correlated with high MCMV titers and not
th the presence of NK cells. Tabl e V shows that C57BL/6 mi ce in-
fected with MCMV and depleted of NK cells with antibody had slightly
higher IFN levels than control MCMV-infected mice , correlating with
higher virus titers. This indicates that the antibody to asialo GM
does not enhance virus synthesis by inhibiting IFN production.
Effect of NK Cell De l et i on on MHV Infecti on. Results similar to
those obtained with MCMV are shown for MHV in Table VI. Anti-asialo
-treated mice had 4-50 fold higher spleen MHV titers and 4-500 fold
higher liver MHV titers as compared to controls. As seen wi th MCMV
NK cell depletion had a greater effect on virus titers in C57BL/6 mice
than it did in C3H/St mice. In both strains , NK cell depletion resulted
in higher plasma IFN titers , correlating with high MHV titers. In-
fection with MHV by day 3 resulted in the formation of 5-10 white
necrotic foci on the surface of the liver. NK cell-depleted mice had
10-20 fo 1 d more of these foci on thei r 1 i vers as compared to controls
(data not shown), correlating with the higher virus titers seen in
these mice.
Effect of NK Cell De letion on Vaccinia Virus Infection. Table VII
shows that NK cell depletion had a significant enhancing effect on
vaccinia virus synthesis in the livers and spleens of C57BL/6 mice and
in the spleens but not the livers of C3H/St mice. At this point in
the infection , plasma IFN was undetectable , correlating with low virus
titers under these conditions of infection.
Hi sto atholo Liver secti ons were exami ned for pathology in mi ce
infected with the viruses whose synthesis had been altered by antibody
to asialo GM l or mice treated with antibody alone. Treatment with
antibody to asialo GM l alone did not result in any liver pathology in
uninfected C57BL/6 mice. In control MCMV-infected mice, inflammatory
foci were either arranged around degenerati ng hepatocytes or el se
degenerating hepatocytes were at the periphery of the foci. The
lesions ranged from 1-6 hepatic cords in width (Figs. 2a , 2c). In the
smaller lesions, mononuclear cells, presumably Kupffer cells, were
predominant (Fig. 2e). The larger lesions contained more degenerating
hepatocytes and neutrophi 1 s (Fi g. 2f). In MCMV - infected anti-asialo
-treated mice inflammatory foci were more numerous (Table VIII
Figs. 2b, 2d) and larger. Intranuclear eosinophilic viral inclusion
bodies were frequently seen (Fig. 2c). Large , confluent necrotic
areas i nfil trated by neutrophi 1 s were al so present in the MCMV- i n-
fected mice treated with anti-asialo 8M 1 (Fig. 2b).
In control mice infected with MHV the inflammatory lesions ranged
from small (2-3 cords wide) to large lesions, 5-8 hepatic cords in
width (Fig. 3a). The large lesions contained many degenerating acido-
philic hepatocytes, nuclear debris , neutrophils and mononuclear cells.
The smaller lesions contained fewer neutrophils, relatively more
mononuclear cells and fewer degenerating hepatocytes. In MHV- i nfected
mice treated with anti-asialo 8M
than in control mice (Table VIII).
more i nfl ammatory foci were seen
These foci tended to be 1 arger
contained more degenerating hepatocytes , and in some areas the in-
flammation was almost confluent (Fig. 3b). Some of the 1 i vers from NK
cell-depleted MHV-infected mice had areas of confluent hepatic necrosis
and i nfl ammation.
Livers from control mice infected with vaccinia virus had small
inflammatory foci consisting of 1 or 2 degenerating hepatocytes sur-
rounded by mononuclear cells (Fig. 4a). In animal s infected with
vaccinia virus and treated wi anti-asialo l' the inflammatory foci
. were mo re numerous (Table VIII) and 1 a r ge r with a wi dth of 3 hepat i 
cords (Fig. 4b). These lesions contai ned more degenerating hepato-
cytes , neutrophils and nuclear debris.
-. "'-
Discussion
The results indicate that depletion of NK cells by antibody to
asialo GMl renders mice more susceptible to 3 out of 4 viruses examined.
The virus titers were up to 500-fold higher in the NK cell-
depleted
mice, and pathological lesions in the livers, i . e., the degree of
hepatitis , correlated with virus production. Because this antibody
appears to selectively deplete mice of NK cells 
vivo , (26) we favor
the hypothesis that the effects produced by this antibody are a result
of NK cell dep et ion. We cannot rule out that another untested ef-
fector mechanism is not influenced by this treatment , but most systems
(cytotoxic macrophages , polymorphonuclear leukocytes, NC cells,
cytotoxic T cells, surface immunoglobulin-bearing cells, antigen
presenting cells, etc. ) appear normal. Thi s is thus the best evidence
to date that NK cells have antiviral properties vivo and supports
previous results arguing for or against a role for NK cells in murine
infect ions wi th LCMV , MCMV , and MHV.
In the present study the synthesis of LCMV in either acutely or
persistently infected mice was not influenced by the NK cell depletion.
We have never found any indication that NK cells contribute to re-
sistance to LCMV. Most strai n di fferences in regards to suscept i bi 1 ity
to LCMV are minor and do not correlate with NK cell activity
(38 39).
NK cell-deficient mice synthesize amounts of LCMV comparable to 
normal
heterozygous 1 i ttermates at early stages of the i nfecti on (40). LCMV-
infected cells are not particularly sensitive to NK cell-mediated
lysis vitro (12), and while theY are lysed preferentially when
injected vivo , the effector cell responsible for this lysis (though
undefined) is not an NK cell (41).
Antibody to asialo GM 1 rendered mice more sensitive to MCMV
, and
this correlates with previous investigations. Strai ns of mice with
high NK cell activity are more resistant to MCMV infection than strains
with low NK cell activity (22). NK cell -defi c i ent bei ge mi ce are
hi ghl Y suscepti b 1 e to MCMV , and resi stance to MCMV can be transferred
by bone marrow from mice with normal NK cell levels (23). Hydrocorti -
sone treatment renders mice more susceptible to MCMV in a manner which
correl a tes wi th reduced NK cell act i vi ty caused by the drug (42).
MCMV is a member of the herpesvi rus group, and Lopez and coworkers
have shown correl ati ons in mouse and man between NK cell evel s and
resistance to HSV-1 infection (19). In the mouse model resi stance to
HSV is dependent on the bone marrow, which is essential for NK cell
development (19). Recently, Habu et. ale have shown that mice de-
pleted of NK cells with antibody to asialo GM 1 become more susceptible
to HSV- 1 infect ion In vitro studies have suggested that outgrowth
of B cells infected with Epstein-Barr (EBV) virus, another member of
the herpesvirus group, may be influenced by NK cells (43) and that
these NK cells may preferentially lyse EBV-infected targets (11).
These data coll ecti vel y support the hypothesi s th t NK cell s may pl 
major roles in resistance to various members of the herpesvirus group.
MHV was another vi rus whose i nfecti on was enhanced by antibody to
as i a 1 0 GM 1 . This is consistent with previous work showing that resistance
to MHV3 (a different but related strain) requires a bone marrow 
cell
which matured at the third week of life (21). Newborn mi ce, whi ch
were sensitive to MHV3' could be protected by cell transfers which
included a T cell, macrophage, and bone marrow (NK?) cell component
(21).
Though NK cells are activated to high levels in vaccinia vi rus-
infected mice (31), there are little data either supporting or re-
futing the concept that the NK cells play a role in resistance. Our
data indicate that NK cells do provide resistance to vaccinia vi r us
and may even be the difference between a successful or abortive in-
fect ion. In some of our experiments vaccinia virus pfu s were only
detected in mice treated with antibody to asialo GM
NK cells could provide resistance to virus infections by pre-
ferentially lysing virus- infected cells l! vivo , thereby inhibiting
the spread of vi rus. It has al so been suggested that they coul d have
antiviral properties by secreting large amounts of IFN (44). Our
data, however, indicate that IFN production is not inhibited when NK
cells are depleted l! vivo In contrast , there was usually more IFN
produced by NK cell-depleted animals, probably correlating with the
greater virus stimulus. Though not extensi vely studi ed it appeared
from our work that depletion of NK cells had more of an effect on
virus titers in C57BL/6 mice than in C3H/St mice. The reason for thi s
is not -known. One possible explanation is that C3H mice are reported
to have higher levels of NK cells than C57BL/6 mice (45). Perhaps the
antibody was not totally effective in elminating the higher levels of
tissue-associated NK cells in the high NK strain (C3H) mice.
Why the synthesis of MCMV , MHV and vaccinia virus is enhanced by
NK cell depletion while synthesis of LCMV is not is unknown at present.
Si nce LCMV causes a persi stent i nfecti on in mi ce in nature , LCMV may
have evolved in such a way as to escape NK cell surveillance.
establish an infection in mice for our studies , MCMV and MHV had to
fi rs t be adapted by vi vo passage , and vacci ni a vi rus , even at hi 
dose inoculum , replicated poorly vivo Thi s suggests that these
viruses had to overcome barriers that did not inhibit LCMV. There
may, howeve r, be other reasons why LCMV woul d be di fferent from the
other viruses. LCMV is a relatively noncytopathic virus , while MCMV
MHV , and vaccinia virus are highly cytopathic. NK cells may prefer-
entially lyse target cells which have been stressed by a cytopathic
vi ru s . A related issue is that of IFN protection. IFN not only
activates NK cells but also protects target cells from lysis mediated
by activated NK cells (41). Thymocytes and tumor cell s taken from
LCMV-infected mice are resistant to NK cell-mediated lysis (47 48).
IFN-medi ated protection requires cellular RNA and protein synthesis
(47). Hence, cells infected with cytopathic viruses may not become
IFN-protected because cellular macromolecular synthesis is inhibited
(49), while cells infected with noncytopathic viruses may become IFN-
protected. IFN will protect LCMV-infected L-929 cells from activated
NK cell-mediated lysis vitro (Welsh , unpublished data).
It is thus becoming clear that NK cells may represent a potent
effector ann of the host response. The e vi dence th at they p rov i de
resistance to implanted syngeneic tumors is overwhelming (1). They
may also be a major mediator of antibody-dependent cell-mediated
cytotoxicity, which may play an important role in immunity to in-
fection after antibody is synthesized (1). Our results here and those
of Habu et. al. , while not totally conclusive , provide the strongest
evidence to date that NK cells are mediators of natural resistance to
virus infections. However , in the unlikely event that another un-
defined mechanism is responsible for our results, it remains inter-
esting that a potent antiviral natural resistance mechanism is
eliminated by this antibody to asialo GM
- ,.- - '.. '
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Table I. Augmentation of NK Cell Activity During
Acute and Persistent Viral Infections
1. a
% Speci fi c 51 Release
From
Infect ion YAC- 1 Tar ets
Acute MCMV 71.
None 40.
Acute MHV 48.
None 30.
Acut e Vaccinia Virus 58.
None 41.
Acute LCMV 63.
None 27.
Pers i stent LOW 35.
None 10.
2. a
3. a
4. a
5. b
C57BL/6 mice were injected 3 days previously with
stated in Materi al s and Methods, and spl een cell s
a 100: 1 effector to target rati 
vi rus as
were used at
Three-month-ol d congenitally infected BALB/c mice and age-matched
controls were used.
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Table III. Lack of Effect of NK Cell Depletion On Spleen Virus Titers
in BALB/c Mice Persistently Infected with LCMV
Ant i -AGM % N K Ly s i s
65. + 6.
7 + 3.
1091OPfu/
Sp l een
7 + 0.
8 + 0.
Groups of four 5-month-old BALB/c mice persistently infected
with LCMV were injected i. v. with anti-asialo G1 1 or left un-
treated. Three days later, mice were sacrificed and NK cell-
mediated cytotoxicity and spleen virus titers were determined
(see Materials and Methods).
Table IV. Lack of Effect of NK Cell Depletion on Blood Virus Titers in
BALB/c Mice Persistently Infected With LCMV.
109 10 pfu/ml blood
Day Post-
Treatment Anti-Asialo GM TreatedNo Treatment
treatment wi anti-Blood sampl es from mi ce were taken just before
asi ala GM I and for three days thereafter. 
Each col umn represents
successive bleeds from an individual mouse.
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Table VIII. Increase in Infl ammatory Foci in the Livers
Vi rus Infect ion
of NK Ce ll-Oep 1 eted Mi 
Inflammatory Foci per 10 low power fields
Control b Anti -asi al 0 
MCMV
(13- 115)
158
( 150-166)
MHV
(3-10) (10-109)
1.2
((1- (3-23)
Vaccinia
The numbe rs represent the mea n number of i nfl ammatory foc i 
10 low power fields utilizing an Americal optical one-ten
microscope with a lOx objective and lOx wide field oculars,
yi el ding a field diameter of 1. 7 mm.
N = 4.
The numbers in parentheses represent the range of foci seen in
individual liver sections.
Fi gure Legends
Figure 1. Protocol used in NK cell depletion studies.
Figure 2. Liver sections from MCMV-infected mice.
A, control mouse
liver showing 3 inflammatory foci (arrows) arranged around degener-
ating hepatocytes (Magnification = 100 X); B, anti-asialo GM
-treated
mouse liver showing a small inflammatory focus (arrow) and a large
confluent area of hepatic necrosis (double arrows) (Magnification =
100 X); C, control mouse liver showing a small inflammatory focus
(arrow) (Magnification = 160 X); D ant i-as i a 10 GM I treated mouse
liver showing multiple areas of inflammation arranged around de-
generat i ng hepatocytes. Cells with intranuclear inclusion are easily
seen (arrows) (Magnification = 160 X); E, Control mouse liver showing
a small inflammatory focus composed predominantly of mononuclear cells
(Magnification = 400 X); F, a large lesion from an anti-asialo GM
treated mouse 1 i ver contai ni ng neutrophi 1 s, mononuc lear cell s and many
degenerated necrotic hepatocytes (Magnification = 400 X).
Figure 3. Liver sections from MHV-infected mice. A, control mouse
liver showing a single, well defined, large focus of inflammation
(arrow); B, an anti-asialo GM -treated mouse liver showing a single
large irregular lesion (double arrows) and portions of 2 other lesions
(arrows). The inflammation is almost confluent (Magnification = 160 
X).
Figure 4. Liver sections from vaccinia virus-infected mice.
, control
mouse liver showing a single small lesion (arrow); B, an anti-asialo
treated mouse liver showing 2 medium-sized lesions (arrows)
ca t ion = 160 X).
(Magnifi -
4-6 hours
N=4
3 days
LIVER SPLEEN
VIRUS PLAQUE
ASSAY
SPL E EN
ASSAY
Pi gure 
PLASMA
INTERFE RON
ASSAY
Figure 2
Figure 3
Figure 4
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PATHOGENESIS OF MURINE CYTOMEGALOVIRUS INFECTION
IN NATURAL KILLER CELL-DEPLETED MICE
Running head: NK CELLS IN MURINE CMV PATHOGENESIS
Jack F. Bu kowski, Bruce A. Woda, and Raymond M. Wel sh*
Departments of Pathology and of Molecular Genetics and Microbiology,
University of Massachusetts Medical Center,
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ABSTRACT
The effect of natural killer (NK) cells on the course of acute
and persistent nurine cytomegalovirus (MCMV) infection was examined
by selectively depleting NK cell activity by injection of mice with
antibody to asialo GMl , a neutral glycosphingolipid present at high
concentrations on NK cells. The dose of MCMV re~ired to cause 50
percent mortality or morbidity in control C57BL/6 mice dropped 4-
and greater than ll- fold, respectively, in mice first treated with
anti-asialo GMl. NK cell-depleted mice had higher (up to lOOO- fold)
virus titers in their lungs, spleens, and livers at 3, 5, 7 , and 9
days postinfection. Spl eens and 1 i vers of control mi ce were
virus- free by 7 days postinfection, and their lungs showed no signs
of active infection at any time. In contrast, MCMV had di sseminated
to the lungs of NK cell- depleted mice by day 5 , and these mice still
had moderate levels of virus in their lungs, spleens, and livers at
day 9. Ma rkedly severe pathological changes were noted in the
livers and spleens of NK cell-depleted, MCMV- infected mice. These
included ballooning degeneration of hepatocytes and spleen necrosis.
MCMV-infected NK cell-depleted mice had severe spleen leukopenia,
and their spleen leukocytes exhibited a significantly lower (up to
13-fold) response to the T cell mitogen concanavalin A when compared
to uninfected or MCMV- infected control It a ppea red that NK cell 
exerted their most potent antiviral effect early in the infection,
in a pattern correlating with IFN production and NK cell activation;
treatment with anti-asialo GMI later in infection had no effect on
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vi ru s t i te rs .
The relative effect of NK cell depletion on MCMV pathogenesis
. t depended on the i njecti on ro te of vi ru s. NK cell depletion greatly
augmented MCMV synthesis and pathogenesis in mice inoculated either
intravenously or intt:peritoneally, but had no effect on the course
of disease following intranasal inoculation at any time point
exami ned. One month after i . p. inoculation of virus, NK cell
depletion resulted in a 6- fold increase in salivary gland virus
titers in persistently infected mice, suggesting that NK cells nay
be importnt in controlling virus synthesis in the salivary gland
wring persistent infection. This treatment did not, however,
induce dissemination of virus to other organs. These data support
the hypothesis that NK cells limit the severity, extent, and
duration of acute MCMV infection, and that they may also be involved
in regulating the persistent infection.
104
INTRODUCTION
Human cytomegalovi rus (CMV) (reviewed in 33, 36, 44) is a
ubi(Jitoos herpesvirus capable of causing congenital birth defects
(13), mononucleosis (24), hepatitis (12), and interstitial
pneumoni ti s (14). It causes acute, persistent, and latent
infections, and can be rectivated from a latent state (reviewed in
44). CMV infection is particularly troublesome when patients are
imnnosuppressed wring tumor therapy and transplantation
procedures; patients freCJently contract CMV pneumonitis, which has
a hi gh mart li ty ra te (14). CMV itself is imnnosuppressive (46),
and the combination of that effect with the effects of chemotherapy
and radiation can lead to opportnistic infections such as
Pneumocystis carinii (43).
Because of its similarity to human CMV, IIrine cytomegalovirus
(MCMV) (reviewed in 44) infection in mice has been used extensively
as a model to study the pathogenesis of and the imlJne respone to
CMV. Such studies have shown a peak in natural killer (NK) cell
activity 3-5 days postinfection (1, 41) and a virus-specific H-
restricted cytotoxic T lymphocyte (CTL) response 6- 20 days
postinfection (39). The CTL response is thought to be responsible
for the clearance of the virus late in infection (18). However,
there are marked differences ;n the susceptibility of various
strains of mice to MCMV (as jUdged by death 3-5 days postinfection)
and res; stance correlates wi th the magni tude of the NK cell rather
than CTL response (1). No strain- related differences ;n macrophage
..- -_ ,.. . . "
, I
"..". ...
u" ,
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function or macrophage susceptibility to MCMV infection have been
found (3 48).
NK cell-mediated cytotoxicity is augmented clring acute
(17 54) and persistent (4) viral infections. This is a result
of both proliferation and activation of the NK cell population (2).
NK cells can be directly activated by interferon (IFN) (8, 51, 55)
or by vi ra 1 glycoprotei ns (6). Indi rect evi dence has supported the
concept tha t NK cell s may media te resi stance to herpes simpl ex vi rus
(30), Friend leukemia virus (26), and mouse hepatitis virus (MHV)
(29, 50). With regard to MCMV, Shellam and coworkers (1) showed that
strains of mice having high NK cell activity were more resistant to
MCMV infection than strains having low NK cell activity, and they
also observed that NK cell- deficient homozygous beige mice were more
susceptible to infection than their heterozygous NK-sufficient
littenntes (49). Using bone mrrow chimeras they demonstrated that
bone marrow-derived cells were responsible for this resistance (49);
however, since beige mice have other immne defects (52) it was not
certain which defect was responsible for the lowered resistance.
There is some suggestive evidence that a lymphocyte my control
salivary gland MCMV titers during persistent infection (16), and
that a lymphocyte resembl ing an NK cell, in concert with serum from
mice persistently infected with MCMV, can mediate antibody dependent
cell-mediated cytotoxicity (ADCC) against MCMV- infected targets (40).
Recently, antibody to asialo GM1, a regent which selectively
depletes NK cell activity vivo (11, 23), has become available.
While almost totally depleting NK cell activity, it has no effect on
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cytotoxic macrophage (23), cytotoxic T (22, 23), or natural cytotoxic
(NC) cell (unpublished) functions. In addition, the concanavalin A
(Con A) response (11) and the percentage of thy- l positive (22) and
surface inm.moglobulin positive (unpublished) cells found in the
spl eens of 
.! 
vi vo- trea ted mice a re una ffected. I t does not react
with granulocytes (11), and in the presence of complement lyses less
than 5 percent of the total number of spleen leukocytes (22 25),
whil e elimi na ti ng vi rtua lly all la rge granula r lymphocytes, which
contain the NK cells (25). We have recently shown that mice treated
with this antibody synthesize more MCMV, MHV, and vaccinia virus in
their livers and spleens and have greater virus- induced liver damage
than do untreated mice 3 days postinfection (5). The antibody did
not abrogate resistance to infection by inhibiting the IFN response,
as antibody- treated MCMV- infected mice had higher levels of plasm
IFN than untreated, MCMV- infected mice (5).
The resul ts presented in thi s pa per show that NK cell- depl eted
mice undergo a more severe and disseminated infection of longer
duration than control MCMV- infected mice, and that NK cell depletion
is most effective early in infection. The suppression of the T cell
response (19) seen in control MCMV- infected mice is greatly enhanced
in NK cell-depleted mice, correlating with higher virus titers and
delayed viral clearance. Finally, we present some evidence
sugg sting that NK cells may playa role in controlling persistent
MCMV infection.
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TERIALS AND METHODS
Animals. C57BL/6 (+/+ , bg/+ , and bg/bg) and BALB/c mice were
purchased from the Jackson Laboratory, Bar Harbor, ME. Mice of
either sex, 6 to 12 wk old, were used in these experiments.
Cells . YAC- l cells were derived from a Moloney leukemia
virus- induced lymphoma in A/Sn mice and were mintained in RPMI 1640
medium (GIBCO, Grand Island, NY) supplemented with antibiotics,
glutamine, and 10 percent heat- inactivated fetal bovine serum (FBS)
(M.A. Bioproducts, Walkersville, MD). Mouse embryo fibroblasts
(MEF) were obtained as described (47) from C57BL/6 mouse embryos,
and maintained in miniml essential medium (MEM) (GIBCO) with the
same additives as listed above. 929 cell s, a conti nuous 1 iver
cell line derived from C3H mice, were naintained in ftM, as above.
Virus. The Smith strain of MCMV was obtained from Dr. John Nedrud,
Case Western Reserve University School of Medicine, Cleveland, OH
(35). This virus was mintained by in vivo passage in weanling
BALB/c mice. Salivary glands from mice inoculated 2 to 3 wk
previously with 10
4 pfu MCMV were homogenized in a 10 percent
suspension and cleared by centrifugation. Aliquots were stored at
0 C in 10 percent DMSO. The Indiana strain of vesicular
stomatitis virus (VSV) was used in the interferon assays.
Anti-asialo GM1 antiserum. Rabbit antiserum to asialo GMI was
, I
purchased from Wako Chemicals, USA, Inc., Dallas, TX. This
antiserum has previously been shown to deplete NK cell activity 
vivo and in vitro (11 22, 23) selectively. To deplete NK cell
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activity.! vivo , anti-asialo GM1 was diluted 1/10 in RPMI medium
and given i. v. in a volume of 0. 2 ml.
Cytotoxici ty assay. Assay medium was RPMI medium suppl emented with
1 M N-2-~droxylethylpiperazine- 2-ethanesulfonic acid (HEPES)
(Sigma Chemical Company,? St. Louis, MO), 10 percent FBS, glutamine,
and antibiotics. The assay was perfonned as described (55).
Briefly, YAC- l target cells, labeled with 100 jlCi sodium chromate
Cr; New England Nuclear Corp., Boston, MA) for 1 hr at 37
were washed and mixed with various numbers of effector cells in
round- bottomed microtiter wells at 104 cells/well. For
spontaneous rel ease detenni nati on, medium was added to the well s,
and 1 percent Noni det p..4Q was added for RBxinum rel ease
dete nni na ti on. Plates were incubated 4 to 16 hr at 370 C in a
humidified atmosphere of 5 percent CO2' 95 percent air. At the
end of the incubation, plates were centrifuged at 200 x G for 5 min,
and 0. 1 ml of the supernatant was collected and counted for
radioactivity in a Becknn Gamma 5500 counter (Becknn Instruments,
Palo Alto, CA). Data are expressed as percent specific release:
100 x (cpm experimental - cpm spontaneous)
(cpm maxinum - cpm spontaneous)
Spontaneous rel ease was between 8 and 33 percent. Standa 
deviations of (Jadruplicate replica samples were less than 10
percen of the mean and were not listed in the tables. Resul ts of
cytotoxicity assays against YAC- l cells using individual mice are
tabula ted as the mean percent speci fi c 5lCr release of fou 
sepa ra te mi ce :. SEM.
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Virus titration MCMV titers were Qetennined by using a 10 percent
homogenate of tissue taken from individual mice. The number of
plaqJe- fonning units (pfu) was detennined by pla(Je assay using MEF
and 10- fold dilutions of tissue homogenate. Resul ts a re expressed
as the geometric mean titer, i.e., the arithmetic averages of the
logs 'of four separate animals titrated for virus individually 
SEM. Titers reported are 10910 pfu per whole spleen, both lungs,
both submxillary salivary glands, and gram of liver. Where
standa rd errors are omi tted, one or more mi ce in that pa rti cula r
grop had no detectable virus in that orgn, and these mice were
assigned a virus titer e(Jivalent to the lowest amount of virus
detectable by our assay method, and averaged together with the other
mice in that same grop.
designated " less than'"
In this instance, the resul ting number was
The P values represent the significance of
the differences of the means between the designated sample and the
nonn 1, non-anti body- trea ted control, and were ca cula ted usi ng
Student' s t- test. The mean lethal dose (LD ) was calculated by
the method of Reed and Meunch (45), using 4 mice per group and
serial 2- fold dilutions of MCMV. The mean morbidity dose (morbidity
dose ) was calculated in the same manner, using ruffled fur and a
tunched posture as criteria for cl inical illness.
Mitogen stinulation Spleen cells were dispensed in flat- bottomed
micro-titer wells at 3 x 10
5 cells/well in medium containing 2
\lg/ml concanavalin A (Con A) (Sigm) or medium alone. These cells
were incubated in the same IInner as those used in cytotoxicity
assays for two days, followed by addition of 1 \lCi 3 thymidine
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(New England ttclear) to each well. The next day, the cells were
harvested using a MASH (Belco, Vineland, NJ) and counted in a li~id
scintillation counter (Beckmn). Spleen cells from at least two
mice were pooled, and each number represents the mean counts per
minute (cpm) of 4 clplicate wells SEM.
Interferon (IFN) assay. Blood was coll ected in hepa ri nized Na tel son
tubes from the retro-orbital sinus of mice anesthetized with ether,
and plasm was obtained by centrifugation. Pe ri tonea 1 wa shes we re
obtained by injecting mice i. p. with 3 ml cold RPMI medium and
collecting the fluid with a Pasteur pipet. This wash was
centrifuged at 200 x G for 5 min, and IFN assays were perfonnd on
the supernatants. Plasm or peritoneal wash ,samples were titrated
by twofold serial dilutions in a 96-well, flat- bottomed microtiter
plate to which L-929 cells were added at 3 x 10
4 cells/well.
Eighteen to 24 hr later, the wells were challenged with 100 TCID
uni ts of VSV. IFN ti ters were expressed as the 1092 of the
highest reciprocal dilution resulting in 50 percent reduction in
cytopa thi c effect. Resul ts a re expressed as the geometri c mean
titers of fou-r separate animls titrated for IFN indiviclally SEM.
Histopathology Tissue sections were fixed in ooffered fonnlin,
embedded in paraffin, cut at 4 m, and stained with
hemtoxylin-eosin. An American optical 110 microscope was used for
examining tissue sections. A low power fi el d refers to the use of a
lOx objective and 10x wide field oculars, yielding a field diameter
of 1.7 l1. Tissue sections were examined in a " blind. mnner,
without knowing whether or not the mouse was NK cell-depleted.
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RESUL TS
Susceptibility to MCMV infection When titnited in control C57BL/6
mi ce, 5 x 10
5 pfu of MCMV we re eq. i va 1 ent to one LD 
50' b. t 
when
these mice were treted with anti-asialo GM1 4-6 hours before
i nfecti on, only 1.2 x 10S pfu were e~ i valent to one LDSO. At 
dose of 1.S x 10
S pfu, 7S percent of antibody- treated mice and 0
percent of control mice died (P(.Ol). Whereas the dose of this
stock re~ i red to cause SO percent morbi di ty (morbi di ty dose ) in
control mice was 2 x 10
S pfu, the morbidity dose
SO in
anti-asialo GM1- treted mice was less than 1.8 x 10
4 pfu, the
lowest dose used in the titnitfon. Further, in other experiments
reportd throghout this paper, a dose of S x10
3 pfu rotinely
rendered NK cell-deficient mice clinically ill while having no
visible effect on control mice. Ttus" there were 4- and at least
11- fold decreases in LDSO and morbidity dose SO , respectively,
when NK cells were depleted by tretment with anti-asialo GMl.
Antibod;; tretment did not abrogate resistance to MCMV by
i nhi bi ti ng the IFN response, as both control and anti body- trea ted
mice had similar plasll IF titers 6 hours after i . p. inoculation
wi th 3 x 10
S pfu MCMV. 
Control and NK cell-depl eted mi ce had
3+0 2 and 9. S+0 3 1092 units IFN/ml plasll, respectively. With
regard to the local IFN response, control and NK cell- depleted mice
had 2. 3 and 3. 0+0 4 1092 units IFN/ml peritoneal wash,
, I
respectively. These data, coupled with our previous observation at
3 days postinfection with S x 10
3 pfu (S), indicate that antibody
112
tretmnt did not abrogate the IFN response 6-72 hors postinfection.
Effect of NK cell de letion on vi ral s nthesis, dfssemina tfon, and
clearance. Control mice or those treted with anti-asialo GMI were
injected fop. with 5 x 103 pfu MCMV and sacrificed at various
. times postinfection. The results listed in Table 1 show that NK
't. .
cell- depleted mice had significantly higher virus titers in the
spleen, lung, and liver than control mice at 3, 5 , 7 , and 9 days
postinfection. The magnitude of the differences in virus titer was
most pronounced in the spleen, with NK cell- depleted mice having as
nuch as a 1000 times more vi ruSe Though di ssemi na ti on of vi rus to
the salivary gland was not accelerated in NK cell- depleted mice, an
active infection of the lung was noted at 5 , 7, and 9 days
postinfection only in NK cell- depleted mice (Table 1) with control
mice always having fewer than 100 pfu in their total lung tissue.
These results indicate that NK cell depletion resulted in incresed
viral dissemination to the lung.
By nine days postinfection, control mice had no detectable
vi rus in thei r spl eens and ivers, whi 1 e NK cell- depl eted mi ce sti 
had about 5000 pfu/orgn (Table 1), indicating that viral clearance
from these organs was delayed.
As reported previously (5), NK cell-mediated lysis was almost
totally eliminated by anti-asialo GMI treatmnt when assayed 3 days
postinfection (Table 1). By 5 days postinfection lytic activity was
again detectable, and on day 9, NK cell activity on a cell- to-cell
basJs was compa rabl e to the control.
Under these conditions of infection, control mice did not
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pas ti nfecti on. In contrast, NK cell- depleted mice were clinically
III
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ill
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become clinically ill (i.e., oonched posture and ruffled fur), and
their livers and spleens were completely virus- free by 7-9 days
ill 4- 9 days postinfection, with moderately high virus titers in the
lung, spleen, and liver 9 days postinfection (Table 1), eventually
falling to undetectable levels by 12- 15 days postinfection (data not
shown) . In both untreated and antibody- treated mice, MCMV remained
in the salivary glands for at least five weeks.
Patholo . As reported earlier (5), livers from NK cell-depleted
mice 3 days postinfection had more foci of inflamnation than nonml
MCMV- infected mice as well as large areas of hepatic necrosis (data
not shown). Five days postinfection, livers from control
MCMV- i nfected mice had resol ving focal hepati ti s and were undergoing
active regeneration (Fig. lE). There were IIny mitotic figures, and
the hepa tocytes had vesi cula r cytopl asm and pl eomorphi c nucl ei. The
inflalltory foci were sllll, numbering two per low power field, and
were composed predominantly of mononuclear cells with a few a ani xed
neutrophils. Though a few giant cells were seen, cells with viral
from control MCMV- infected mice 9 days postinfection. Regenera ti ve
inclusions were not present. In contrast, ivers from NK
cell- depleted, MCMV- infected mice had severe and continuing disease,
and were yellow and atrophic in appearance (Fig. IB). The
hepatocytes had severe ballooning degeneration with R1ltifocal ares
of inflamition, and cells with viral intranuclear inclusions were
present (Fi g. IF). No regenera ti ve changes were evi dent.
Continuing resolution of hepatitis was evident in livers taken
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changes were nea ring compl eti on, as 11 vers had fewer mi toti c fi res
and diminished nuclear pleomorphism compared to those examined five
days postinfection (Fig. 1G). There was one inflanmtory focus per
5 low power fields, and small portal lymphocytic infiltrates were
. "
present. Livers taken from NK cell-depleted MCMV- infected mice at 9
days were undergoing active regeneration, but had continuing focal
hepatitis which appeared to be in the early stages of resolution
(Fig. lH). There were many mitotic figures, and the hepatocytes had
vesicula r cytoplasm and pl eomorphi c nucl ei. There were 5
inflammtory foci per low power field, and although there were no
viral inclusions, some giant cells were present. In NK
cell-depleted, MCMV- infected mice, hepatitis and liver damage at 9
days was more extensive than that seen in control MCMV- infected mice
at 5 days postinfection.
Spl eens from control MCMV- infected mice 9 , days postinfection
were larger than those of uninfected mice (Fig. 1A). They had
tlperplasia of the white pulp and floridly reactive genninal centers
with imJ1noblasts and plasma cells present in the nBrginal zones
(Fig. lC). The red J1lp was relatively decreased in amount, and
contained occasional neutrophils. Cells with viral inclusions were
not present. At 9 days, spl eens from NK cell-depl eted MCMV- infected
mice exhibited nultifocal necrosis (Fig. lA). Microscopically, , I
perifollicular necrosis and extensive destruction of the red J1lp
were seen (Fig. 10). MJltiple sllll and large thrombi were present
in red J1lp vessels (Fig. lD). It is likely that necrosis of the
red pulp eventuated in thrombosis of blood vessels with superimposed
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infarction of large areas of the spleen. Genninal centers were not
present, but there were focal aggrega tes of plasRB cell 
with viral inclusions were not present.
Cell s
Although some lungs examined 5 7, and 9 days postinfection had
mild focal interstitial pneumonitis, there was no difference in lung
pathology between NK cell- depleted and control mice.
Effect of NK cell depl etion on MCMV- induced illnosuppression
Previous results have demonstrated that spleen cells from
MCMV-infected mice have a diminished response to the T cell mitogen
concanavalin A (19). Table 2 confinns these results, and also shows
that NK cell depletion enhances this MCMV- induced suppression, while
having no effect on the Con A response in uninfected mice. On days
5, 7, and 9 postinfection, mice treted with antibody had Con A
responses l3-fold, 5- fold, and 2- fold lower than control
MCMV- infected mice, respectively. NK cell depletion also resulted
in MCMV- i nwced 1 eu kopenia. Whereas anti body treatment a lone had no
detectable effect on spleen cell numbers (11, unpublished),
anti-asialo GM1- treated MCMV- infected mice had up to 5- fold fewer
spleen leukocytes than MCMV- infected controls (Table 3).
Depletion of NK cells on various days postinfection In order to
detennine the time interval wring which NK cells were exerting
their most potent antiviral effects, we treted grops of mice with
anti asialo GM1 on days 0, 1, and 2 postinfection and compared these
gro ps to control MCMV- i nfected mi ce; all mi ce were sac ri fi ced 
day 3 postinfection. No significant differences in liver virus
titers were seen between the groups whose NK cells were depleted at
" "
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0, 1, or 2 days postinfection, but all 3 groups had 25 to 50- fold
hi gher ti ters than control MCMV- infected mice (Table 4).
contrast to the liver data, depletion of NK cells 2 days
In slight
postinfection failed to enhance spleen virus titers as effectively
as depletion at days 0 or 1, but nonetheless significant enhancement
of day 3 virus titers was noted in all NK cell- depleted mice. This
indicates that the absence of NK cells between days 2-3 and days 1-
resulted in enhanced day 3 virus titers in the liver and spleen,
respecti vely. Thi s means tht NK cell s present between 2 and 3 days
postinfection were re(Jired for the antiviral effect. This period
of time corresponds to that necessa r, for IFN production and
activation of NK cells (49). Note that MCMV infection induced
higher day 3 plasll IFN titers in anti-asialo GM1- treated mice than
in control mice, rega rdless of whether the antibody was given 0, 1,
or 2 days postinfection (Table 4).
We next tested whether NK cell depletion later in infection
(day 6, when spleen virus is still detectable) would have any effect
on vi ra 1 ti ters in the spl een 9 days posti nfection. Tabl e 5 shows
that the dose of anti-asialo GMI which totally depleted NK cell
activity in our previous experiments (Table 1, day 3) reduced NK
cell-mediated lysis by only about 30 percent, when given on day 6
and assayed on day 9 postinfection. tal so had no effect on day 9
I I
virus titers in the spleen, liver, or lung. This was in contrast to
the data we had obtained when giving the antibody 4 to 6 hours
before infection. This was not an unexpected result, since activated
NK cells are more resistant to the effects of anti-asialo GMl
-:;-(:
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treatmnt (H. Yang et. al., DBnuscript in preparation). In ordr j I
address the possibility that day 9 virus titers were unaffected due
to incomplete elimination of NK cells, we gave antibody on 3
separate days (6, 7, and 8) postinfection, or none at all, and
sacri ficed the mice on day 9. Table 5 shows that most of the NK
cell activity was removed by this tretmnt, but that mice
I; ,undergoing this treatment had no signi ficant difference in vi rus
titers as compared to controls. This shows that NK cells are not
necessa ry for the el imina tion of vi rus that occu rs in the spl een
between days 6 and 9, nor does NK cell depletion at 6-9 days
postinfection bring about dissemination to the lung or reppearance
of virus in the liver.
Effect of inoculation rote on NK cell-mediated resistance NK cell
depl eti on had simila r effects on MCMV synthesi s 3 days posti nfection
whether the virus was given Lp. or Lv. Table 6 shows that
differences as great as lOOO- fold were noted in the spleen, and NK
cell- depleted mice also had low but detectable virus titers in the
lung, which would increse by day 5 (Table 1). These data confinn
and extend our previous results (5). NK cell-defi ci ent bei ge mi 
yielded similar results (Table 6), in accord with the observation of
Shellam et. ale (49).
In contrast to the above observations, NK cell depletion had no
effect on the course of intranasal infection at 3 days or at later
times postinfection (Table 7). During the first 5 days after
intranasal MCMV infection, virus synthesis occurs only in the lung
( 21 ) . NK cell depletion had no effect on lung virus titers at any
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time postinfection, nor did it result in accelerated dissemination
to the salivary gland (Table 7) or to any other organ tested
(spleen, liver, kidney) (data not shown). In fact, dissemination to
any 0 rgan except the sa 1 i va ry gl and was ra rely seen, and it di d not
correlate with the presence or absence of NK cells.
NK cell depletion enhances salivary gland MCMV titers during
ersistent infection. To examine the role of NK cells in
controlling persistent MCMV infection, we treated mice 30 days
postinfection (infectious virus is found only in the salivary gland
at this time) with thioglycolate and RPMI or thioglycolate and
anti-asialo GMI. The thioglycolate techni(Je was reported by
Braughtigam et. ale (3) to facilitate rescue of MCMV from latently
infected mi ce. Fi ve days after thi s trea tment (35 days
postinfection), the mice were sacrificed; their peritoneal
I1crophages were cocultivated with ftF, and their spleens, livers,
kidneys, blood, lungs, and salivary glands were titrated for virus.
MCMV was isola ted from all macropha ge cul tu res from both control and
NK cell-depl eted mi ce. NK cell depletion had no effect on the
rapidity of virus isolations from cocultivated peritoneal
mac ropha ges, nor di d it resul t in the rea ppea rance of i nfecti ou s
virus in any of the organs tested (data not shown). However, 
cell depletion resulted in a 6- fold increase in salivary gland
virus titers in three separate experiments (Table 8). Ttus, NK
cells nay be involved in limiting viral synthesis in the salivary
gland ck ring the persistent phase of the infection.
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DI SCUSSI ON
The results presented in this paper suggest that NK cells nay
playa major role in limiting the mortality, morbidity, spleen
necrosis, hepatitis, and inm,lnosuppression associated with acute
MCMV i nfecti on. It is likely that they limit the severity and
wration of the infection by controlling viral synthesis and
di ssemi na ti on du ri ng the fi rs t few days of i nfecti on. OUr
experiments (Tabl es 4+5) suggest that NK cell s my exert thei r most
effective antiviral action at a time correlating with the onset of
peak IFN prowction (49), NK cell activation (49), and NK cell
division (2), Le., between 24 and 72 hours postinfection. Though
mice depleted of NK cells 4-6 hours preinfection had elevated virus
titers 3-9 days postinfection (Table 1), mice depleted of NK cells 6
days postinfection had no detectable virus in their spleens or
livers on day 9 (Table 5), suggesting that NK cells may not be
necessary for viral clearance later in the course of acute
infection, when MCMV-specific T cells are present. Clearance of
virus later in infection has been shown by Ho (18) to be a function
of H-2 restri cted MCMV-specifi c T cell 
NK cell depletion before MCMV infection results in a 500 to
lOOO- fold increase in spleen virus titers 3 days postinfection,
before CTL are detectable. The delayed clearance of virus seen 9
days postinfection in NK cell-depleted mice may simply be we to the
large viral antigen load resulting from NK cell depletion early in
the infection, or it could also be due to increased virus-
induced
.."'''
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suppression of T cell function. It is well known tha t MCMV can
suppress T cell function (37 19), and that the degree of suppression
correlates with virus titers (19). In our study, mice depleted of
NK cell s had hi gher vi rus ti ters and a gre ter degree of
MCMV-induced suppression of the Con A response (Table 2) as compared
to con trol Since the Con A response is a measure of T
cell- dependent function, it is likely that viral clearance, also a T
cell- dependent function, could be inhibited, resulting in an
infection and illness of longer dJration.
The conseqJences of NK cell depl eti on on the pa thogenesi s of
MCMV i nfecti on were profound. Severe ballooning degeneration of
hepatocytes has previously been reported in irradiated,
MCMV- infected mice (15), but due to the lack of specificity of
irradiation, the iJ1ne deficit responsible for this was not
detennined. Mims and Gould (34) reported spleen necrosis (but not
thrombosis and infarction) in MCMV- infected mice. However, even
. when high inoculating doses are given, mouse strains with
genetically high NK cell activity (CBA, C57BL/6 , and C57BL/I0) (38)
do not present with spleen necrosis, wheres strains with
genetically low NK cell activity (A, BALB/c) (38) have necrotic
spleens (34). OUr experiments confinn and extend this correlation,
showing that NK cell depletion of C57BL/6 mice followed by a low
dose (5 X 10
3 pfu) MCMV infection resulted in spleen necrosis.
The absence of NK cells also resulted in dissemination of the
virus to the lung. This condition, coupled with iJ1nosuppression,
could set the stage for opportnistic infection in hUlJns.
I ". ,!,on
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Imnunocompromi sed cancer and transplant pa tients, whose NK cell
acti vi ty is low, are suscepti bl e to CMV pneumoni ti s (42). Almost
all patients with acquired imnunodeficiency syndrome (AIDS) have
active CMV infection (27), and though the evidence for CMV as a
cause for AIDS is no convincing, it is certainly possible that
lowered NK cell activity could allow CMV to flourish and to exert
its imnunosuppressive effects, establishing optimal conditions for a
putative AIDS- causing agent or other opportunistic agents to take
o ve r .
Whereas NK cell depletion had a dramatic effect on the course
of i . p. or i v. MCMV infection, it had no detectable effect on the
coo rse of intranasal infection. Nt cells are present in the lung
(41), and this laboratory has shown that antibody to asialo GMI
depl etes lung NK cell acti vi ty and prevents the rejecti on of
NK-sensitive YAC- l cells from the lung (C. Biron, K. Okunura, S.
Habu, and R. Welsh, J. Virol. in press, JVI 608). innan et. al.
(41) have shown that cortisone treatment increases lung MCMV titers
during the first 7 days of intranasal infection, and they suggested
that this increse was due to the depletion of lung NK cells they
observed. Our present results indicate that NK cells are not
mediating resistance wring intranasal infection, and that some
other cortisone-sensitive effector system (not T cells) (41) is
, I
responsible for resistance against MCMV in the lung. In support of
this concept, Biron et. al. (J. Virol. in press, JVI 608) have
demonstrated that a cortisone- sensitive non-NK cell is responsible
for preferential rejection from the lungs of vi rus- infected cell s
. - - ----- -- - ..
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overuninfected cells in 4 hour.! vivo cytotoxicity assays.
A recent report (10) had suggested that early IFN prociction, 6
hou rs posti nfecti on, media ted resi stance to MCMV infection ei ther
di rectly, or via NK cell acti va tion. au r present ci ta show tha t 
cell depletion with anti-asialo GMI did not abrogate the early IFN
response. Therefore, lack of IFN cannot account for the lowered
resistance in the antibody- treted mice.
When administered in vivo , anti-asialo GMI antibody has no
de tecta bl e effect on any illne functi ons tested other than NK cell
activity (11 23). However, it does bind to some monocytes and
thymocytes (11), and it coul d possi bly have unknown effects on
non- lymphoid tissue. Recent work in our laboratory (J. Bukowski and
R. Welsh, unpublished) provides further evidence that it is indeed
NK cells which are mediating resistance. Athymic nude mice treted
with anti-asialo GMl have enhanced MCMV titers. Newborn mice (which
are NK cell-defi dent) which recei ved adoptively transferred control
acilt spleen cells resist lethal MCMV infection. The adult cells
still protected if they were immnochemically depleted of T cells or
depleted of IIcrophages and granulocytes by size separations. Acilt
cells did not protect if NK cells were removed by antiboQy to asialo
GMl. Selgrade and Osborn (48), using the same adoptive transfer
system, also demonstrated that IIcrophage- depleted adult spleen
, I
cells could mediate protection. A potential mechanism for NK cells
to control MCMV infection is also seen from our unpublished results
showing that in the presence of IFN, which protects uninfected
targets, MCMV- infected cells are ITch more susceptible to NK
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cell-mediated lysis.
MCMV has the capacity to establish persistent and latent
infections, which can be rectivated under conditions of
iRInosuppression (20 32), even in the face of IOderately high
an ti body ti te rs. While we have so far not demonstrated a role for
NK cells in controlling rectivation of latent infection, we have
shown that NK cell depletion wring the persistent phase of the
infection results in significant increses in salivary gland virus
titers (Table 8), but not dissemination of the virus from that
o rga n . To ou r knowl edge, thi s is the fi rs t body of evi dence in
support of a role for NK cells in limiting viral synthesis in a
persistent viral infection.
It thus appears that NK cells nay playa role in limiting viral
synthesis and virus- inclced pathology in the early stages of some
acute viral infections, but not others, such as LCMV (5). The
present da ta suggest tha t NK cell s act ea rly in acu te MCMV infection
to rewce the viral load at a time period corresponding to IFN
production and activation of NK cell-mediated cytotoxicity, but
before virus-specific antibody and cytotoxic T cells are
detectable. An incresed viral load in NK cell- depleted mice could
lead to dissemination of virus to the lung. More virus leads to
enhanced suppression of the T cell response which could likely
result in delayed clearance of virus, and a prolongation of
hepa ti tis. It thus appears likely that NK cells acting early in the
infection can limit the severity, extent, and duration of acute MCMV
infection, and that they may playa role in controlling persistent
124
i nfecti on.
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TABLE 1, continued
Mice were either left untreated or given anti-asialo GMI
(anti-AGM1) 4-6 hrs before i. p. injection of 5 x 10 3 pfu MCMV.
Four C57BL/6 mice in each treatment group were sacrificed at various
times postinfection; virus titrations and NK cell assays were
performed. The assay length was 16 hrs, and the effector to target
ratio was 11:1.
p( .
001.
Where numbers are preceded by a less than l/ symbol (d, one or
more mice had no detectable virus in that organ (see Materials and
Me thods) .
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TABLE 2 , continued
Mice were left untreated or given anti-asialo GMl (anti-
AGM1).
Four to six hr later, half of each group was infected 
i . p. with 5 x
3 pfu MCMV and the other half was left untrea ted. Mi ce were
sacrificed at va rious days postinfection and the spleen cells were
assayed for response to Con A stinulation as described in Materials
and Methods. Each time point represents a separate assay with its
own control from uninfected mice.
per minute (x 10 ) + SEM.
ND, not done.
Results are expressed in counts
'Ii
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TABLE 4, continued
Sixteen mice were injected i . p. with 5 x 10
3 pfu MCMV on day 0
and divided into groups of One group was 
eft untreated and the
other 3 groups were given anti-AGMI 0, 
1, or 2 days postinfection.
All mice were sacrificed on day 3 postinfection for determination of
spleen NK cell activity, virus titers, and IFN 
titers.
See legend to Table 1, footnote c.
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TABLE 5 , continued
Two groups of 4 mice were injected i. p. with 5 x 10
3 pfu MCMV.
On day 6 postinfection; when 200-500 pfu virus are present in the
spleen, one group was given anti-asialo GMl (anti-
AGM1) i. On day
9, the mice were sacrificed, and virus titrations and NK cell assays
were perfonned.
Same as exp 1, except mice were given anti-
AGMl
See legend to Table 1, footnote c.
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TABLE 6, conti nued
Groups of 4 mice either untreated or given anti-AGMI were
injected either i . p. or i . v. with 5 x 10 pfu MCMV 4-6 hrs later.
All animals were sacrificed on day 3 postinfection , and virus titers
were. detennined.
p( .
001.
The data in this experiment were published previously (5) and
included in thi s tabl e for compa ri son.
See legend to Table 1, footnote c.
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TABLE 7 , conti nued
Groups of 4 mice either untreated or given anti-AGMI were
inoculated intra nasally with 10
5 pfu MCMV 4-6 hrs later. Mice
were sacrificed at various times postinfection; virus titers and NK
cell acti vi ties were determined.
See egend to Ta b 1 e 1, footnote c.
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TABLE 8, continued
Mi ce were injected i. P wi th 5 x 103 pfu MCMV. Thi rty days
., ..
later, groups of 5 mice were injected with either RPMI medium or
anti-asialo GM1 (Anti-AGMl), followed by 3 ml 3 percent
thioglycolate broth i .
p. 
These mice were sacrificed 5 days later
and their organs were titrated for virus; spleen NK cell activity
was also detennined.
p( .
001
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FIGURE LEGEND
Figure 1.
A) Spl eens from control MCMV- infected (1), control uni nfected
(2), or anti-asialo GM1- treated, MCMV- infected (3) mice. The spleen
from the control infected mouse (1) is hyperplastic. The spleen
from the anti-asialo GMl- treated, MCMV- infected mouse 
(3) shows
extensive infarction. Ba r = o. 38 cm.
B) Liver lobes from control MCMV- infected (1), control
uninfected (2), or anti-asialo GMl- treated, MCMV-
infected (3) mice.
The liver lobe from the anti-asialo GM1- treated, MCMV-
infected mouse
(3) is smaller and pale in color as compared to the 
control
MCMV- infected (1) or control uninfected (2) mouse.
Ba r = 0. 40 cm.
C) Spl een from control MCMV- i nfected mouse showi ng hyperplastic
white pulp and intact red pulp. Bar = 100 11m.
D) Spleen from anti-asialo GMl- treated, MCMV- infected mouse
with inactive white pulp and necrotic red 
pulp. I nset shows
thromboembolus (arrow) in a splenic vein. Bar = 100 11m.
E) Liver from control mouse 5 days after MCMV infection shows
regeneration. The hepatocytes have pleomorphic nuclei and mitoses
are frequent (arrows). Few inflanvtory cells are seen. Bar = 50
11m.
F) Liver from anti-asialo GMl- treated mouse 5 days after MCMV
! '
infection. The hepatocytes show severe ballooning degeneration.
;..
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Hepatocytes with viral intranuclear inclusions are present
(a rrows). Inflammtory cells are sprinkled throghout the liver and
regenerative changes are not yet apparent. Ba r = 50 11m.
G) Liver from control mouse 9 days after MCMV infection.
Continuing resolution of the hepatitis is evident. The hepatocyte
nucl ei remain somewhat pl eomorphic and binucl eate cell s are
freCJent. A few inflammtory cells are present in a portal triad
(arrow). Ba r = 50 11m.
H) Liver from anti-asialo GMl- treated mouse 9 days after MCMV
infection shows resolving hepatitis. The hepatocyte nuclei are
somewhat pleomorphic. The ballooning degeneration has resolved.
Foci of inflammatory cells still remain. A liver giant cell is
present (a rrow) . Bar = 50 j,m.
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Abbrevi at ions
IFN interferon
natural killer
CTL cytotoxi c T lymphocyte
MEF mouse embryoni c fibroblast
vacc i ni a vi rus
LCMV lymphocyt i c chori omeni ngi tis vi rus
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Introduction
Interferon (IFN) induced during virus infection may limit disease by direct
medi at i on of anti vi ra 1 effects in cell s or by modul at i on of the host response.
IFN induces the activation and proliferation of natural killer 
(NK) cells (1-3),
enhances macrophage-mediated phagocytosis 
(4) and cytotoxicity (5), and may be
required for the generation of cytotoxic T cells 
(CTl) (6). IFN also alters the
membrane of target cells, rendering them 
resistant to NK cell-mediated lysis (7)
and inducing the expression of cell surface proteins, including major histo-
compatibility (MHC) antigens (8, 9). CTl recogni ze vi ra 1 ant i gens in the context
of syngeneic class I MHC antigens (10). It is thus possible, though never
shown, that IFN may condition target cells for increased susceptibility to anti-
viral CTL by inducing MHC antigen expression. We show here that IFN 
great ly
enhances the susceptibility of virus-infected mouse embryonic fibroblasts 
(MEF)
to CTl-mediated lysis and that this correlates with increased expression of
mouse MHC (H- 2) antigens.
\--
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Materi a 1 s and Methods
An i ma 1 s . C57BL/6 and BALB/c mi ce were purchased from the Jackson Laboratori es,
Bar Harbor, ME. C3H/St mi ce were purchased from West Seneca Laboratori es,
West Seneca, NY. Mice of either sex, 6 to 16 weeks old were used in these
experiments.
Cells. Mouse embryonic fibroblasts (MEF) from BALB/c (H- ) or C57BL/6 (H-
) mice were prepared as described (16), and maintained- in minimal essential
medium (MEM) (GIBCO, Grand Island, NY) supplemented with antibiotics, glutamine,
and 10 percent heat-inactivated fetal bovine serum (FBS) (M. A. Bioproducts,
Walkersvi11e, MD). The continuous cell lines L-929 (H- ) and MC57G (H-
were also mai ntai ned on MEM. BHK cells were grown in Dulbecco s MEM with 10%
tryptose phosphate broth as an additive.
Vi ruses. Lymphocytic choriomeningitis virus (LCMV), Armstrong strain, was
grown in BHK cell s. Vaccinia virus (VV), strain WR , was grown in mouse L-929
ce 11 s.
Treatment of target cell s. Target cells were dispensed in 60 mm Petrie dishes
and some were infected with LCMV at an m. o. i. of . 05 and incubated for 2 days.
VV was added at an m. i. of 5. 0 and the incubation period was 10 hr. IFN-
(Lee Biomo1ecu1ar , San Diego, CA) was then added to some of the virus- infected
and uninfected cultures at 10, 000 U/ml, and the incubation was continued for
an additional 12-24 hrs. In some experiments, supernatants contai ni ng 64 U/ml
IFN- '6generated from concanavalin A-stimulated spleen cells were added. The
cells were then used as targets in cytotoxicity assays.
Cytotoxicity assay. Assay medium was RPMl- 1640 medium supplemented with 0. 1 M
hydroxyethylpiperazine- 2-ethanesulfonic acid (HEPES) (Sigma Chemical
Co., St. louis, MO), 10% FBS, glutamine, and antibiotics.
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The assay was
performed as described (1). Briefly, target cells labeled with 100 uCi sodium
chromate (New England Nuclear , Boston, MA) for 1 hr at 37 C were washed and
mixed with various numbers of effector cells in round-bottomed microtiter
wells at 10
4 target cells/well. For 
spontaneous release determination , medium
was added to the wells, and 1% Nonidet P- 40 was added for maximum release
determi nat ion. Plates were incubated for.fj-8 hrs. at 37 . in a humidified
atmosphere of 5% C02' 95% air. At the end of the incubation, plates were
centrifuged at 200 x g for 5 min, and 0. 1 ml of the supernatant was collected
and counted for radi oact i vity in a Beckman Gamma 5500 Counter (Beckman
Instruments, Palo Alto, CA). Data are expressed as percent speci fi c rel ease:
100 x (cpm experimental - cpm spontaneous)
cpm max mum - cpm spontaneous
Spontaneous release was between 16 and 28%. Standard de vi at ions of quadru-
plicate replica samples were less than 10% of the mean, and are not shown.
Quantitation of cell surface anti ens. For analysis of LCMV surface antigens,
5 x 105 target cells were treated with mouse anti-LCMV antiserum at a final
dilution of 1:50 in a volume of 150 ul, and incubated for 45 min at 4 The
cells were washed and then treated with 100 ul fluorescein isothiocyanate
(FITC) - conjugated goat anti-mouse immunoglobulin (Cappell Laboratories,
Cochranville, PA) at 1:40 for 45 min at 4 The cells were washed and
subjected to analysis by flow cytometry. Surface H- 2 antigens were quantitated
by the same method, using congenic anti- b (B10. A anti-BID) or anti-
(BID anti-BIO. D2) antisera obtained from Dr. Rolf Kiessling, Karolinska
Institute, Stockholm, Sweden, and used at a final dilution of 1:60.
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Results and Discussion
CS7BL/6 (H- ), C3H/St (H- ), or BALB/c (H- ) mice were inoculated i.p.
with 10
7 p.
u. of vaccinia virus (VV) strain WR or 8 x 10
4 p.
u. of lymphocytic
choriomeningitis virus (LCMV) strain Armstrong.
Seven days ater, the mi 
were sacrificed and their spleen leukocytes were used as CTL effectors in
cytotoxicity assays. The target cells were low-passage CS7BL/6 or BALB/c 
MEF,
or the continuous cell lines, L-929 (H- ) and MC57G (H-
). 
'ells were
either untreated, treated with IFN
, infected with VV or LCMV, or infected 
and
later treated with IFN as described in Materials and Methods.
After 1 abe 1 i ng
with Na Cr04' they were used as targets for 
CTL. The results in Figure 1 A,
B, C indicate that pretreatment of VV-or LCMV-
infected MEF with 10, 000 U/ml
IFN- resulted in a substantial increase in the sensitivity of these targets
to virus-specific lysis by CTL.
IFN-P did not enhance the low levels of
lysis observed with uninfected cells.
Pret reatment wi th supernatants contai ni ng
64 U/ml IFN- generated from concanavalin A-stimulated spleen cells yielded
virtually identical results (data not shown).
Lysis of the virus- infected
IFN-)?-treated targets was mediated by CTL, as it was H- 2 restricted and
eliminated by pretreating the effectors with monoclonal anti-
thy 1. 2 antibody
nd compl ement (data not shown). In contrast to the results with T 
cell
killing, IFN- induced protection of both uninfected and LCMV-
infected target
cells against lysis by activated NK cells 
(Fig. 1 D, H). Thi s demonstration
of IFN-mediated protection against NK 
cells indicates that IFN was not increasin\
target cell sensitivity to lysis in 
general. Further, IFN-treated cells did
not exhibit greater spontaneous release 
of label, and they were equally
resistant to anti-LCMV antibody plus complement-mediated lysis as 
compared to
controls (data not shown).
I '
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IFN-induced enhancement of sensitivity to lysis by CTL was seen with both
, '1
" ,
C57BL/6 and BALB/c MEF , suggesting that this phenomenon may be a general
property of low-passage MEF 
(Fig. 1 A, B, C). However, IFN- pretreatment of
virus-infected continuous cell lines, i. e. LCMV-infected L-
929 (Fig. 1 E), VV-
infected L-929 (data not . shown), LCMV- i nfected MC57G (Fi g. 1 F), VV-
i nfected
MC57G (Fig. 1 G), did not enhance their sensitivity to lysis by CTL.
Thi s was
not an unexpected result, as these targets are already highly sensitive to 
lysis by CTL.
The structures recognized by virus-specific CTL are virus-
induced surface
proteins in association with class I MHC antigens 
(10). IF N i s It n own 
enhance the cell surface expression of both MHC (8,
9) and certain viral antigens
(11) in some systems. To investigate the possibility that IFN was altering
surface antigen expression on MEF, we quantitated surface H-
2 and LCMV antigens
by treating MEF with fluorescein-
labeled antibodies and analyzing the cells by
, flow cytometry. The results show that IFN-
pretreatment of MEF had no
significant effect on the expression of surface LCMV antigens 
(Fig. 2 A), but
that both uni nfected and LCMV- i nfected MEF had substantial increases in surface
2 expression (Fig. 3 A, C, F). Analysis of the continuous cell line MC57G
al so showed that surface expressi on of LCMV anti gens 
remai ned unchanged after
IFN pretreatment (Fig. 2 B), but in contrast to the MEF, MC57G cells had
similar levels of surface H-2 antigens whether or not they were pretreated
with IFN-)? (Fig. 3 B, D). Infection with LCMV had only a minor effect on
this observation. MC57G cells were sensitive to other IFN-mediated effects,
as IFN protected these cells from NK cell-mediated lysis 
(Fig. 1 H). The
level of surface H-2 on the untreated MC57G cells was 
simi lar to that on IFN-
treated MEF , suggesting that MC57G cells may already express a level of surface
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2 antigens high enough for efficient association with viral antigens to be
good targets for CTL. Treatment of MEF 
(Fig. 3 E) or MC57G cells (data not
shown) with supernatants contai ni ng 64 U/ml IFN- 
generated fromconcanaval i n
A-stimulated spleen cells yielded nearly 
identical results.
Since MHC class I-restricted virus-specific T cells are known to eliminate
virus 
(12), it is possible that IFN enhances this process by increasing
the sensitivity of virus-infected cells to lysis by CTL.
The source of the
IFN could be either virus-induced IFN-
or IFN- "I produced by T cells upon
recognitio of a target (13). T cell-produced IFN- may locally enhance MHC
expressio in focal areas of infection, thereby increasing the sensitivity of
T cell recognition of virus- infected tissue. Recent fi ndi 
ngs by Pfau and his
associates (14) show that IFN treatment of mice infected intracranially with
LCMV leads to increased mortality.
Si nce death in thi s system has been shown
to be caused by virus-specific T cell-
dependent destruction of brain tissue
(15), it is possible that IFN may be enhancing H-
2 antigen expression on the
surface of brain tissue leading to more destruction of LCMV-
infected cells by
virus-specific T cells. This IFN-induced enhancement of MHC antigens on
virus-infected cells may thus possibly augment T cell-
dependent immunopathology
as well a T cell-dependent cl earance of 
vi rus.
We thank Ms. Marcia McFadden for performing the flow cytometry, and Ms.
Dottie Walsh for typing the manuscript.
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Summary
Interferon (IFN) pretreatment of low-passage mouse embryonic fibroblasts
(MEF) infected with lymphocytic choriomeningitis virus or vaccinia virus
rendered these cells 2 to 3 times more susceptible to lysis by H-
2 restricted
virus-specific cytotoxic T lymphocytes 
(CTL) than control, virus-infected MEF.
The increased sensitivity to lysis correlated with increased expre
sio
surface H- 2 antigens, but not viral antigens.
Cont i nuouS cell 1 i nes already
highly sensitive to CTL-mediated lysis and already expressing high levels of
surface H- 2 antigens were unaffected by IFN pretreatment.
These resul ts
suggest that IFN treatment, by increasing surface H-
2 levels, may result in
increased association of surface H-
2 and virus antigens, which could lead to
enhanced recognition and lysis by virus-specific 
CTL.
;1'
. .
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Fi gure Legends
ure 1. Enhancement of LCMV- and vv-specific T cell-mediated lysis by pre-
treatment of MEF with IFN.
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uni nfected targets. o --- c
A. BALB/c day 7 LCMV- immune
spleen cells were used as CTL effectors 
again t LCMV-infected or uninfected
BALB/c MEF. Same as A, except CTL were C57BL/6 and targets were C57BL/6
MEF. C. C57BL/6 day 7 VV-immune spleen cells were used as effectors against
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(1) against LCMV-
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infected or uninfected L-929 cells.
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Fi ure 2. Surface expression of LCMV antigens.
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Introduction
Natural killer cells become activated (reviewed in 1) and proliferate
3) during the early stages of virus infections, and it has been
hypothesized that they may play a role in natural resistance to viruses
(1) . Although there have been numerous demonstrations of NK cell-
. .
mediated lysis of virus-infected cells in vitro (reviewed in 4), there
has been no definitive demonstration of an antiviral role for NK cells
i n vi vo . Suggest i ve data in support of thi s hypothesis ha ve all been
subject to other interpretations. The mai n approaches ha ve been 
correlate susceptibility to virus infection with NK activity which was
either determined genetically or manipulated experimentally.
In thi s regard, perhaps the best evi dence has been gathered for
murine cytomegalovirus (MCMV)
3 infection. Shellam and coworkers have
shown that genetic resistance of mice to MCMV correlates with their NK
cell activity (5 6), that homozygous beige mice, which have a defect
in NK cell-mediated cytotoxicity, are highly susceptible to MCMV, and
that resistance along with NK cell activity is restored to beige mice
by transfers of bone marrow cells from normal mice (6). Newborn mi ce
which have low NK cell acti ity, are highly sensitive to MCMV 
(7), as
are adult mice whose NK cell activity has been depleted by nonspecific
immunosuppression (8 9). Recently, we have shown that antiserum to
asialo GM 1' a reagent which rather selectively eliminates NK cell
activity in mice, greatly enhances MCMV growth and pathogenesis (10
11).
Biological response modifiers, which activate NK cells in vivo in the
absence of IFN, render mice more resistant to MCMV; this resistance is
abrogated by antiserum to asialo GM 1 (12).
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The above experiments provide a strong argument for a role of NK
cells in resistance to MCMV, but they are not definitive.
For example
beige mice have a biochemical defect whi ch affects functi 
ons other
than NK cells (13), and asialo GM 1 is a common molecule found on
several cell types (14 15). To 
more definitively assess the role of
NK cells in virus infections, we have developed cellular adoptive
transfer methods to identify the effector cells mediating 
natural
res i stance. These methods are used to mani 
pul ate i nfecti ons with MCMV
and with lymphocytic choriomeningitis virus 
(LCMV), which appears to
resist NK cells. LCMV synthesis is normal in beige mice 
(16) and in
mice treated with anti-asialo GMI (10). We 
report here that transfer
only of those populations of cells containing NK 
cell activity can
protect suckl i ng mice agai nst MCMV but not LCMV.
Further , adoptive
transfer of cloned NK but not T cells provide resistance to MCMV but
not to LCMV. These data provide compelling evidence in favor of a
role for NK cells in at least one 
(MCMV) virus infection.
, rr-
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Materi al s and Methods
An i ma 1 s . C57BL/6 and BALB/c mice were purchased from the Jackson
Laboratories, Bar Harbor, ME, then bred in our own facility.
SWR/ J
athymic nude mice were a gift from Dr. Aldo Rossini
, University of
Massachusetts Medical Center. Donor mice in adopti 
ve transfer studies
were 4- 8 wks old, unless otherwise noted.
Cells . YAC-1 cells were derived from a Moloney leukemia virus-
induced
lymphoma from an A/Sn mouse and were maintained in RPMI-
1640 medium
(GIBCO, Grand Island, NY) supplemented with antibiotics, glutamine
and 10% heat-inactivated fetal bovine serum 
(FBS) (M. Bi oproducts,
Walkersvi11e, MD). Mouse embryo fi brobl asts 
(MEF) were obtai ned as
described (17) from C57BL/6 embryos.
Vero cells are a continuous
monkey kidney cell line. 929 is a continuous liver cell line
derived from C3H mice. These cells were maintained in minimal essential
medium (MEM) (GIBCO) with the same additives as listed above.
Baby
hamster kidney (BHK) 21/13S cells were maintained in Dulbecco
s modi-
fi ed Eagl e medi um (GIBCO) suppl emented with 10% tryptose phosphate
broth and the same additives as listed 
above.
Viruses. The Smith strain of MCMV was obtained from Dr. John Nedrud,
Case Western Reserve University School of Medicine
, Cleveland, OH
(18). Salivary glands from BALB/c mice inoculated 2 to 3 wk previously
wi th 104 pl aque formi ng units (PFU) of MCMV were homogeni 
zed in a 10%
suspension and cleared by centrifugation.
Al iquots were stored at -
C in 10% dimethyl sul foxide. The LCMV used in these studi 
es was the
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Armstrong strain, which was grown in BHK cells 
(19). The Indiana
strain of vesicular stomatitis virus 
(VSV) was used in the IFN assays.
totoxicit Assa Assay medium was RPMl- 1640 supplemented with 0.
M N- hydroxyl ethyl pi perazi ne- 2-ethanesul foni c aci 
d (HEPES) (Si gma
Chemical Co., St. Louis , MO), 10% FBS
, glutamine , and antibiotics.
The as say was performed as descri bed (19). Briefly, target cells
labeled with 100 uCi sodium chromate (New England Nuclear
, Boston , MA)
for 1 hr at 37 C were washed and mixed with various numbers of effector
cells in round-bottomed microti ter well s at 10
4 target cell s/well.
For spontaneous rel ease determinati ons , medi urn was 
added to the
wells, and for maximum release determinations
, 1% Nonidet P-40 was
ad ded . Plates were incubated for 4 to 16 hr at 37
C in a humidified
atmos phere of 5% C02 and 95% 
ai r. At the end of the i ncubat ion
plates were centrifuged at 200 X 9 for 5 min
, and 0. 1 ml of the super-
natant was collected and counted for radioactivity in a Beckman Gamma
5500 counter (Beckman Instruments , Palo Alto
, CA). Data are expressed
as percent specific release:
100 x
Spontaneous rel ease of radioacti vity was between 10 and 20%.
Standard
deviations of quadruplicate replica samples were less than 10% of the
mean and were not listed in the tables.
1'-
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Virus titration. Spleen and liver virus titers were determined by
using a 10% homogenate of tissue taken from 
individual mice. The
number of PFU was determined by plaque assay using MEF and Vero cells
for MCMV and LCMV, respectively. Virus titers are reported per spleen
and per gram of liver Resul ts are expressed as the 
geometri c mean
titer, i. e., the arithmetic averages of the logs of four separate
animal s ti trated for vi rus i ndi vidually the standard error of the
mean (SEM). The P val ues represent the si gni fi cance of the di f-
fe rences of the means between the designated sample and the ap-
propriate control, and were calculated using Student'
s t-test.
Antisera. Rabbit antiserum to asialo GM I was purchased from Wako
Chemicals, USA, Inc., Dallas , TX. This antiserum has previously been
shown to selectively deplete NK cell activity 
vivo and in vitro
(14 20). To deplete NK cell activity vivo, anti-asialo GM I was
diluted 1/10 in RPMI medium and given i. v. in a volume of 0.
2 ml , 4-
hr befo re chall enge wi th vi rus. In adopti ve transfer experiments, donor
spleen cells from control mice treated with anti-asialo 8M l were used
18-24 hrs after antibody treatment. Monoclonal anti-thy 1. 2 antibody
was provided by Dr. Edward Clark, Genetic Systems Corp., Seattle, WA
and used at a final dilution of 1:900. Monoclonal anti-Ly 5. 1 (clone
M1/89. 18) and anti-Ia (clone M5/114) antibodies, gifts from Dr. Eric
Martz, University of Massachusetts , Amherst
, MA (21) were used a final
dilution of 1:40 and 1:100 , respectively.
The antiserum to NK 1. 2 was
a g1ft from Dr. Robert Burton (22) and was used at a final dilution of
1: 40. For vitro treatment of spleen cells, 2. 5 - 4. 0 x 10
8 spleen
leukocytes were suspended in 2. 5 ml RPMI containing antibody and
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incubated for 20-30 min at room temperture with occasional agitation.
Two hundred and fifty ul of guinea pig serum (a source of C' ) was then
added and the incubation ' was continued at 37 C for an additional 45
mi n. The cells were washed twice and resuspended in RPMI for use in
adopt ive transfer and cytotoxicity assays. The cell numbers transferred
refe r to the number of vi ab 1 e cell s before the antibody and C' treatment.
Cloned NK cells. NKIB6BI0 , a clone of IL- dependent NK cells derived
from C57BL/6 mice, was maintained as described (23), with a few modifi-
ca t ions. Growth medium was RPMI-1640 supplemented with 2mM L-glutamine,
1 mM sodium pyruvate , 0. 1 mM MEM non-essential amino acids (GIBCO), 5
x 10
5 M 2-mercaptoethanol
, 50 U/ml penicillin and streptomycin , 100
ug/ml gentamyci n, 5% FBS , and 24% supernatant deri ved from concanaval in
A-stimulated mouse spleen cells as a source of IL-2. For use in
experiments, cells growing in 25 or 75 cm
2 flasks were washed and
adherent cells were removed with trypsin-EDTA (GIBCO) and diluted 1:4
in growt h medi um. Thi s suspensi on was then incubated at 37 C for 1 hr
in a conical test tube , with occasional agitation. Cell s were then
counted, pelleted at 200 x g for 5 min , and resuspended in RPMI for
use in cytotoxicity assays and adoptive transfers. As a control , a
C57BL/6-derived cytotoxic T line (CTLL-2 clone 15 H) (24), routinely
used as indicator cells in IL-2 bioassays, were also used.
Ado tive transfers. Recipients were C57BL/6 suckling mice 3-5 days of
age. Before use in experiments , mice from several litters were pooled
and randomly assigned to lactating mothers. Groups of 4-9 mi ce were
given an injection of cloned NK cells or mouse spleen cells treated in
various ways. The volume was 0. 1 ml delivered i.p. using a 1 
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syringe and a 30 gauge needle. The next day, mice were challenged
with 6 x 10
3 PFU of MCMV or 8 x 103 PFU of LCMV i . p. in a volume of
1 ml. Mice were either. monitored daily for survival, or sacrificed
3 days later and their spleens removed for virus titration 
(see Fig. 1
A) . In some experiments using the cloned NK cells (23) four-week old
C57BL/6 mice were given four weekly doses of 200 rads of 
radiation
from a 60Cobalt source. Fi ve weeks after the last dose, the mice were
given 10 ul anti-asialo GM I i. v., followed 2 days later by 4 x 10
cloned NK cells, half given i. p., the other half given i.
Si x days
later, i.p. and i. v. injections were again administered
, each con-
sisting of 10
6 cloned NK cells. Ten days after the last injection
groups of 5 mice were challenged with an 
i . p. injection of 10
4 PFU of
MCMV. Controls consisted of irradiated, anti-asialo GM
-treated mice
not receiving injections of NK cells. Three days ater, the mice were
sacrificed, and their spleens and livers were titrated for virus 
(see
Fig. 1 B).
Interferon assa Blood was collected in heparinized Natelson tubes
from the retro-orbital sinus of mice anaesthetized with ether, and
plasma was obtained by centrifugation.
Pl asma were ti trated by two-
fold serial dilution in a 96-well, flat-
bottomed microtiter plate to
which L- 929 cells were added at 3 X 10
4 cells/ well. Eighteen to 24
hr 1 ater, the well s were challenged with 100 TC 1050 units of VSV.
IFN
titers were expressed as the 1092 of the highest 
reciprocal dilution
resulting is a 50% reduction in cytopathic effect.
Results are ex-
pressed as the geometric mean titers of separate animals titrated for
IFN individually 
SEM.
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Centrifu al elutriation. Size separation of cells was accomplished
using a Beckman JE-6B centrifuge (2). About 1 x 10 spleen leukocytes
were treated with deoxyribunuclease (Sigma) to prevent clumping.
These cells were then loaded into the rotor which was spinning at 3200
rpm at 5 The rate of flow of elution medium (Hank' s balanced salt
so 1 ut ion , 1. 5% cal f serum) was 15 , 22 , 28 , and 46 ml Imi n and corresponded
to fract ions 1 through 4 , respecti vely. Cell recovery was about 65%.
Fraction 2 was used as a source of purified lymphocytes.
Enrichment of NK cells. Spleen leukocytes (1. 6 x 10 ) were passed
through nylon wool col umns and then further separated on di scont i nuous
Percoll gradients according to the method of Kumagai et ale (25) with
some modifications. One part lOX phosphate buffered saline (PBS) and
one part FBS were added to 8 parts Percoll to obtain 80% Percoll.
This was further diluted using RPMI-1640 containing 10% FBS. Six to 7
X 10
7 cells were suspended in 3 ml 64% Percoll and pipetted into a 15
ml conical test tube. Three ml of 59%, 50%, and 37% Percoll were
sequentially layered on top of the cell suspension. Centri fugat i on at
300 x g at 20 C was 45 min in duration. Cells at the very top of the
gradient were discarded. Cells floating atop the 59 and 50% Percoll
bands were pooled, and those atop the 63% band were pooled with those
in the pellet. The 1 atter cell s were found to be devoi d of NK cell
activity, and were used in adoptive transfer experiments. The cell s
fran the 59 and 50% bands were pool ed and further purifi ed on a second
Percoll gradient. Six x 107 of these cells were suspended in 6 
59. 5% Percoll and 3 ml of 55. 0 and 37. 0% Percoll were sequentially
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layered on top of the cell suspension. Centrifugation was carried out
as before, and cells floating atop the 55. 0% Percoll band were washed
and used in adoptive transfer studies , as they were found to be enriched
for NK cell activity.
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Resul ts
Protection a ainst lethal MCMV b ado tive transfer of adult s
leen
leukoc tes or l hoc tes. Suckl ing mice have low NK cell acti vity
and are much more susceptible to MCMV infection than adult mice 
(7),
and Sel grade and Osborn have shown that adul t spl een 1 eukocytes coul 
protect suckling mice against lethal MCMV infection 
(17). Figure 2 A
shows that adoptive transfer of 5 X 10 , 1 eukocytes from 4-8 wk 01 
mice significantly prolonged the survival of mice lethally infected
with MCMV , but that transfer of 1. 7 X 10
7 or fewer leukocytes did not.
Fi gure 2 B shows that 5 X 10
7 spl een 1 
eukocytes from 5 wk 01 d donors
were significantly more effective than those from 17 day old donors in
prolonging the lives of MCMV-infected suckling mice.
To further
define which population of leukocytes was providing protection, we
obtained purified spleen lymphocytes by performing centrifugal elutri-
ation on unseparated spleen cells. Fraction 2 was routinely found to
contai n about 98% lymphocytes and ( 1% of the cell s were capabl e of
phagocytizing yeast particles , indicating minimal contamination with
mac rophages. Figure 2 C shows that these purified lymphocytes were
more capable than unfractionated leukocytes in prolonging survival.
These experiments demonstrate that protection can be mediated by a
popul ation of spl een lymphocytes present in adul t but not 17 day 01 d
mi ce.
T cell de letion does not affect rotective ca acit Spleen leuko-
cytes were depleted of T cells by treatment with monoclonal anti-thy
2 and C' and then adoptively transferred into recipient suckling
---
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mi c e . This treatment kills about 35% of the cells, eliminates LCMV-
specific cytotoxic T cell activity of sensitized spleen cells, but has
little effect on NK cell activity (19). Fi gure 2 0 shows that T cell-
depleted spleen leukocytes were just as protective as those treated
with C' only, leading us to conclude that protection occurs in the
absence of adoptively transferred T cells.
Another line of evidence
indicating that protection can occur without T 
cells, is shown in
Figure 3. Athymic nude mice were either left untreated or selecti vely
depleted of NK cell activity by injection with anti-asialo GM I antibody.
Four to six hours later, the mice were challenged with MCMV. 
The data
show that MCMV-infected NK cell-depleted mice had 5-6 times more liver
virus and 2-3 times more spleen virus than control MCMV-
infected mice.
This provides evidence that T cells are not required for the anti-
asialo GM 1 antiserum-mediated exacerbation of MCMV infection.
letion of NK cells results in loss of 
rotection. Spleen leukocytes
from adult mice either untreated or NK cell-depleted by injection with
anti-asialo GM 1 18-
24 hr earlier were adoptively transferred into
suckling mice. This treatment reduced NK cell activity from 21 to -
7% . Figure 2 E shows that the cells from mice depleted of NK 
cell
activity by anti-asialo GM 1 failed to prevent the death of mice infected
with MCMV , whereas control leukocytes totally prevented death.
Treatment
of leukocytes with monoclonal anti-Ly 5 antibody and C' reduced NK
cell activity from 20 to 8. 6% and eliminated the protection
, but
treatment with monoclonal anti- Ia antibody and C' , which killed 40% of
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spleen leukocytes , but did not deplete NK cell activity, had no effect
on the ability of spleen cells to protect (Fig. 2 F). 
This shows that
leukocytes depleted of B cells and other la-
bearing cells can still
protect agai nst 1 ethal i nfecti on.
Reduction of s leen virus titers b ado tive transfer bf NK-enriched
Leukoc es. Since previous studies showed that increased 
survival
correlates with lower spleen MCMV titers (11), we titrated the spleens
of MCMV-infected suckling mice 3 days postinfection.
The data in
Table 1 A, B, C, D, show that ' those mice receiving control adult
spl een leukocytes had si gni fi cantly lower spl een MCMV ti ters than
those receiving no cells. Transfer of nylon wool-
passed cells also
reduced MCMV titers in recipients, confirming the data in Figure 2
showing that cells depleted of B cells and macrophages can protect
(T ab 1 e 1 A). Nylon wool-passed leukocytes were next subfractionated
in Percoll gradients to enrich for or to deplete NK cells (Table 1 
B).
The experiment depicted in Fi gure 2 A suggested that 1. 7 X 10
7 control
spl een cells did not enhance survi val, but that three times as many of
these cells did. Table 1 B shows that 1. 7 X 10
7 control spleen cells
resulted in only a 3-5 fold reduction in MCMV titers in the recipient
spleens, but that the same number of cells enriched 3-
fold for NK cell
activity in low density fractions after Percoll purificatio resulted
in about a 1. 5 10910 (50-fold) decrease in MCMV titers. Mice receiving
an equal number of Percoll-separated hi gh-densi ty cell s devoi d of 
cell activity were not at all protected. Thus, nylon wool passed
Percoll gradient fractionated spleen cells enriched for NK 
cell activity
:i'
;.;
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have an enhanced capacity to reduce vi rus ti ters as compared to control
spleen leukocytes or those devoid of NK cell activity.
Fai 1 ure of NK- eted eukoc tes to reduce vi rus titers. Irrunochemi ca 
depletion of NK cell activity from the donor spleen before adoptive
transfer drastically reduced the ability of the spleen cells to inhibit
- .
MCMV synthesis in recipients. Transfer of adult spleen cells treated
with anti-NK 1. 2 and C' (Table 1 C) or spleen cells from anti-asia10
treated mice (Table 1 D) resulted in recipient spleen MCMV titers
which were nearly a 10910 higher than those of recipients receiving
control adult spleen cells.
Cloned NK cells rovide rotection a ainst MCMV. To fu rthe r st ren gthen
the evidence that NK cells are mediating antiviral effects vivo , we
used the cloned IL- dependent NK cell line NK1B6B10 as donor cells in
adopt ive transfer experiments. The data in Table 1 D, E show that
these cells were extremely effecti e in reducing MCMV titers , as mice
receiving the cloned NK cells had about 500-fo1d less MCMV in their
spleens than did mice receiving either no cells or an IL- dependent T
cell clone (CTLL-2 clone 15 H) (24) also derived from C57BL/6 mice.
On a ce11-to-ce11 basis the NK clone was greater than 100-ti mes more
effective than adult leukocytes , as 5 X 10
5 of the cloned cells were
far more effective at reducing MCMV titers than were 5 X 10
7 leukocytes.
These experiments show that an NK cell clone by itself can limit MCMV
replication, and that an irrelevant T cell clone cannot. Cloned NK
cells were also capable of enhancing the survival of MCMV-infected
mice, as 75% of mice receiving only 3 X 105 NK cells survived , as
compared to 0% of control mice (Fig. 4).
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To test whether the NK clone could protect adult mice from MCMV
6-week-old mice were irradiated four times with 200 Rads at weekly
intervals to deplete NK cell activity and then given injections of the
cloned NK cell s . The reconstituted recipients had elevated spleen NK
activity and reduced virus titers in their spleens and livers (Fig.
. .
5) . IFN levels were slightly higher in the unreconstituted mice
which synthesized more virus. The experiments provide evidence that
NK cells can mediate antiviral effects in adult as well as suckling
mice.
Ado t ive transfer of NK cell s has no effect on LCMV ti ters. Previous
evidence (10 16) has suggested that NK cells do not play a role in
limiting LCMV synthesis during acute or persistent infection. To test
this hypothesis using our adoptive transfer system, we transferred
either 5 X 10
7 adult spleen cells or 5 X 105 cloned NK cells into
suckling mice and then challenged them the next day with LCMV. Tab 1 e
2 A , B shows that the transfer had no effect on LCMV synthesi s in the
spleens of recipient mice. Thus , adopti ve transfer of NK cell s markedly
inhibited MCMV synthesis but had no effect on LCMV synthesis.
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Discussion
The results presented in this paper provide compelling evidence
that NK cells play a major role in imiting MCMV synthesis and MCMV-
induced mo rtal i ty. Table 3 summarizes this evidence and collectively
shows that the phenotype of the protective cell population is that of
+ -
a nylon wool non-adherent , aS1alo GM I ' NK 1.
, Ly 5 , thy- , Ia 
low-density lymphocyte. This describes an NK cell (reviewed in 26).
In each case, the presence or absence of NK cell 
acti vity in the
adoptively transferred population correlated with resistance and
sensitivity to MCMV , respectively.
Because data for survi val curves must be accumul ated over a
period of 2-3 weeks, it is possible that over that period of time
subpopulations of spleen cells could differentiate and subsequently
provi de resistance, maki ng the resul ts di ffi cul t to interpret. However
in many experiments , suckling mice receiving NK cells were larger and
weighed more than mice not receiving NK cells, even three days postin-
fection (data not shown). Previous studies with anti-asialo GM
suggested that NK cells could mediate their antiviral effects up to 3
days postinfection, but not at 6-9 days (11). The present experiments
involving titration of MCMV in the spleen 3 days postinfection confirm
th is res ul t and i ndi cate that the resul ts are not due to di fferent i a-
tion and sensitization of T cells over the long time period.
T ce 11 s
are reported to mediate antiviral effects 6- 30 days postinfectio
. (27). Further arguments against a role for T cells early in infection
! T'
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include the fact that NK depletion lowers the resistance of athymic
nude mice to MCMV infection (Fig. 3) and the lack of effect of T cell
depletio by antiserum to thy 1. 2 plus C' on the antiviral action of
transferred spleen cells (Fig. 2 D). Whereas some NK cells express
some thy 1 antigen .(26), the concentrations of antiserum and C' used
he re deplete CTl activity but have 
itt 1 e effect on endogenous NK cell
activity (19).
Selgrade and Osborn (17) concluded that either unstimulated
macrophage-depleted spleen leukocytes or thioglycollate-
induced peri-
toneal macrophages could enhance 
survi val of MCMV-infected suckl 
ing
mice. However, the nature of the spleen leukocyte was not identified.
It was not shown whether unstimulated macrophages could provide re-
si stance to MCMV, as the macrophages used in those studi es 
were thi 0-
glycol late- induced. Our studies were not designed to answer this
question, but nevertheless show that spleen cells depleted of macro-
phages by nylon wool passage or size separatio
retained the capability
to provide protectio Thus , adoptive transfer of macrophages is not
essent i al to transfer of resi stance. Antibodies which leave macro-
phage function intact, such as anti-asialo GM l' anti-
Ly 5, and anti-
2, eliminate both NK cell activity and protection against MCMV.
There has been little evidence to implicate neutrophils in re-
s i stance to MCMV. Our adoptive transfer experiments show that populations
of spleen lymphocytes with ) 98% purity are quite capable of mediating
resistance. Neutral i zi ng anti body can be detected as early as 3 days
postinfectio of adult mice, and thus could possibly mediate protectio
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(28), but our experiments show that depletion of B cells by treatment
with anti- Ia and C' or by nylon wool passage did not remove the pro-
tective capacity of spleen cells, indicating that adoptive transfer of
B cells was not required for protection.
The survi val curves i ndi cated that 5 X 10
7 adu 
1 t sp 1 een cell s
could prolong survival of MCMV-infected mice, but that 3-
fold fewer
ell s c ou 1 d not. If the protecti on were medi ated by NK cell s , then 3-
fold fewer spleen cells with three times as much NK 
cell activity
should protect. This prediction was supported by our data, as 1.
7 X
7 unfractionated spleen cells or the same number of NK cell-deficient
spleen cells did not fully protect , while 1. 7 X 10
7 spleen cells
enriched 3-fold for NK cell activity significantly reduced MCMV titers.
Previous work using an IL- dependent cloned NK cell line showed
that these cells were capable of mediating resistance to tumor implants
and bone marrow transpl ants (29). These cell s have the phenotype
aS1alo GM I ' NK 1.
2 , thy- , Ly 1 , Ly an are capable of mediating
in vitro lysis against NK-sensitive YAC- l tumor cells 
(23). Our
results show that these cells are capable of providing protection
against MCMV , but not LCMV. In contrast , a cloned T cell line also
derived from C57BL/6 mice provided no protection , indicating that
cloned lymphoid cells in general do not necessarily protect.
The data
obtained with cloned NK cells also indicate that no other adoptively
transferred cell population was needed for protection; NK cells either
directly mediated resistance or were solely responsible for triggering
reci pi ent defense mechani sms.
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We concl ude from our resul ts that NK cell s can provi de protecti on
against at least one (MCMV) but not all (LCMV) virus infections.
There are other data consistent with the concept that NK cells playa
role in murine infections with herpes simplex virus (30), mouse hepatitis
rus (10 31), Friend leukemia virus (32), and vaccinia virus (10).
There also is evidence consistent with the hypothesis that NK cells
may inhibit outgrowth of tumor cells persistently infected with measles
or vesicular stomatitis virus (33). Evidence agai nst a rol e for 
cells has been provided for LCMV (10 16) and Sindbis virus (34). Why
NK cells should play a role in some but not all virus infections is
not known, but the accompanyi ng paper shows that the NK cell system
may have an ability to selectively lyse cells infected with MCMV , an
NK-sensitive virus , but not LCMV , an NK-resistant virus.
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Summary
Adoptive transfer studies were carried out to determine the role
of NK cells in resistance to murine cytomegalovirus 
(MCMV) and lymphocytic
choriomeningitis virus (LCMV). Leukocytes from adult mice were trans-
ferred into suckling mice 1 day prior to infection with virus.
Re-
si stance was measured by enhancement of survi val and reducti on of
virus synthesis in the spleens of recipient mice.
The phenotype of
the cell population capable of mediating resistance to MCMV was that
of a nylon wool non-adherent , asialo GM ' NK 1.
, Ly 5 , thy-
, low-density lymphocyte; this is the phenotype of an NK cell.
Cloned NK cells but not cloned T cells provided resistance to MCMV in
suckling mice. Cloned NK cells also provided resi stance to MCMV in
irradiated adult mice, and antibody to asialo l' wh 
i c h depl etes 
cell activity vivo, enhanced the synthesis of MCMV in athymic nude
mi ce. Neither adult leukocytes nor cloned NK cells influenced LCMV
synthesis in suckling mice. We conclude that a 
general property of
NK cells may be to provide natural resistance to virus infections and
that NK cells could protect mice from MCMV but not from LCMV.
i ..
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Tabl e 1
Reduct ion of MCMV titers by adopti ve transfer of
NK cell act i vi t 
% NK lysis
lo910 PFU
E:T donor cell s cell s/treatrnent MCMV /s
1 een
rned i urn 1 + 0.
N. D. 5 X 10 cont ro spleen 5 + 0.
5 X 10 nylon wool-
passed spl een
3 + 0.
rnedi urn 9 + 0.
7 X 10
7 NK-depleted 1 + 0.
39. 7 X 10 NK-enri ched 5 + 0.
14. 1.7 X 10 cont ro 1 s p 1 een
4 + 0.
14. 0 X 10 control s p 1 een 1.4 + U.
rned i urn 1 + 0.
29. 5 X 10 control spl een 7 + 0.
24. 5 X 10 control spleen + 8 + 0.
5 X 10 control spleen +
anti -NK + C 7 + 0.
rned i urn 6 + 0.
23. b 5 X 10 control spl een 2 + 0.
5 X 10 anti -AGM 1 spl een 1 + 0.
N. D. 5 X 10 cloned NK cell 1.9 + 0.
rned i urn
5 + 0.
40. 5 X 10
5 cloned NK cell s 1.8 + 0.
5 X 10
5 cloned T cells 4 + 0.
.:'
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Table 1 - Continued
Groups of 4 suckling mice were given i. p. injections of cells
treated as i ndi cated above, or RPMI -1640 medi urn. The next day,
they were challenged with 6 X 10
3 PFU of MCMV. Three days
later the mice were sacrificed and their spleens were titrated
for MCMV.
% NK lysis refers to % specific release
at a given effector:target (E:T) ratio
Materi al s and Methods.
agai nst YAC-l targets
as desc ri bed in
p ( .
001 as compared to medium.
01 as compared to 1. 7 X 10
7 control spleen.
 
01 as compared to control spl een + C I
01 as compared to control spleen.
g
001 as compared to cloned T cell s.
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Tabl e 2
Adoptive transfer of cell populations containing NK
cell activity has no effect on LCMV titers
Cell s/treatment
109
10 pfu
LCMV /s l een
7 + 0.
4 + O.
medi urn .
5 X 10 control spleen
medi urn
5 X 105 cloned NK cells
7 + 0.
7 + 0.
Groups of 4 suckling mice were given i. p. injections of
cells treated as indicated above, or RPMI medium. The next
day, they were challenged with 8 X 10
3 of PFU LCMV. Three
days ater, the mi ce were sacri fi ced and thei r spl eens were
titrated for LCMV.
Not significantly different from medium.
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Tabl e 3
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Summary of adopti ve transfer experiments
Cell s/treatment
Contro 1 adul t spleen eukocytes
Contro 1 adul t spl een lymphocytes
17-day-old spleen leukocytes
Contro 1 spl een + anti-thy 1. 2 + C' yes
Control spleen + anti- Ia + C'
Control spleen + anti-Ly 5 + C'
Spleen leukocytes from anti-asialo
GM-treated mi 
Control spleen + anti-NK 1. 2 + C'
Cloned T cell s
Cloned NK cell s
Low-density spleen cells
High-density spleen cells
NK ce 11
acti vit
antiviral effect
ai nst MCMV
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
:!.
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Fi ure Le end
Fi ure 1. Adoptive transfer protocols. Cloned NK cells or spleen
eukocytes from adu1 t C57BL/6 mice 6-8 week 01 d were fractionated and
given i.p. to suckling mice 3-5 days old. The next day, MCMV or LCMV
was given i.p. The mice were either monitored for survival for 20
days, or sacrificed 3 days postinfection and their spleens titrated
for virus. Adult C57BL/6 mice were given four weekly doses of
radiation and then given cloned NK cells i.p. and i. v. The mice were
then challenged with 10
4 PFU of MCMV i.p. and were sacrificed 3 days
ater.
Fi ure !. Effect of adoptive transfer of various spleen cell popu-
lations on survival of MCMV- infected suckling mice. Suckling mice 3-
days old were given 5 X 10
7 spleen cells (unless otherwise indicated)
or medium i.p. followed 24 hr later by 6 X 10
3 PFU of MCMV i.p. Mice
were monitored for survival for 20 days. Vari ous numbers of adu1 t
sp1 een eukocytes were transferred. N = 5 mi ce/ group. Sp 1 een
leukocytes from suckling and weanling mice were used as donor cells.
N = 5-6 mice/group. Spleen leukocytes or size-separated 1ympho-
cyt es we re used as donor cell s. N = 6 - 7 mi ce/ group. Sp 1 een
leukocytes treated with C. or anti-thy 1. 2 and C. were used as donor
cells. N = 7 mi ce/ group. Spleen leukocytes from control or anti-
asia10 GM treated mice were used as donor cells. N = 7-9 mice/group.
F. Spleen leukocytes treated with C. , anti-Ly 5 and C. , or anti-
and C' were used as donor cells. N = 6 mi ce/ group.
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Fi ure l. NK cell depletion lowers resistance to MCMV in nude mice.
GroupS of four SWR/ J athymi c nude mi ce were eft unt reated or gi ven 20
u1 anti-asia10 GM 1 i.
v. Four to 6hr later, these mice were chal-
lenged with 5 X 10
3 PFU of MCMV i.p. Three days later , the mice were
sacrificed and their organs were titrated for MCMV , their spleens were
assayed for NK cell activity, and their plasma was titrated for IFN.
Fi ure i. Cloned NK cells enhance survival of MCMV-infected suckling
mice. Cloned NK cell s were adopti ve1y transferred into reci pi ent
suck1 i ng mi ce and then cha 11 enged 24 hr ater wi th 6 X 10
3 PF 
U of
MCMV. Control mice received no cells. Mice were observed 20 days for
mortal ity.
Fi ure 
N = 8 mice/group.
Cloned NK cells inhibit MCMV replication in adult mice.
Adult C57BL/6 mice were irradiated and left untreated or injected with
cloned NK cells as described in Materials and Methods. . These mice
were then challenged with 10
4 PFU of MCMV i .p. and sacrificed three
days ater. Spleens and livers were titrated for MCMV, spleens were
assayed for NK ce11 activity, and plasma was titrated for IFN.
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Abbrevi at ions:
LCMV ymphocyt i c cho ri omen i n gi tis vi rus
MCMV muri ne cytomega 1 ovi rus
vaccinia virus
MOl mu1tip1icity of i nfecti on
MEF mouse embryo fi brob1 ast
natura1 ki11er
IFN interferon
CPE cytopathic effect
SEM standard error of the mean
MHV mouse hepati tis vi rus
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Introduct ion
Since the augmentation of natural killer (NK) l cell activity
during acute viral infection was first described (1-4), circumstantial
evidence that NK cells may play a role in .the host defense against
virus infections has been accumulating (5-8). Much of this evidence
has been obtained using acute murine cytomegalovirus (MCMV) infection
as a model. Mice with low NK cell activity caused by lack of age (9),
genetic predisposition (10), immunosuppressive drug treatment (11), or
the beige mutation (8) are more susceptible to MCMV infection. Se 1 ecti ve
depletion of NK cell activity by injection with antibody to asialo
I results in increased virus synthesis and severe pathological
ch anges in MCMV- i nfected mice (12 13). In contrast to the resul ts
with MCMV , all the available evidence suggests that NK cells do not
protect mi ce agai nst lymphocyti c chori omeni ngi ti s vi rus (LCMV) i nfecti on
(12 15). We have recently shown that nylon wool non-adherent
asialo GM
I ' NK 1.
2 , Ly 5 , thy- , Ia , low-denslty lymphocytes
(this is the phenotype of NK cells) when adoptively transferred to NK-
cell deficient suckling mice result in enhanced survival and reduced
virus titers in MCMV-infected but not LCMV-infected recipients
Further, IL- dependent cloned NK cells also provided resistance to
MCMV , but not LCMV.
Both LCMV and MCMV induce the activation of NK cells in vivo
(10 16), but it is not known why NK cells provide resistance to MCMV
but not LCMV. Some evi dence (17) suggests that MCMV can induce NK
I .
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cells with characteristics different from those induced by other
viruses. It is thus possible that MCMV is capable of inducing a type
of specialized antiviral NK cell whereas LCMV is not.
A possible mechanism whereby NK cells could mediate antiviral
effects is by preferential lysis of virus-infected cells over uninfected
cells . Endogenous spleen cells containing NK cell activity lyse MCMV-
infected cells more effi ciently than uni nfected cell s (18, 19), but
this is not known to occur in the LCMV system 
(16). Acti vated 
cells lyse LCMV-infected and uninfected cells to the same degree
(16, 20), but MCMV-infected cells are less sensitive than uninfected
cells to lysis by effectors resembling activated NK cells 
(10). This
decreased sensitivity of virus-infected targets to activated NK cells
has also been observed with several other virus-cell systems 
(20).
Tri nchieri and coworkers (21) made the observati on that human
target cells could be protected from NK cell-mediated lysis by interferon
(IFN) pretreatment, but not if they were infected with vaccinia 
(VV)
or influenza viruses. Further, they demonstrated that target 
cell s
treated with inhibitors of protein or RNA synthesis could not be
protected by IFN (21), and thi s was confi rmed in the muri ne system
(22) . Because MCMV shares wi th i nfl uenza and vacci ni a vi ruses the
ability to induce a cytopathic effect (CPE), and because LCMV is
relatively noncytopathic (23), we tested the hypothesis that LCMV- but
not MCMV- or VV-infected cells could be protected from NK cell-mediated
1 ys i s by IF N.
\rlll
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In thi s paper, we characteri ze the endogenous and MCMV-acti vated
effectors capable of lysing MCMV-infected targets as NK cells, and we
show that IFN pretreatment almost totally protects uninfected and
LCMV-infected cells, while leaving MCMV- or VV-infected cells susceptible
to lysis by activated NK cells. We also show that selective depletion
of NK cell activity in vivo results in increased titers of spleen MCMV
but not LCMV in mice simultaneously infected with both viruses. These
data could explain why NK cells may play a role in resistance to MCMV
and VV , but not LCMV.
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Materi al s and Methods
Animal s. C57BL/6 and BALB/c byJ mi ce were purchased from the Jackson
Laboratory, Bar Harbor , ME. C3H/St mi ce were purchased from West
Seneca Laboratories, West Seneca , NY. Mice of either sex 6 to 10 wk
old were used in these experiments.
Cells. YAC-l cells were derived from a Moloney leukemia virus- induced
lymphoma in A/Sn mice and were maintained in RPMI 1640 medium (GIBCO
Grand Island, NY) supplemented with antibiotics, glutamine, and 10%
heat-inactivated fetal bovine serum (M.A. Bioproducts, Walkersville,
MD) . 929 is a continuous cell line from C3H mice. Mouse embryo
fibroblasts (MEF) were obtained as described (24) from C57BL/6 embryos.
Vero cells are a continuous monkey kidney 
cell line. These cells were
maintained in minimal essential medium (GIBCO) with the same additives
as 1 i sted above. Baby hamster kidney (BHK 21/13S) cells were main-
tained in Dulbecco s modified Eagle medium 
(GIBCO) supplemented with
10% tryptose phosphate broth and the same 
additi ves as isted above.
Vi ru ses. The Smi th strai n of MCMV was obtai ned from Dr. John Nedrud,
Case Western Reserve University School of Medicine, Cleveland, OH 
(25).
Salivary glands from BALB/c mice inoculated 2 to 3 wk previously with 10
PFU of MCMV were homogenized in a 10% suspension and cleared by centrifu-
gation. Aliquots were stored at - C in 10% dimethylsulfoxide.
For
infection of target cells, salivary gland virus was passed in MEF 3 times,
and aliquots were stored at - C without dimethylsulfoxide.
The LCMV
used in these studies was the Armstrong strain, which was grown in BHK
cells (26). The WR strai n of VV was grown in L-929 cell s. The Indi ana
strain of vesicular stomatitis virus (VSV) was used in the IFN assays.
1'1, I
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Infect i on of tar et cell s. MEF were dispensed in 25 cm
2 plastic
flasks (Falcon; Oxnard, CA), and were infected with MCMV at a multipli-
city of infection (MOl) of 3-5 and used in cytotoxicity assays 3 days
1 a ter . Greater than 99% of the cell s were infected, as judged by cyto-
pathic effect (CPE). With LCMV, the MOl was . 005-
05 and the cells
were used in cytotoxicity assays 3 days post- 
infection, when they
were fully susceptible to LCMV-specific T 
cell-mediated lysis. Cell s
were infected wi th VV at an MOl of 5, and used as targets 24 hr 
ater.
Interferon retreatment of tar et cell s. Twel ve to twenty-
four hr
before use in cytotoxicity assays, when
) 99% of MCMV- or VV- infected
MEF had CPE, or when about 80% of LCMV-
infected MEF were susceptible
to LCMV-specific T cell-mediated lysis, beta 
interferon (Lee Biomolecular,
San Diego, CA) was added to the culture fluid at 10
000 U/ml. These
cells, along with untreated control cells, were 
then washed and labeled
as described in the next section.
totoxi cit assa Assay medi urn was RPMI- 1640 medi 
urn suppl emented
with 0. 1 M N- hydrOxylethylpiperazine- 2-ethanesulfonic acid (HE 
PES)
(Sigma Chemical Co., St. Louis, MO), 10% FBS, glutamine, and antibiotics.
The assay was performed as described (16). Briefly, target cells
labeled with 100 uCi sodium chromate (New England Nuclear, Boston, MA)
fo r 1 hr at 37 C were washed and mi xed with various numbers of effector
cells in round-bottomed microtiter wells at 5 X 10
3 target cells/well.
For spontaneous release determinations, medium was added to 
the wells,
and 1 % Nonidet P-40 was added for maximum release determinations.
Plates were incubated for 4 to 20 hr at 37 C in a humidified atmosphere
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of 5% C02 and 95% 
ai r. At the end of the incubation, plates were
centri fuged at 200 X G for 5 mi n, and 0.
1ml of the supernatant was
collected and counted for radi oacti vity in 
a Beckman Gamma 5500 counter
(Beckman Instruments , Palo Alto, CA).
Data are expressed as percent
specific release:
Spontaneous rel ease was between 10 and 38 
Standard devi at ions of
quadruplicate replica samples were less than 10% of the mean and were
not 1 i sted in the tables.
Activation of effector cells. 
C57BL/6 mice were injected i.
p. with 3
X 10
5 PFU salivary gland MCMV, and spleen cells were isolated the next
day (10). For LCMV , the dose was 8 X 10 
PFU, and the spleen cells
were used 3 days later (16).
Ant i se ra. Rabbit antiserum to asialo GM1 was purchased from Wako
Chemicals, USA, Inc., Dallas, TX.
This antiserum has previously been
shown to select i ve 1 y deplete NK 
cell acti vi ty i'n and .i 
vi t ro ,
diluted 1:10 in RPMI medium and given i.
v. in a volume of 0. 2 ml
, 4-
( 27 -3 0) . To deplete NK cell activity in 
vivo, anti-asialo GM 1 was
hr before challenge with virus.
Anti-asialo GM1 was used in vitro at
a final dilution of 1:20. Monoclonal anti-thy 1.
2 antibody was
provided by Dr. Edward Clark, Genetic systems Corp., Seattle, WA and
used at a final dilution of 1:150.
Monoc 1 ona 1 anti -Ly 5. 1 antibody,
clone M1/89, a gift from Dr. Eric Martz, University of Massachusetts,
Amherst , MA (31), was used at a final dilution of 1:10. 
For in vitro
treatment of spleen cells, 2- 5 X 107 spleen leukocytes were suspended
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in 100 ul antibody and incubated for 20-
30 min at room temperature.
Twenty-five ul guinea pig serum diluted 1:2, a source of C
, was then
added, and the mixture was further incubated at 37
C for 45 min.
The cells were then washed twice and resuspended in assay medium for
use as effectors in cytotoxicity assays.
Rabbi t anti-mouse beta
interferon (Lee Biomolecular) was first absorbed with MEF, and then
used at a final dilution of 1:20 in cytotoxicity 
assays.
Interfe ron assa Samples of culture fluids were titrated by twofold
serial dilutions in 96-well, flat-bottomed microtiter plates, to which
929 cells were added at 3 X 10
4 cells/well. Eighteen to 24 hr
later, the wells were expressed as the 1092 of the highest 
reciprocal
dilution resulting in 50 % reduction in CPE.
Virus titration. Spleen virus titers were determined by using 10%
homogenates of tissue taken from individual mice.
LCMV was quanti t i ated
by plaque assay on Vero cells, which are nonpermissive for MCMV growth.
Inclusion of MCMV in LCMV plaque assays had no effect on the number of
LCMV pl aques. MCMV was quantitated by plaque assay on MEF.
With
spleen homogenates containing both viruses, LCMV was neutralized with
gui nea pi g anti -LCMV serum before quanti 
tat i on of MCMV. This antiserum
had no effect on MCMV ti terse Resul ts are expressed as the geometri 
mean titer, i.e., the arithmetic averages of the logs of four separate
animal s ti trated for vi rus i ndi vi dua lly standard error of the mean
(SEM) . The P values represent the significance of the differences of
the means between the desi gnated sampl e and the normal, non-anti 
body-
treated control, and were calculated using Student I
S t-test.
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Resul ts
sis of MCMV-infected MEF b leen cells from MCMV or LCMV-
infected mice. Spleen cells from mice infected with either MCMV or
LCMV were more capable of lysing MCMV-infected MEF, uninfected MEF, or
YAC-1 cells than were control spleen cells 
(10) (Table 1). This lysis
was not virus-specific, as LCMV-activated NK cells were quite capable
of lysing MCMV-infected MEF, as well as uninfected MEF and YAC-
1 cells
(Table 1). Throughout this study, we consistently observed that LCMV-
induced NK cells lysed target cells more efficiently than MCMV-
induced
effectors, regardless of the target 
cell type used in the assay.
Another consistent finding was that MCMV-
infected MEF were more resistant
than uninfected MEF to lysis by activated NK cells (Table 
1).
Characteristics of MCMV-activated killer cells.
Though others (10 17, 19,
had determined that MCMV-activated effector cells had some characteristics
of NK cells, definitive characterization with currently available
reagents was lacking. Whereas treatment of effectors with anti-thy
2 and C' had no effect on target lysis 
(10) (Table 2 A), addition of
anti-asialo GM1 or anti-
Ly 5. 1 in the presence of C' significantly
reduced spleen cell-mediated lysis of all three targets (Table 2 B).
Spleen cells from MCMV- infected anti-asialo- treated mice also did
not lyse MEF, MCMV-infected MEF, or YAC cells (Table 2 C). 
Taken
together, these data characterize the MCMV-activated spleen effector
cells as NK cells. Note again that MCMV-
infected MEF tended to be
more resistant than uninfected MEF to activated NK cells.
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Effect of NK cell de letion on virus titers in mice simultaneousl
infected
wi th MCMV and LCMV. Previous studies (12) showed that selective
depletion of NK cell activity by injection of anti-asialo GM 1 antibody
resulted in enhanced synthesis of MCMV , mouse hepatitis virus (MHV),
and VV , but not LCMV in tne spleen and liver. Whereas it is likely
that the differences in the sensitivity of viruses to NK cells 
vivo is at the target cell level, the possibility existed that MCMV,
VV, and MHV induced an antiviral effector mechanism not induced by
LCM V. In order to determine whether this antiviral selectivity
ranained when an II NK-sensitive
ll virus (MCMV) and and II NK- insensitive
virus (LCMV) are present in the same animal, we infected both control
and NK cell-depleted mice with MCMV and LCMV simultaneously. 
The data
in Table 3 show that NK cell depletion of these dually infected mice
results in a 63-fold increase in spleen MCMV titers as compared to
control dually infected mice , while having no effect on spleen LCMV
t i te rs . Thus, the results obtained in mice infected simultaneously
with LCMV and MCMV (Table 3) were the same as those obtained in mice
infected with either LCMV or MCMV (12) and argue against the hypothesis
that an antiviral effector cell is induced by MCMV but not LCMV.
sis of MCMV-infected MEF b control s leen cells. Endogenous spleen
cells were capable of lysing NK-sensitive YAC- 1 cells in 4 hr cyto-
toxi ci ty assays , but both uninfected and MCMV- i nfected MEF were lysed
poorly by these effectors (Table 4). However
, when the assay length
was increased to 20 hr, the lysis of MCMV-infected MEF was substantially
IIiI
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highe r than that observed after 4 hr, whereas the lys 
is of uni nfected
MEF remained unchanged (Table 4). This confirms previously published
work (18). Table 4 shows that spleen cells from mice treated with
anti-asialo GM in vivo were incapable of lysing YAC-
l, MEF, or MCMV-
infected MEF. In contrast to the resul ts obtai ned wi th MCMV- i nfected
MEF, LCMV-infected MEF were just as insensitive as uninfected MEF to
lysis by endogenous spleen cells (Table 5).
Previ ou s studi es by Lee and Ke 11 er showed that enhanced 1 ys is of
MCMV-infected fibroblasts over uninfected cells is independent of IFN
induction, as pretreatment of these effectors with actinomycin 0,
which inhibits IFN induction, had no effect on the enhanced lysis
( 18 ) . In order to test this hypothesis more directly, we added antibody
to mouse beta IFN to the culture fluid during cytotoxicity assays in
order to examine its effect on lysis. Whereas untreated cul ture fl ui d
from spleen cells and MCMV-infected MEF had 32 units/ml IFN after a 20
hr incubation, fluid containing anti- IFN antibody had less than 4
units/ml (the lower limit of detection in our assay). Tab 1 e 6 shows
that antibody treatment had no effect on the enhanced lysis of MCMV-
infected MEF over uninfected MEF.
IFN rotects LCMV-infected and uninfected but not MCMV- or VV-
infected cell 
from NK cell-mediated sis. Tri nchi eri and Santo 1 i (21) showed that
seve ra 1 types of human target cell s coul d be pr otected from human NK
cell-medi ated lysis by IFN, but not if they were virus- infected.
order to exami ne whether or not thi s phenomenon is ope rat i ve in the
\ 'l
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muri ne CMV system, MCMV- i nfected or uni nfected MEF were untreated or
pretreated for 18-24 hr wi th IFN. Whereas IFN almost totally protected
uninfected MEF from NK cell-mediated lysis, it had no protective
effect on MCMV-infected MEF (Table 7). 
Thus, in contrast to the
results obt-ained in the absence of IFN pretreatment of target.
cells,
MCMV- i nfected MEF were si gni fi cantly sensiti ve to acti vated 
cell-medi ated lysis than uninfected MEF when target cells were pre-
conditioned with IFN (Table 7).
Results similar to those obtained with MCMV-
infected cells were
obtained using VV- infected cells. Table 8 shows that VV- infected
cells are not more sensitive than uninfected cells to activated NK
cells . However, IFN did not protect VV-infected MEF to the same
extent as it protected uninfected cells from NK cell-mediated lysis.
When cells were pretreated with IFN, VV-
infected cell s were lysed to a
significantly greater extent than uninfected cells.
Simi 1 ar results
were obtained using L-929 target cells (data not shown).
In contrast to the resul ts obtai ned wi th MCMV-
i nfected target
cells, IFN pretreatment was just as effective at protecting LCMV-
infected MEF as uninfected MEF, regardless of whether NK cells were
act ivated by LCMV or MCMV i nfecti on (Tabl e 9). Simi 1 ar resul ts were
obtained using L-929 target cells (data not shown).
Thi s shows that
IFN can protect uni nfected and LCMV- i nfected MEF, and that the 
vi rus
used to activate the NK cells does not affect this result.
Despi te
the fact that LCMV-infected and uninfected MEF were almost totally
I '
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protected by IFN against NK cell-mediated lysis (Table 9), IFN treatment
did not diminish their susceptibility to LCMV-specific cytotoxic T
cells. Spleen cells taken 7 days postinfection and containing virus-
specific T cells lysed 80% of infected and only 23% of uninfected MEF
at an effector to target of 100: 1 in 
a 16 hr assay.
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Di scuss ion
Several laboratories have reported NK-like effectors induced
during acute MCMV infection (10 19), but depletion of activity by
treatment with a reagent which selectively depletes NK 
cell activity
(anti-asialo GM1 antibody, e. ) has not been previously reported.
Masuda and Bennett (17) reported that MCMV-
induced spleen cells capable
of killing YAC-1 cells were resistant to anti-
NK antibody and C
This is not surprising, since virus-
induced NK cells are known to be
mo re res i stant to treatment wi th anti -NK antibody and C 
I (32, 33). The
data in Table 2 showing sensitivity to anti-asialo GM 1 and anti-
Ly 5.
(27, 34) and resistance to anti-thy 1. 2 conclusively demonstrate that
this effector is an NK cell.
The fact that NK cells play different roles in LCMV and MCMV
infect ions coul d be due to the nature of the effector 
cell s generated
in each of these i nfecti ons. For instance , it is possible that LCMV
either suppresses or does not induce the generation of a particular
type of NK cell needed to mediate antiviral effects, whereas MCMV does
induce such antiviral NK cells. However
, the resul ts of our experi-
ments using mice simultaneously infected with both viruses argues
against these possibilities , as NK cells provided protection against
MCMV , despi te the presence of lCMV
, agai nst which NK cell s provided no
protection, despite the presence of MCMV.
The resul ts of these experi-
ments reduce the likelihood that differences in NK 
cell generatio
effector function account for differences seen during MCMV and LCMV
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infect ions. It is also unlikely that NK cells are mediating antiviral
effects by secreting IFN. NK cell depletion results in a substantial
increase in both IFN levels and virus titers 6-
72 hr after challenge
with MCMV, while having no effect on IFN levels and virus titers in
. .
mice challenged with LCMV (12 13), a virus whose synthesis is enhanced
in mice depleted of IFN by treatment with antibody to IFN 
(35).
A mechanism whereby NK cells could eliminate virus while preserving
normal tissue is by preferential lysis of virus-
infected cells over
un infected cells. In suppo rt of thi s concept , the data presented here
indicate that endogenous spleen cells are capable of lysing MCMV-
infected MEF more effi ci ently than uni nfected MEF, confi rmi 
n9 the
findings of others (18). Whereas Lee and Keller (18) had partially
characterized the endogenous effector cell, they did not eliminate the
cytotoxic activity by using a reagent which selectively depletes NK
cell act ivi ty. Thi s was a parti cul arly important poi nt, as we have
characterized previously undescribed, non-
NK effectors capable of
preferentially lysing MHV-infected targets (36
37). Our present data
clearly show that anti-asialo GM 1' a reagent which selectively depletes
NK cell activity (27-30), eliminated the cytotoxicity. 
In contrast to
the results with MCMV , LCMV-infected MEF were not lysed by endogenous
NK cells. This could be one reason why NK cells do not play
a role in
limiting LCMV infection (12).
The fact that MCMV-infected MEF are lysed more efficiently than
uninfected MEF by endogenous NK cells is possibly a result of NK 
cell
activation during the course of the 20 hr incubation period 
(38).
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However, this putative activation is probably not due to IFN
, as
increased lysis of MCMV-infected targets occurs even in the presence
of actinomycin D, which inhibits IFN productio
(18). Ou r present
data confirm this observation in a more direct manner
, as specific
elimination of IFN with an antibody had no effect on lysis.
Thi s
. . '
putative activation could be mediated by MCMV-
induced glycoproteins,
as is the case wi th measl es vi rus (39). It is unlikely that the
reason for the sensitivity of MCMV-
infected MEF to endogenous NK cells
in long assays is enhanced bi ndi ng or 
II recognition
" of targets by NK
cells, as MCMV- infected MEF were actually 
less sensitive than uninfected
MEF to lysis in short (4 hr) assays by NK cells activated 
vivo
MCMV or LCMV infection. We have observed this 
phenomenon in other
virus systems (20), and there are a number of possible explanations
for this observation. MCMV infection could inhibit the ability of
target cells to bind to NK cells, as is the case with herpes simplex
virus (HSV)-infected Vero cells (20). Another possibility is that
bi ndi n9 abi 1 i ty remai ns intact, as for Sendai vi rus-
i nfected L-929
cells (20), but that the lethal hit is not delivered effectively by
the NK cell. This could be due to IFN protection of the virus-
infected
target , as IFN induced early in the infection may be capable of 
protect-
ing some virus-infected target cells before the viral replicative
cycle has progressed far enough to alter host protein and RNA synthesis,
processes Which are necessary for IFN protection 
(21). However, the
fact that we di d not detect IFN in our MCMV- i nfected MEF cul tures
makes this less likely.
11:
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When MEF were infected with MCMV for two days with a hi gh MOl (3-
5), they could not be protected from NK cell-mediated lysis by addition
of 10
4 U/ml of exogenous IFN, a dose whi ch almost totally protected
uninfected and LCMV-infected MEF (Tables 5 and 7). The reason for
these di fferences may be that MCMV i nfecti on causes CPE and alters
cellular metabolic processes (40 41), one of which may be necessary
for IFN protection, while LCMV infection causes little CPE and does
not affect the levels of cellular protein and RNA synthesis 
(23).
VV-infected cells, whose synthesis of host cell proteins is shut down,
are not protected by IFN (21) (Table 6). IFN treatment , however , did
not render LCMV-infected MEF insensitive to all types of cell-mediated
lysis, as we have shown that IFN pretreatment actually increased by 2-
3 fold the sensitivity of these LCMV-infected MEF to lysis by LCMV-
specific cytotoxic T cells
The observation that target cells could be protected from NK
cell-medi ated lysis by IFN was shown to be operative 
vivo by Welsh
and coworkers (22, 42). They found that thymocytes or tumor cell s .
isolated from virus-infected or IFN-treated mice are protected against
NK cell-mediated lysis in vitro (42). Also, tumor cells pretreated in
vitro with IFN and then injected into mice were rejected more slowly
than untreated cells (22).
From these data , one could put forth a theoretical model explaining
how NK cells may exert antiviral effects in vivo while preserving
normal tissue. Early in infection, endogenous NK cells may become
locally activated in an area having many MCMV- or VV-infected cells.
I'll
, j' 
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This activation could be directly at the cell surface, perhaps via
viral glycoproteins, or it could be caused by IFN produced locally.
Though some uninfected cells might be killed by this indiscriminate
process, NK cell-mediated lysis would be taking place in an area
havi ng a rel ati vely hi gh percentage of infected cell s, and damage to
normal tissue would be localized and minimal.
If the i nfecti on becomes
more systemic, high levels of IFN would be induced 
(8), and IFN- induced
NK cell activation (8 10) and proliferati
(43) would take place.
Whereas normal cells would be protected by IFN against lysis by these
activated NK cells (21), MCMV- or VV-
infected cells would not receive
protectio , and would therefore be lysed. During an LCMV infection
endogenous NK cells would not preferentially lyse LCMV-
infected cells
by an IFN-independent activation mechanism 
(16), and later in the
infection, when high levels of IFN are induced 
(1), both uninfected
and LCMV-infected cells would be protected from activated NK cell-
medi ated lysis. If these mechanisms were operative, one would expect
that NK cells would protect a host against MCMV or VV, but not LCMV.
Direct evidence exists for a protective role of NK cells against MCMV
and VV , but not LCMV , as selective depletion of NK 
cell activity 
vivo enhances MCMV and VV infection, while having no effect on LCMV
infection (12) (Table 3).
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Summa ry
Spl een effector cell s induced early duri ng acute muri ne cytomegalo-
virus (MCMV) infection were characterized as natural killer 
(NK) cells
by their sensitivity to treatments with anti-asialoGM 1 and anti-
Ly 5
antisera in th presence of C' and their lack of sensitivity to anti-
thy 1. 2 and C' treatment. Selective depletion of NK cell activity by
injection with anti-asialo GM 1 antibody rendered mice more susceptible
to infection with MCMV , but not lymphocytic choriomeningitis virus
(LCMV) when mice were simultaneously infected with the two viruses,
suggesting that NK cell-mediated antiviral effects may depend on
target cell susceptibility to NK cell-mediated lysis rather than the
ability of a virus to induce a specialized antiviral NK cell.
support of this concept, in long (20 hr) cytotoxicity assays, endogenous
NK cells lysed mouse embryonic fibroblasts (MEF) infected with MCMV
much mo re effi ci ently than LCMV- i nfected or uni nfected MEF. The
duration of the assay suggests an effector activation
, but addition of
antibody which neutralized the interferon (IFN) induced during cyto-
toxicity assays had no effect on lysis. Thi s di fference in lys is was
probably not a result of greater sensitivit
of these MCMV-infected
MEF to lysis, as these targets were 
less sensitive than uninfected MEF
to lysis by MCMV- or LCMV-activated NK cells in short-term 4 hr assays.
When MEF and MCMV-infected MEF were pretreated with 
IFN, activated NK
cell-medi ated lysis of MCMV- i nfected MEF was undimi ni shed and was much
higher (up to 4-fold higher) than that of uninfected MEF, whose sensi-
tivity to NK cell-mediated lysis was almost totally abolished by IFN
pr etreatment. IFN also failed to fully protect cells infected with
J -
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vaccinia virus (VV) against NK cell-mediated lysis.
In contrast to
the results obtained with MCMV or VV, LCMV-
infected MEF were almost
totally protected by IFN against LCMV or MCMV-activated NK cell-mediated
lysis. These data could explain how NK cells might selectively eliminate
MCMV-or VV-infected but not LCMV-infected or uninfected cells during
acute infection in vivo , and why NK cells may play
a role in resistance
to MCMV and VV , but not LCMV.
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Tab 1 e 
Lys i s of MCMV- Infected and Uni nfected MEF and YAC-
1 Cell s
by Spleen Cells From MCMV- or LCMV- Infected Mice
ercent ecific 51 release
MEF
Effector Cell s E: T (MCMV) MEF Y AC-
MCMV-act i vated 100 19. 26. 56.
11. 15. 36.
20.
LCMV-act i vated 100 32. 38. 72.
19. 24. 55.
11. 30.
Spleen cells from MCMV or LCMV-activated C57BL/6 mice 3 days
post infect i on were prepared as descri bed in Materi al s and Methods
and used as effectors in 4 hr cytotoxicity assays.
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Tab 1 e 
Characteristics of MCMV-Activated Killer Cells
ercent s ec i fi c Cr release
MEF
Treatment MCMV)
23.
MEF
41.
Y AC-
none 74.
73.19.
16.
40.
40. 72.
ant i-thy
1.2 + C'
12. 13. 51.
53.
none
11. 11.
24.ant i -
5 + C'
ant i -AGM
+ C'
50.
none 15.
nti AGM
1 n Vl vo
Spleen cells from MCMV-infected C57BL/6 mice were treated with
various antisera and C' , as described in Materials and Methods,
and used in 4 hr cytotoxicity assays. Effector to target ratios
were 100:1 in expo A , B, and 50:1 in exp. C.
Anti-asialo GM1 (anti-AGM ) was given 4-6 hr before virus challenge.
Table 3
Effect of NK Cell Depletion on Spleen Virus Titers in
Mice Infected Simultaneously with LCMV and MCMV
ant i -
asialo GM
10910 pfu/spl een
MCMV LCMVpercent NK lysi 
62. 0 + 0.
8 + 0.
6 + 0.
7 + 0.
Groups of 4 C57BL/6 mice were either left untreated or treated
with anti-asialo GM1' as described in Materials and Methods.
Four to 6 hr later, each mouse was infected simultaneously by
i .p. inject i on of 8 X 104 PFU of LCMV and 7 X 104 PFU of MCMV.
Three days later, the mice were sacrificed, and pooled spleen
cells were assayed for NK cell activity against YAC- 1 cells at
100:1 E:T; assay length was 6 hr. Spleen virus titers were
determi ned by pl aque assay, as descri bed in Materi a 1 s and
Met hods.
P ( . 001 , as compared to non-anti body-treated controls.
Not significantly different from non-anti body- treated controls.
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Tab 1 e 
Lys is of MCMV- Infected and Uni nfected MEF and YAC- 1 Cell s
by Spleen Cells From Control or Anti-Asialo GM Treated Mice
Assay
1 en
4 hr
ercent s ecific 5:Cr release
MEF
(MCMV) MEF Y AC -Treatment E: T
100 18.none
anti -AGM 100
1. 6
1. 7
1. 5
1. 220 hr 100 28.
11.
38.
18.
none
1.2
ant i -AGr 100
1.0
1.2
1. 5
Spleen cells from control or anti-asialo GM1 (anti-AGM treated
C57BL/6 mice were used as effectors in cytotoxicity assays performed
as described in Materials and Methods.
Table 5
Lys; s of LCMV- Infected and Un; nfected MEF
and YAC-1 Cells by Endogenous Spleen Cells
As s ay e rcent ec if; c Cr re 1 ease
len E: T MEF (LCMV) MEF YAC-
4 hr 100
16.
20 hr 100 1.9 40.
22.
1.0 13.
Spleen leukocytes from control C57BL/6 mice were used as
effectors ; n cytotox; c; ty assays performed as descr; bed
; n Mater; al s and Methods.
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Tab 1 e 
Anti- IFN Antibody Does Not Affect Lysis of MCMV- Infected
or Uni nfected MEF by Endogenous NK Cell s
ercent s eci fi c 51Cr release
Treatment E: T MEF MCMV) MEF
YAC-
100 19. 10. 35.none
11. 23.
16.
Ant i - IFN 100 17.
34.
10. 22.
12.
Cytotoxi city assays were performed as desc ri bed in Mat-
eri al s and Methods; assay ength was 18 hr.
Anti- IFN antibody (Anti- IFN) was included in the assay
at a final dilution of 1:20.
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Table 7
Interferon Protects Uni nfected But Not MCMV- Infected
MEF F rom Activated NK Ce ll-Medi ated 
Lysis
ercent ecific 51 re 1 ease
Assay MEF IFN
IFN
1 e n t h E: T (MCMV) MEF (MCM 
MEF MEF
4 hr 200 12. 12.
25.
100 21. 1.5
12.
8 hr 200 19. 24.
43.
100 13. 18. 32.
12. 22.
Spl een effector cell s were from MCMV- i nfected C57BL/6 mi ce.
Target cells were eft untreated or pretreated wi 
th IFN as des-
cribed in Materials and Methods, then used in cytotoxicity
assays.
' T
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Table 8
Reduced Ability of Interferon to Protect Vaccinia- Infected
Cells From LCMV-Activated NK Cell-Mediated Lysis
Effector :Tar
Tar et Cell 100
ME F (V V) 31. 17. 14.
MEF (VV) IFN 20. 11.
32. 22. 15.
MEF IFN 11.
Spleen cells from LCMV-infected C3H/St mice were used as a
source of NK cell effectors. Assay ength was 6 hr. Resul ts
are expressed as percent specific 51cr release.
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Table 9
Interfe ron Protects LCMV- Infected and Uni nfected
MEF From Activated NK Cell-Mediated Lysis
ercent s ecific 51Cr release
MEF IFN IFN
Effector cells E: T LCM V) MEF (LCMV) MEF MEF
LCMV-act i vated 200 51. 14. 51. 13.
100 42. 45. 10.
28. 31.
MCMV-act i vated 200 29. 12. 29. II.
100 21. 21.
17. 16.
LCMV or MCMV-activated spleen cells from C57BL/6 mice were
used as effectors. Target cells were left untreated, or pre-
treated with IFN, as described in Materials and Methods, then
used in cytotoxicity assays.
J:' '
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CHAPTER 3
Discussion
The Antiviral Role of NK Cells in Vivo
The fact tha t NK cell s areca pa bl e of media ti ng tumor
surveillance has been well established (reviewed in ref. 77 and in
introwction) . I t is not yet known what effects, if any, NK cell s
have against bacteria, fungi, protozoa, or yeast, but ouch
circumstantial evidence (see introduction) favors a role for NK
cells against certin virus infections, although this evidence his
been fa r from conclusive.
Direct evidence for an antiviral role of NK cells had been
lacking, due to the absence of methods for specifically depleting NK
cell activity in vivo. Antibody to asialo GMl, a neutral
glycosphi ngol i pi d present at hi gh quanti ti ti es on NK cell s,
selectively depletes NK cell activity in vivo, while having no
detectable effect on other imnne functions (2 20, 78). Using
this reagent, we have shown that NK cell depletion results in up to
1000- fold increases in MCMV, MHV, and VV titers (11, 111) in the
spleens and ivers of acutely infected mice 3 days postinfection,
before speci fi c imnne responses such as CTL are detectabl e (48).
Correlating with increased virus synthesis, these NK cell-depleted,
virus-infected mice also had more extensive hepatitis (11, III-Fig. Irl
and spleen necrosis (III-Fig. 1) than virus- infected, control mice.
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In agreement with expectations based on previous data (50, 52), NK
cell depl eti on had no effect on the cou rse of acute (11- Tabl e 2) 
persistent (II-Tables 3 and 4) LCMV infection. These data, although
not totally conclusive, provided the most convincing evidence to
date that NK cells ' were capable of mediating antiviral effects in
vivo, and that their importance varied depending on the virus.
Anti-asialo GMl does not affect any known imnne functions other
than NK cell function, but it does rect with some monocytes and
thymocytes (20), and could have unknown effects on some yet
undefined resistance mechanisms.
Because of these uncertainties, we performd adoptive transfer
studies using MCMV as a model system. Using a variety of physical
and immnochemical techni~es to enrich and deplete NK cell activity
we have, for the fi rst time, obtained defi ni ti ve evi dence that 
cells are capable of mediating antiviral effects in vivo (V). The
results showed that the cell population mediating the resistance had
the phenotype of an NK cell: a nylon wool nonadherent, asialo
+ -
GMI , NK 1. 2 , Ly 5 , Thy- , Ia , low- density lymphocyte
(V-Table 3). Further, IL- dependent cloned NK cells (but not T
cells) were able to provide resistance, showing that no other
adopti vely transferred cell popula ti on was necessa ry to obta in
resistance (V-Table 1 and Figs. 4 and 5).
Sel grade and Osborn (68), using the same adoptive transfer
system as we used, showed that either thioglycollate- stinulated
peri tonea 1 macrophages or endogenous, IIcrophage-depl eted spl een
1 eu kocytes coul d enhance su rviva 1 in MCMV- infected suckl i ng mi ceo
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However, the nature of the spleen leukocytes responsible for the
resistance was unknown. Johnson (69) su gges ted tha t a 00 1 t bu t not
suckl ing macrophages mi ght provide resi stance to herpes simpl ex type
1 (HSV- 1), and Hirsch et ale (70) showed that adoptive transfer of
adult macrophages enhanced survival of HSV- infected suckling mice,
but characterization of the cells responsible for protection was not
carried out with currently available regents. Tardieu et al. (40)
used a simila r adopti ve transfer system to demonstra te that
transfers of adult unstilllated T cells, macrophages, and bone
marrow cells could enhance survival of MHV- infected suckling mice.
Aga in, the na tu re of the bone ma rrow cells provi di ng p rotecti on wa 
unknown, but bone mrrow cell s from mice less than 3 weeks of age
did not protect, and this corresponds to the age at which NK 
cell
activity begins to develop. OUr current data regarding MCMV and MHV
provide strong evidence that these investigators were observing the
antiviral effects of NK cells in their studies involving adoptive
transfers of spl een 1 eu kocytes and bone ma rrow cell s. au r cu 
rrent
studies with MCMV definitively show that aoolt 
mcrophages are not
re~i red for resi stance of suckl ing mice to MCMV. Na ive adul t
spleen cells depleted of mcrophages by nylon wool passage (V-Table
1) or by size sepanition (V-Fig. 2) still protected against MCMV.
Treatments which depleted NK cell activity but left 
mcrophages
intact, such as anti-asialo GM1 (V-Table 1 and Fig. 2), anti- NK 1.2
(V-Table 1), and anti-Ly 5 (V-Fig. 2) and complement destroyed the
protective capacity of adult spleen cells. As stated previously,
aoolt mice treted with anti-asialo GMl, a treatmnt which leaves
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macrophage function intact (20, 78), were nuch more susceptible to
MCMV and MHV infection, again showing that NK cell s were media ting
resistance. Habu and Okunura (79) have also shown that use of this
antibody lowers resistance to HSV- l. To sumllrize, our data do not
disprove that macrophages could be. providing some protection, but
for the first time, we show that NK cells depleted of RBcrophages
can provide resistance against a virus infection (V).
It has been known for over 10 years that T cells have antiviral
effects in vivo (73). It is recognized that T cells are responsible
for clearing virus (48,73,80), and recovery fro illness caused by
virus infections is attributed to T cells (81). However,
virus-specific T cells are not detected until 4- 10 days
postinfection (32,48), and are thus unli kely to contriwte to host
resistance during the first few 
ys of acute virus infection of a
noniDIne host. Ckr evidence indicates that NK cell-mediated
protection against morbidity and mortality early during acute
infection (3-5 days postinfection) takes place without the
participation of T cells (III, Figs. 2 and 3). Athymic nude mice
depleted of NK cells by injection with anti-asialo GM1 synthesized
up to 6 times more MCMV in thei r organs as compa red to nude mice not
receiving antibody (V-Fig. 3). Adult spleen cells depleted of T
cells by treatmnt with monoclonal anti- thy 1. 2 and complement still
protected suckling mice against lethal MCMV infection (V-Fig. 2), so
transfer of T cells is not essential to transfer of resistance.
There has been little evidence to implicate neutrophils in
resistance to virus infections. Our adoptive transfer experiments
:1'
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show tha t populations of lymphocytes wi th greater than 98 percent
purity are ~ite capable of mediating resistance (V-Fig. 2).
Although virus-specific antibody can be detected as early as 3 days
postinfection (49), the role of antibody in virus infections is
thought to be one of protection aga i nst rei nfection by the same
virus subse~ent to recovery from that same virus (81), as peak
antibody titers are most often seen after the recovery phase
(82,83). Our experiments show that depletion of B cells by
treatment with anti- Ia and complement (V-Fig. 2), or by nylon wool
passage (V-Table 1) did not deplete the protective capacity of
adopti vely transferred spl een cell s.
Our survival curves indicated that 5 x 10
7 acklt spleen cells
could prolong survival of MCMV- infected mice, wt that 3- fold fewer
cell s cou 1 d not (V-Fi g. 2) . If the protection were mediated by NK
cells, then 3- fold fewer spleen cells with 3 times as much NK 
cell
activity should protect. This prediction was supported by our data,
as 1.7 x 10
7 unfractionated spleen cells did not fully protect,
while 1. 7 x 107 spleen cells enriched 3-fold for NK cell activity
provided as nuch protection as 5 x 10
7 unfractionated spleen cells
(V-Table 1).
Previous work using an IL- dependent cloned NK cell line
derived from C57BL/6 mice (84) showed that these cells were capable
of mediating resistance to tumor implants and bone marrow
transplants (85). These cell s are 1a rge granula r lymphocytes wi th
the phenotype asialo GMI , NK 1. 2 , Ly 1 , Ly 2 , thy-
. and are capable of mediating in vitro lysis of NK- sensitive YAC-
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tumor cells (84). Our results clearly show that these cells are
capable of providing protection against MCMV (V-Table 1 and Fig. 1),
oot not LCMV (V-Table 2). In contrast, a cloned T cell line also
derived from C57BL/6 mice provided no protection, indicating that
cloned lymphoid cells in general do not necessarily protect.
Because data for survival curves nust be accunulated over a
period of 2- 3 weeks, it is possible that over that period of time
subpopulations of adoptively transferred spleen cells could
differentiate and provide resistance, DB king it difficult to tell
which type of cell is providing the resistance. Previous work by
Shellam et al. (46) showing that radiation bone DBrrow chimeras
crea ted by transferri ng donor bone DB rrow cell s into i rradia ted
recipients reflected the MCMV resistance patterns and NK cell
activities of the donors was subject to this criticism, as recipient
mice were not challenged with virus until 8 weeks after adoptive
transfer. OUr present studies showing that adoptively transferred
spleen cells containing NK cell activity result in reduced virus
titers 3 days postinfection (V-Table 1) lowers the possibility that
a subpopulation of these cells differentiated inside the recipient
and subse~ently provided protection. This is especially true when
referring to the specific immne response (CTL and antibody) which
ta kes 6- 15 days to fully develop. Even more defi ni the in thi 
rega rd a re the data obtained wi th adopti ve transfer of cloned NK
cells, which reooced day 3 virus titers up to 500- fold (V-Table 1).
We do not know if adopti vely transferred NK cell s (given i .
are capable of populating recipient spleens. Our unpublished data
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indicate that recipient spleen NK cell activity is not changed by
adoptive tninsfer of NK cells whether the recipient 
is left
uninfected or challenged with LCMV. Peritoneal NK cell activity of
recipient mice was not examined. However, NK cell-
deficient
suckling mice receiving NK cells followed the
next day by MCMV
challenge had more spleen leukocytes and greater NK cell activity
than MCMV-challenged mice receiving no NK cells. 
This result could
be explained by a repopulation of the recipient spleen by donor
cells (which did not occur in uninfected or LCMV-
infected
recipients), but is more likely a result of NK cell-mediated
antiviral effects, possibly occurring in the 
peritoneum, which is
the site of both virus inoculation and NK 
cell tninsfer. Reduced
MCMV titers in the peritoneum could lead to reduced spread of virus
to the spleen, reducing the spleen leukopenia and inhibition of NK
cell activity associated with high spleen MCMV titers 
(46). A third
a 1 tema ti ve is that donor cell s cou 1 d be tri ggeri ng reci pi ent
antiviral mechanisms in the peritoneum, which act at a distant site,
g. inside the spleen. Finally, donor NK cells may be populating
the recipient spleen, but their activity nay be undetectable using
in vitro cytotoxicity assays.
The Role of NK Cells IAring Persistent Virus Infection
The persi stent phase of a vi rus i nfecti on is geneni lly defined
as a period of time after the acute phase during which infectious
vi rus can be i sola ted from the host. A balance between the vi rus
, .
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and the host' s defense mechanisms has been struck: the host does
not eliminate the virus, yet the ability of the vinas to act in an
immediately harmful way is held in check by host defense mechanisms,
many of which remain undefined. I will limit the discussion to
persistent infections in the mouse involving LCMV and MCMV.
Persistent LCMV infection has been studied extensively, yet the
mechanism of persistence still remains unknown. Establishment of
persistent LCMV infection can be accomplished by inoculating newborn
mice (86) or inmnosuppressed adult mice (73) with LCMV. Mice
infected in utero or at birth carry LCMV for life, and the vinas is
present in virtually every orgn, though mice often do not show
overt di sease symptoms (86). Ea rly studies (87) concluded that no
specific inmne response (T or B cell) was generated to LCMV , rot
the classic studies of Oldstone and Dixon (88) deomonstnited that
virus-specific antibody exists in immne complexes composed of
antibody-virion aggregates, which probably lead to chronic immne
complex disease (90). A T cell response has never oeen demonstnited
during persistent infection (76), but adoptive transfer of
vi rus-specifi c CTL causes a ma rked reducti on in vi rus ti ters, ro t
not total elimination of the virus (91).
Ex tens ive s tu di es on ou r pa rt (I - Ta b 1 e 1) showed tha t these
persi stently infected mi ce have abnornlly hi gh 1 evel s of NK cell
activity as compared to uninfected controls. This NK cell activity
was elevated for at least 6 months (I-Table 1), well after the time
period during which NKcell activity in control mice becomes
extremely low (1, 5). The most likely explanation for this high NK
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cell activity is the fact that these mice have low levels (32-
U/ml )of IFN type I in their plasm, which is known to activate NK
cells. r report (I-Table 4) and that of Saron et al. (92) were
the first to show the presence of IFN in mice persistently infected
. .
with LCMV. The NK cells in these mice were not undergoing
blastogenesis, but were capable of doing so when the mice were given
poly I:C, a potent IFN inducer (I-Figs. 1 and 2). It is still not
known whether this elevated NK cell activity is a result of
increased numbers of NK cells or increased lytic activity on a per
ce 11 ba s is.
Because persistently infected mice had elevated NK cell
activity, we hypothesized that this activity my be keeping LCMV
ti ters under control. Previous evidence (52) using different LCMV
and mouse strains ar ed against a role for NK cells in controlling
this infection, as cyclophosphamide treatments, which reduce NK cell
activity, did not alter LCMV titers in these persistently infected
mice. However, it was not known whether or not the mice used in
that previous study had elevated NK cell activity. Our results
(II-Tables 3 and 4) showed that specific depletion of NK cells using
antibody to asialo GMI had no effect on LCMV titers in the blood or
the spleen. The reason for this lack of effect could be that
LCMV- infected target cells are, under conditions prevailing in vivo,
insensitive to NK cell-mediated lysis. This will be discussed in a
subse~ent section.
In contrast to persistent LCMV infection, the persistent phase
of MCMV infection is transient and occurs after inoculation of
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either newborn or imounocompetent adult mice (93,96). After
resolution of acute infection, the virus persists in the spleen but
more fre~ently in the salivary gland for several months, after
whi ch time it becomes undetectabl e, and has presumeably become
latent. During persistent or latent infection, CMV-specific CTL
activity is undetectable, but antibody titers are at high levels.
Treatment of these mice with cyclophosphamide or cortisone causes
reactivation and dissemination of latent virus, without affecting
antibody titers (95). Treatmnt of mice with cortisone during the
persistent phase of the infection increases salivary gland MCMV
titers while inhibiting the infiltration of lymphocytes into the
salivary gland (82). Because drug- indJced rectivation of latent
virus and drug-induced increses in salivary gland virus titers
wring persistent MCMV infection ta ke place in the face of high
antibody titers and at a time when CTL activity is undetectable, we
tested the hypothesis that NK cells may be limiting virus
replication during the persistent phase of MCMV infection. CAr
results show that specific depletion of NK cells using antibody to
asialo GM1 resulted in a 6- fold increse in salivary gland MCMV
titers (III-Table 8). However, no dissemination of the virus to
other orgns was noted, and attempts to cause rectivation of latent
MCMV infection using anti-asialo GM1 have been so far unsuccessful.
Nonetheless, these experiments provide the first solid piece of
evi dence that NK cells may playa role in con troll ing persi stent
infection. It is noteworthy that NK cell depletion has no effect on
salivary gland virus titers during acute MCMV infection, despite
l-=
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causing major increases in spleen and liver virus titers ciring the
atute phase (III-Table 1), and causing increases in salivary gland
titers during the persistent phase (III-Table 8). A possible
mechanism to explain this difference could be NK cell-mediated ADCC
aga rist MCMV-infected targets. This has been shown by Manischewitz
et al. (98) to occur in vitro using serum from MCMV- infected mice
15-30 days postinfection, that is, after the acute phase txt ciring
the persistent phase of the infection. Perhaps NK cells can control
salivary gland virus titers only by ADCC, and acute salivary gland
infections are not inhibited by NK cells due to lack of
MCMV-specific antibody, which reaches optimal titers at about 15
days postinfection (82 83). TtLs, NK cells could be re(Jired for
control of persistent MCMV infection, despite the existence of high
anti body ti terse
The Effect of NK Cell Depletion on Vinil Pathogenesis
Susceptibility to virus infections varies among individJals and
a 1 so cha nges wi thi n the same i ndi vi dua 1 dependent upon su ch fa cto 
as genotype, age, nutritional status, and stress levels (77). These
factors, some of which can change (Jickly, also affect NK cell
activity. Our studies (III) describe the events whereby a lowered
defense mechanism (i. e. NK cells) can lead to: 1) contnicti on of a
viral disease which otherwise would be totally repelled or
subcl inical; 2) increased severity (possibly leading to death) of a
viral disease which would otherwise be mild; 3) increased duration
'r)
256
of viral disease with delayed recovery.
We found that in some instances, control mice challenged with
low doses of MCMV or'VV were not clinically ill, had no detectable
virus in their spleen and livers, and had no liver pathology at 3
days postinfection. In contrast, mice whose NK cell s were depl eted
with anti-asialo GMI were clinically ill (i . e. ruffled fur and
hunched posture), had moderate amounts of virus in their spleens and
livers, and exhibited pathological liver lesions 
(III). Wi th hi gher
doses of virus, NK cell-depleted mice at 3 days postinfectio
had
increased mortlity and morbidity, associated with massive spleen
and liver necrosis (III-Fig. 1), severe leukopenia (III-Table 3), and
mrked suppression of the T cell response (III-Table 2), as compared
to control vi rus- infected mice.
NK cell-depleted mice also recovered more slowly from
infection, as control mice had no detectable virus in their spleens,
lungs, and livers at day 9 (III-Table 1), whereas NK cell-
depleted
mice did not clear the virus from these organs until 12-
15 days
posti nfecti on. NK cell depletion at 0-
2 days postinfectio had a
marked effect on viral disease, but NK cell depletion late in the
infection (6-8 days) had no effect on MCMV synthesis or clinical
illness (III-Table 4). Thus, the lack of NK cells at this time did
not affect viral clearance, presumed to be a T cell-
dependent
functi on (48).
Thus, the lack of NK cells early in the infection can cause
severe pathological conse~ences at day 
3. Further, the resulting
increased virus titers are likely the cause of the diminished T 
cell
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function seen in these NK cell-depleted, virus-infected mice, as
MCMV is known to suppress T cell function (99, 100). This diminished
T cell function (assayed by Con A response) probably results in
delayed clearance of virus and thus a prolongation of disease.
Whereas NK cell depl etion had a profound effect on the
pathogenesis of MCMV infection after i.
p or i . v. inoculation, the
course of disease after intranasal inoculation was not affected by
NK cell depletion (III-Table 7). Quinnan et al. (101) have shown
that cortisone treatment of mice during intranasal MCMV infection
results in higher spleen and lung virus titers, concurrent with
lower NK cell activity. They concluded that NK cells in the lung
were mediating antiviral resistance, but our results using 
a more
specific reagent (anti-asialo GMl) for elimination of NK cell
activity show that NK cell depletion is without effect (III-
Table
7). NK cell- deficient beige mice did not undergo more severe MCMV
infection after intranasal inoculation (Ill-Table 7). The reason
whY NK cells limit synthesis after i.p. and 
Lv. wt not intranasal
inoculation is not known, but the lung nay have an 
antiviral
mecha ni sm di s ti nct from tha t of NK cell In support of this
concept, Biron et a 1. (102) ha ve demons tra ted tha t a
cortisone- sensitive non-NK, non-T cell is responsible for
preferential rejection of virus- infected cells over uninfected cells
from the lungs in 4 hour in vivo cytotoxicity assays.
Mechanism of NK Cell-mediated Antiviral Effects
. ,
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There are several mechanisms whereby NK cells could mediate
antiviral effects in vivo. NK cells are known to secrete IFN when
stinula ted wi th tumor cell s, vi ruses, or plant lectins (103). The
secreted IFN cool d then media te antivi ral effects by di rectly
protecting cells aga fnst virus replication, or by modulation of the
host response (e. g. acti va ti on of NK cell s or DBcrophages. The
mechanism of IFN-mediated antiviral action in vivo is currently the
subject of nuch study, and will be discussed in detail later.
However, evidence from our laboratory a es against an NK
cell- derived IFN-mediated mechanism of antiviral action. We have
shown that depletion of NK cells during acute infection with MHV,
MCMV, and VV actually results in higher titers of IFN in the plasDB
and peritoneal wash, correlating with higher spleen and liver virus
titers (II,III). These data indicate that NK cells are not mjor
prooocers of IFN during virus infection.
Throu ghout ou r studi es we ha ve documented that NK cell s do have
anti vi ra 1 effects aga inst MCMV, VV, and MHV, bu t not LCMV
(II, III, V). A possible reason for these differences could be that
MCMV, MHV, or VV are causing induction of a certain type of NK cell
capable of mediating antiviral effects whereas LCMV , which is 
~ite
capable of inducing activation and proliferation of 
NK cells (32),
is not inducing antiviral NK cells, or is causing suppression of
antiviral NK cell induction or effector function. Our results
showing that NK cell depletion of mice infected simultaneously with
MCMV and LCMV ar es against this hypothesis. NK cell depletion
resul ted in a 63- fol d increse in MCMV ti ters in the spl eens of
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these dually- infected mice, despite the presence of LCMV, as
compared to control dually- infected mice, while having no effect on
LCMV titers in these mice (VI-Table 3).
The resu1 ts we ha ve obtained wi th MCMV, VV, and LCMV suggest
that the susceptibility of virus- infected targets to NK
cell-mediated lysis in vitro correlates with NK cell-mediated
antiviral effects in vivo. Whereas LCMV- infected or uninfected
targets are not lysed by endogenous NK cells (32 VI-Table 5),
MCMV- i nfected ta rgets a re lysed by these effectors (VI- Ta bl e 4).
When target cells are pretreated with IFN, activated NK cells
induced during acute virus infections do not lyse norml or
LCMV- infected targets (VI-Table 9), but they do lyse VV- (VI-Table
8) or MCMV- (VI-Table 7) infected targets. These results support
the hypothesis that NK cells mediate antiviral effects in vivo by
lysing virus- infected cells, and that the failure of NK cells to
lyse virus- infected cells results in their failure to mediate
antivi ra 1 effects.
We do not know why endogenous NK cells are capable of lysing
MCMV- but not LCMV- infected targets. The lysis is detectable during
in vitro cytotoxicity assays lasting 18- 20 hours, but not in assays
of a 4 hour duration (VI-Table 4), indicating that the lytic process
may requ ire a cti va ti on of the endogenou s NK- l i ke cell s by the
virus- infected targets. Lee and Keller first showed that NK cells
lysed MCMV-infected cells during cytotoxicity assays and that this
I'ppened in the absence of IFN (41). Casali et ale (58) showed that
measles virus glycoproteins were capable of activating NK cells
: i
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independently of IFN, so it is possible that MCMV glycoproteins on
the infected target cell surface are responsible for activating NK
cell s. Ki rchner et a 1. (104) ha ve shown that i. 
p. i njecti on of
HSV- 1 inacti va ted by ul tra violet li ght can acti va te mouse peri tonea 
NK cells within hours, while no IFN is detectable in the peritoneal
fluid, suggesting that viral components themselves nay be capable of
activating NK cells in vivo, independent of 
IFN. In contrast,
LCMV- infected target cells my not be capable of activating NK cells
(32), resulting in the failure of these targets to be lysed.
MCMV- i nfected cell s a re not simply more sens1 tive than
uninfected or LCMV-infected cells to lysis by NK cells, as NK cells
al ready activated during acute LCMV or MCMV infection actually lyse
MCMV- infected cell s 1 ess effi ciently than LCMV- i nfected or
uninfected cells (36,VI-Table 1). This has been seen with several
virus-cell systems (56), and the reson for it 
is unknown, but could
be due to reduced binding of NK cells to MCMV-
infected targets, or
MCMV- induced alterations in the target 
cell membrane resulting in a
rewced ability of the target cell to trigger the NK cell lytic
mechani sm. IFN is probably not protecting MCMV-
infected ta rget
cells in our system (fibroblast targets), because IFN is not
detectable in our 1CMV-infected fibroblast cultures.
Trinchieri et al. fi rst showed that exogenously added IFN can
protect nonn 1 cell s but cannot protect VV- or influenza
virus- infected cells against NK cell-mediated lysis, nor can it
protect cells whose protein and RNA synthesis has been inhibited by
cyclohexamide and actinomycin 0, respectively 
(61). Cytopa thi c
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viruses such as VV, MCMV, and influenza alter host protein and RNA
synthesis (105), processes reCJired for IFN-mediated protection, and
therefore, cells infected with these viroses are left susceptible to
NK cell-mediated lysis. In contrast, LCMV is a relatively
. . .
non-cytopathic virus (106), and most host cell functions are left
intact. As a result, IFN protects these LCMV- infected cells, and
these cells escape NK cell-mediated lysis.
From these data, one could put forth a theoretical model
explaining why NK cells playa role against MCMV and VV, but not
LCMV. During the initial phase of a VV or MCMV infection,
vi ros- i nfected cell s may acti va te NK cell s via thei r vi ra 
glycoproteins, or by 1 oca lly inwcing IFN. NK cell-media ted lysi 
would therefore only occur in ares where virus- infected cells were
found. As the infection progresses, high levels of IFN are induced,
activating NK cells and protecting nonnl tissue against 
cell-mediated destruction, but leaving MCMV-or VV- infected cells
suscepti bl e to lysi s. In contrast, W ri ng an LCMV infection,
endogenous NK cells would not be activated by LCMV glycoproteins,
leaving LCMV-infected cells intact. As the infection progressed
high levels of IFN would activate NK cells and protect 
nonnl cells
as before, but LCMV-infected cells would be protected as well.
These data could thus explain why NK cells playa role against MCMV
and VV infections, but not LCMV infection.
The Rol e of IFN in Vi rus Infecti ons
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It is well established that endogenous IFN is very important in
providing resistance to virus infections. The most extensive
studies in this area have been done by Gresser and his colleagues
(64,65), using antibody to IFN. Injecti on of mi ce wi th thi 
antibody before infection with HSV- 1, VSV, Newcastle disease,
Moloney sarcoll, and encephalomyocarditis viruses greatly 
increses
the severity of these infections. However, the issue of whether IFN
is mediating direct antiviral effects or acting 
throgh early
nonspeci fi c defense mechani sms such as NK cell s or IIcrophages is
still not resol ved. I will restrict the discussion to interactions
between IFN and NK cells, and later between IFN and T cells.
Because IFN causes activation and blastogenesis of NK cells (32,
34),
it is likely that IFN could mediate antiviral effects by its action
on NK cell s.
The most clearcut evidence for an antiviral role of IFN
independent of NK cells is found in the LCMV system. 
The studies of
Gresser and his colleagues (107) clearly show that treatment of mice
wi th anti body to IFN drall tica lly increases LCMV synthesi s in these
mice. Our data show that injection of mice with anti-asialo GMI
totally depletes NK cell activity, while having no effect on either
IFN 1 evel s or LCMV ti ters (II). These resul ts show tha t the
anti vi ra 1 effect of IFN is independent of NK cell s in the case of
LCMV infection. The data in other viral systems is less clear
, but
the potent role of endogenous IFN against VV, MCMV, and HSV-
1 in
vivo (24, 108, 109) belies the fact that these viruses are relatively
insensitive to IFN in vitro (24). This suggests that IFN IIY be
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mediating antiviral effects via its action on host defense
mechanisms, such as NK cells, which appear to have a potent
antiviral effect against these 3 viruses (79, II, III, V).
The rela the importnce of and the interacti on between IFN and
NK cell s has been studied in the MCMV system more extensively than
in any other. Most laboratories (46 98, 108, 11 , III) agree that NK
cells may be important in the defense against MCMV, and we now have
definitive evidence showing this (V). However, the relative
importnce of IFN and whether or not it has significant NK
cell-independent antiviral effects against MCMV in vivo is
controversial. Grundy-Chalmer et al. (l08) showed a correlation
between early IFN production and resistance to MCMV, but they did
not rul e ou t that the resi stance was NK cell-mediated. au r data
(II, III) show that NK cell depletion results in up to a lOOO- fold
increase in MCMV titers despite substantial rises in IFN titer 6-
hours postinfection, thus showing that high levels of IFN in the
absence of NK cells are not correlated with protection.
Chong et al. (l09) attempted to detennine whether or not IFN
could mediate antiviral effects independently of NK cells.
Injection of antibody to IFN caused NK cell- deficient beige mice to
synthesize 3 times as nuch virus as compared to control beige mice,
when assayed at 3 days postinfection, while having no effect on the
NK ' cell activity on a per cell basis in these mice. However, these
au thors reported spl een necrosi sand 1 eu kopenia caused by anti- IFN
treatment of MCMV-infected mice, and it is therfore likely that
anti- IFN- treated mice had fewer NK cells than control MCMV- infected
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mice. Therefore the modest increse in MCMV titers caused by the
anti- IFN coul d have been due to the effect of the anti bOdy on NK
cells rather than to the elimination of an NK cell- independent
IFN-media ted antivi ra 1 effect. The bei ge mouse is an imperfect
model for NK cell depletion, as these mice exhibit significant NK
cell activity, especially during virus infection (46 II). A better
model to study this (Jestion is that of an anti-asialo GM1- treated
mouse, where total depletion of NK cell activity has been achieved,
even in the face of a virus infection (11, 111). It woul d be
interesting to see what effect anti- IFN tretment has on MCMV
replication in anti-asialo GMl- treted mice.
With regard to prophylactic treatmnt of mice with IFN before
MCMV infection, Cruz et al. (110) showed that injection of suckling
mice with IFN before MCMV challenge resulted in a modest (2- fold)
rewction in salivary gland MCMV titers 12 clys postinfection. More
importntly, they noted that IFN pretreatmnt resulted in a marked
inhibition of MCMV-induced necrosis in the liver, salivary glands,
and brown fat. It is difficult to attrioote this IFN-mediated
protective effect strictly to rec1ction in virus titers, because the
IIgnitude of the reooction was so small. In preliminary experiments
we treated adult mice with the IFN inducer poly I:C 24 hours before
challenge with MCMV. Three days later, these mice had nuch less
severe liver injury than MCMV-infected control mice, as judged by
gross examination, but the same amount of liver virus. Tt1s, IFN
may be protecting liver cells and salivary gland cells from injury,
either by direct effects on these cells (unrelated to inhibition of
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virus synthesis), or inhibition of leukocyte infiltration, or both.
I have already discussed the fact that IFN can protect nornl cells
from NK cell-mediated lysis (see previous section); perhaps this is
the mechanism by which IFN may inhibit tissue injury. It therefore
seems that IFN, while possibly having a slight NK cell- independent
antiviral role wring MCMV infection, nay play more important roles
by activating NK cells (whose antivinil effect against MCMV is
orders of mgnitude higher than any yet demonstrated for IFN alone)
and by preventing tissue injury.
IFN my also have effects on the specific imnne response
du ri ng a vi rus infection. IFN may be re~ired for the genenition of
CTL (72), and gamm IFN is produced by CTL upon recognition of
appropriate targets (111). r data show that virus-
infected
low-passage fibroblasts treated with IFN are 2 to 3 times more
susceptible to virus- specific CTL-mediated lysis as compared to
control virus- infected cells (IV-Fig. 1). The increased sensitivity
to lysis correlated with increased expression of surface H-
antigens, but not viral antigens (IV-Figs. 2 and 3). Our hypothesis
is that IFN-inclced increases in surface class I antigen expression
(112, 113) leads to increased association of these antigens with
viral antigens, creating more structures which are recognizable by
vi rus-speci fic CTL, thus increasi ng the chances that CTL will be
bound to the targets, resulting in enhanced lysis of targets. 
That
2 antigens are pivotal in this scheme is supported by the fact
that IFN had no effect on H-2 expression (IV-Fig. 3) or on
susceptibility to lysis (IV-Fig. l) of cell lines already expressing
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high levels of H-2 antigens.
These observations may be important with regard to the role of
T cells in clearance of vir\s. Since MHC class I- restricted
virus-specific T cells are known to eliminate virus in vivo 
(80), it
is possible that IFN enhances this process by incresing the
. .
sensitivity of virus- infected cells to lysis by CTL. The source of
the IFN could be vir\s-ine1ced alpha or beta, or it may be gamma IFN
proc1ced by T cells upon recognition of a target (111). T
cell-prodJced gamm IFN nay locally enhance MHC expression in focal
a reas of infection, thereby increasing' the sensi tivi ty of T cell
recognition of virus-infected tissue. Recent findings by Pfau and
his associates (107) show that IFN tretment of mice infected
intracranially with LCMV leads to increased mortality. 
Since death
in thi s system has been shown to be caused by vi rus-speci fi c 
cell- dependent destruction of brain tissue (73), it is possible that
IFN may be enhancing H- 2 antigen expression on the 
su rface of brain
tissue, leading to more destr\ction of LCMV- infected cells by
virus-specific T cells. This IFN-induced enhancement of MHC
anti gens on vi rus- infected cell s may thus possi bly augmnt 
cell- dependent immunopa thol ogy as well as T cell- dependent cl ea r-nce
of vir\s. IFN may therefore facilitate antiviral cytotoxicity by
sel ecti vely protecting uninfected ta rgets from NK cell s and by
inc1cing H- 2 expression, which could enhance surveillance by
vi rus-speci fi c T cell s.
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